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Abstract
Prostaglandins E= and Fr>- play major roles in the initiation and
maintenance o-f parturition. There is evidence that they also prime
the uterus prior to parturition. Diets high in n-3 tatty acids
have been reported to be associated with impaired parturition,
whereas uterine infection by the intracellular pathogen Chlamydia
psittaci is associated with abortion and premature labour. In each
case the course of disruption of normal parturition is unknown,
however, impaired or excessive 2—series prostaglandin production has
been postulated to play an important part.
The effect of high dietary n-3 and n-6 fatty acid intake on uterine
fatty acid composition and metabolism by desaturase, elongase,
phospholipase and cyclooxygenase enzymes was investigated. The
effect of Cj, psittaci infection on 2-series prostaglandin production
and its control was also studied. The uterine fatty acid content of
rats maintained on diets high in n-6 and n-3 essential fatty acids
(EFA) for various periods was analysed and compared with a control
group fed a normal pelleted diet. Rapid changes in uterine n-6 and
n-3 fatty acid content were observed after three weeks feeding.
However, in all three diet groups conservation of arachidonic acid
was observed, which was highest in rats fed the n-6 fatty acid diet
and lowest in rats fed the n-3 fatty acid diet. The 20C and 22C EFA
were incorporated into phospholipids to a greater extent than into
neutral lipids.
The distribution of EFA in the individual lipid classes in the three
diet groups indicated selective release of arachidonic acid and
eicosapentaenoic acid into the free fatty acid pool.
Phosphatidylethanolamine arachidonic acid levels were more
susceptible to changes in dietary fatty acid content than those of
phosphatidycholine and phosphatidylinositol. Analysis of
prostaglandins produced by uteri of rats on the three diets, by mass
spectrometry, suggested an inhibitory effect of the n-3 fatty acids
on total prostaglandin production, and the synthesis of the 3-series
prostaglandins E and F.
Pregnant sheep experimentally infected with an ovine abortion strain
of psittaci were found to prematurely release prostaglandin E^
(PGE=) into the amniotic and allantoic fluids. Impaired release of
PGE= into the utero-ovarian vein was also detected in infected
sheep. The plasma oestradiol 17f3 also increased earlier than that
of control sheep.
This study detected competetive inhibition of uterine n-6 EFA
metabolism at the level of esterification, chain elongation,
desaturation and cyclooxygenase metabolism by the dietary n-3 EFA.
In infectious abortion, abnormalities in PGE= and oestradiol 17(3
were detected. The first evidence of 3-series prostaglandin
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The importance o-f fat as an energy source has been recognised for
over 200 years, and in an empirical sense, long before. The
additional function of a certain class of lipids was identified in
the 1930's by G.Q. Burr and M.M. Burr (1929, 1930) who described
acute deficiency states induced in rats by feeding fat free diets.
These states could be reversed only by feeding certain fatty acids
in the diet. The fatty acids used by Burr and Burr to correct the
deficiency symptoms were linoleic acid and arachidonic acid and the
term vitamin F was given to them. This name was later changed to
essential fatty acids (EFA) and a number of other fatty acids have
since been added to the names of linoleic acid and arachidonic acid
in this very important group of lipids.
When an animal is deprived of EFA it develops EFA deficiency
symptoms, which have been extensively identified in the rat (table
1.1). The wide range of deficiency symptoms observed are due to
disruption of a number of EFA—mediated processes at the cellular and
tissue level. Attempts to explain all the symptoms of EFA
deficiency by the loss of one of the functions of EFA, for example
prostaglandin production, have so far been unsuccessful.
The uterus is dependent on a supply of EFA to maintain normal
functional activity. During the life of the mammal the uterus
exhibits various states of activity. Before puberty the uterus
exhibits a quiescent state, after puberty it has cyclical activity
under the control of reproductive hormones. Anabolic and quiescent
1
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Impairment of growth and weight gain
Increased water consumption
Kidney degeneration
Impaired reproductive function and sterility (male and female)
2.
states are observed during pregnancy which change to rapid and
coordinated catabolic and expulsive activity at parturition. Normal
parturition will not occur in the rat if it is EFA deficient (Deuel
et al., 1764) or if n3 fatty acids are supplied as the major EFA
source (Leat and Northorp, 1981; Leaver et al., 1986; Quakenbush et
al., 1942). Microbial infection of the uterus is another cause of
abnormal parturition, with the result often being premature birth
and abortion, or delivery of a dead foetus. Although the importance
of prostaglandins and EFA in the control of uterine activity are
recognised, less is known about uterine EFA composition, and no
reports have been published on the effect of n3 EFA on uterine fatty
acid composition.
1-2 Fatty Acids; Structure. Structural Variation. Nomenclature
and Synthesis
The fatty acid molecule consists of a chain of carbon and hydrogen
atoms with a carboxyl group at one end of the molecule and a methyl
group at the other end. The chain may contain one or more double
bonds between carbon atoms and the double bonds may have either a
cis or a trans configuration, the cis type of double bond is more
common. Fatty acids containing no double bonds are known as
saturated fatty acids, those with one double bond as monounsaturated
and those with more than one double bond as polyunsaturated fatty
acids. In describing a fatty acid with more than one double bond,
the number of carbon atoms before the first double bond counting
from the methyl end of the molecule is usually given. For example,
arachidonic acid may also be known as eicosatetraenoic acid or 20:4
n6. The last name provides the best description of the fatty acid,
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with the number be-fore the colon indicating the number of carbon
atoms in the molecule, the number after the colon indicating the
number of double bands in the molecule, and the n6 indicating that
the first double bond from the methyl end of the molecule is between
the sixth and seventh carbon atoms. Branched chain fatty acids with
carbon-hydrogen side chains, or cyclic fatty acids with carbon rings
are also found in nature, mainly in plants and microorganisms. This
study will only be concerned with the straight chain fatty acids
predominant in mammals.
In most of the metabolic reactions of fatty acids, the fatty acid is
in an 'activated' form, which is formed by the fatty acid linking to
the complex nucleotide, coenzyme A, by a thiol ester bond.
Saturated fatty acid chains are synthesised by successive
condensations of two carbon units originating from malonyl CoA by
fatty acid synthetase enzymes. Saturated fatty acids can be
desaturated within animals by desaturase enzymes. In the animal
there are three main families of long chain unsaturated fatty acids
distinguished by the position of the first double bond from the
methyl end of the molecule, these are the n3, n6 and n9 fatty acids
(see figure 1.1). Fatty acids of the n3 and n6 series cannot be
synthesised by mammalian cells and are termed essential fatty acids.
Fatty acids obtained from the diet or synthesised within the animal
cell that are unsaturated before the n9 position can be further
desaturated towards the carboxyl end of the molecule, but not
towards the methyl end. In plants the opposite is usually true with
the fatty acid being desaturated towards the methyl end. Fatty acid
synthetase and desaturase enzymes will only act on the CoA form of
the fatty acid molecule (Fulco, 1974). Due to the inability of the
4
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animal to desaturate towards the methyl end of the molecule the
different series of fatty acids are not interconvertible.
When essential fatty acids are not present in the tissue the n9
fatty acids (18:1 n9 and 20:3 n9) will accumulate. Arachidonic acid
is the fatty acid that is usually most effective in clearing EFA
deficiency symptoms (Holman et al., 1971). One of the most
important functions of arachidonic acid is as a precursor for the 2-
series prostaglandins and thromboxanes and 4-series leukotrienes.
These locally acting hormones have important effects on many
tissues, including the uterus where they are involved in the
initiation of parturition (Liggins et al., 1977; Mitchell, 1980).
The only EFA activity so far demonstrated for linoleic acid is in
the maintenance of the epidermal water barrier (Hansen and Jensen,
1985). In cats, which cannot further desaturate linoleic acid to
gamma-linolenic acid or arachidonic acid, there is some dispute as
to whether or not administration of linoleic acid will cure EFA
deficiency symptoms (MacDonald et al, 1984; Rivers et al, 1975,
1976).
Although the exact properties of the n6 fatty acids that make them
essential dietary constituents are still unclear it is established
that they are necessary for the maintenance of health in animals.
The role of the n3 essential fatty acids, however, is less clear,
a-linolenic acid will not cure EFA deficiency symptoms in EFA
deficient rats (Greenberg et al., 1950). Studies involving rats on
n3 deficient diets have failed to show development of EFA deficiency
symptoms (Tinoco et al., 1971; Tinoco et al., 1978). However, some
tissues contain high quantities of n3 fatty acids (mainly 22:6n3),
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suggesting specific roles for these fatty acids. These tissues
include the retinas of a range of animals, including humans
(Anderson, 1970), and the brain of humans (Svennerholm, 1968) and
rats (Breckinridge et al., 1973). n3 fatty acids, and in particular
22:6n3 are also tenaciously retained by animals even when on fat
free diets (Forrest & Futterman., 1972). Whether or not the uterus
retains the n3 fatty acids is not known (this has been investigated
in chapters 3 and 4). Although typical EFA deficiency symptoms do
not appear in mammals on diets lacking n3 fatty acids, some
experiments have suggested some symptoms of n3 fatty acid
deficiency. These include a lack of learning abilitiy of rats fed
low levels of n3 fatty acids (Lamptey & Walker., 1976). In contrast
to higher mammals, some fish do exhibit EFA deficiency symptoms when
deprived of n3 fatty acids (Yu & Sinnhuber, 1972). Many beneficial
effects of n3 fatty acids in mammals have, however, been reported,
including those on heart disease (Dyerberg et al., 1978; Wood et
al., 1987; Glomset, 1985) and inflammatory conditions such as
rheumatoid arthritis (Kremer et al., 1987) and psoriasis (Burton,
1989).
The major sources of the essential fatty acids are from plant oils
which provide mainly linoleic acid (18:2n6), but also gamma-
linolenic acid (18:3n6) and a-linolenic acid <18:3n3). Fish oils
are a major source of the n3 fatty acids, providing predominant1y
eicosapentaenoic acid (20:5n3) and docosahexaenoic acid (22:6n3).
In most animals (except cats, Rivers et al., 1975, 1976) the n3 and
n6 essential fatty acids can all be synthesised from their
respective eighteen carbon unsaturated fatty acids, which are a-
linolenic acid for n3 EFA and linoleic acid for n6 EFA. This
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synthesis is carried out by a series of elongase and desaturase
enzymes. Figure 1.2 shows the metabolism of the n9, n6 and n3 fatty
acids, they are all metabolised by the same or a closely related
enzyme sequence. The different fatty acids will compete with each
other for desaturation and elongation (Alfin-Slater & Aftergood,
1968; Rahm & Holman, 1964), with the affinity of the desaturase and
elongase enzymes being in the order of n3>n6>n9 (Brenner, 1974).
Mutual inhibition of the conversion of linoleic acid to gamma-
linolenic acid and eicosatrienoic acid to arachidonic acid has also
been observed (Brenner, 1969) as well as inhibition by trans fatty
acids and saturated fats (Horrobin, 1983; Brenner, 1982). The rate
determining step is the D6 desaturase conversion of linoleic acid to
gamma-linolenic acid or a-linolenic acid to 18:4n3.
1.3 The Distribution and Metabolism of the Essential Fatty Acids in
Cellular Lipids
Lipids constitute at least 507. of the mass of most animal cell
membranes. The three major types of lipid present in cell membranes
are phospholipids (the most abundant), cholesterol, and glycolipids.
Fatty acids are important constituents of phospholipids, cholesterol
esters and glycolipids and play an important structural role in the
membrane. The hydrophobic nature of the carbon chain on the fatty
acids helps to form the membrane into a bilayer with the long
hydrophobic chains of glycolipids and phospholipids pointing inward
towards each other and the polar head groups on the outside of the
bilayer. This discussion shall be mainly concerned with the fatty
acid composition of phospholipids.
8
Figure 1.2






18:2 n6 18:3 n3
delta 6 Desaturase
18:3 n6 18:4 n3
Elongase









22:4 n9 22:5 n6 22:6 n3
1
The phospholipids, for many years, were considered metabolically
uninteresting compounds playing a purely structural role in the
cellular membranes, that once incorporated during the initial growth
of the tissue exhibited very little -further turnover. Recent
studies have, however, indicated the metabolic and regulatory role
of the phospholipids. The two main types of phospholipids found in
the mammalian cell are the glycerophospholipids and the
sphingolipids. Sphingolipids generally have a low EFA content and
most research concerning EFA has centred on the
glycerophospholipids, so only these will be discused. The structure
of a typical glycerophospholipid is shown in figure 1.3.
The most common fatty acids found in animal phospholipids are
palmitic (16:0), stearic (18:0), oleic (18:ln9), linoleic <18:2n6)
and arachidonic (20:4n6> acids. The main types of phospholipid in
the mammalian cell; phosphatidylcholine (PC),
phosphatidylethanolamine (PE), phosphatidylserine (PS) and
phosphatidylinositol (PI), differ in the chemical composition of the
head group.
Phospholipids have distinct fatty acid contents. These differences
could arise either through specific incorporation of the fatty acids
by the acyl-transferases or through the diacylglycerol transferase
with acyl selectivity. Of the four major phospholipids, studies in
rat heart, cultured human keratinocytes and guinea pig uterus have
shown that PE and PC usually contain the most arachidonic acid
(Zijlstra & Vincent, 1985; Punnonen et al., 1987; Leaver & Poyser,
1981; Leaver et al., 1986). Differences in the incorporation of the
n3 and n6 fatty acids into specific phospholipids have been
10
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Figure 1.3
Figure A shows a simplified structure of a glycerophospholipid
molecule. The phospholipid contains a hvdrophilic base group,
attached at one end of the glycerol molecule (base groups may be
choline, ethanolamine, serine, inositol, inositol (monophosphate,
inositol biphosphate or inositol triphosphate). Two fatty acid
molecules form ether or ester linkages with the other two available
hydroxyl groups of the glycerol molecule. Fatty acids bound to
glycerol by ester linkages are known as acyl groups, whereas those
bound by ether linkages are either alkyl or alkenyl groups. Figure
B shows a triacylglycerol molecule with an alkenyl group at R1, an
acyl group at R3 and an alkyl group at R3- Phospholipids containing
a fatty acid bound by an alkenyl and an acyl linkage are known as
plasmalogens. Alkyl or alkenyl linkages are usually found in the 1—
position of the phospholipid with an acyl linkage in the 2-
position. The diacyl and alkenyl - acyl phospholipids are the most
common.
When giving a phospholipid its full name, the identity of the two
fatty acid molecules is given, therefore an inositol phospholipid
containing palmitic acid and arachidonic acid linked by ester
linkages would be named as follows; l-palmitoyl-2-arachidonoyl-3-sn-
phosphatidylinositol, where the sn stands for stereochemical
numbering. The carbon atom of the glycerol linked to the phosphate
group is always numbered three, and the fatty acids linked to the
other two carbons of the glycerol numbered accordingly.
Phospholipids are not essential dietary components and can be
synthesised within tissues. The glycerol phospholipid (molecule can
be divided into five different basic components; the two fatty acid
chains, glycerol, the phosphate group, and the base group. Each of
the constituents can turnover independently and so there is no one
definite route of phospholipid synthesis.
li
observed; Abeywardena et al, (1987) reported a greater displacement
of arachidonic acid by n3 fatty acids in PE of rat myocardial tissue
in rats fed on a long term saturated fat diet followed by diets
containing n3 and n6 fatty acids than other phospholipids. They
also observed preferential incorporation of docosahexaenoic acid
compared to eicosapentaenoic acid in PC, diphosphatidylglycerol and
PE with the greatest incorporation being in PE. Conservation and
specific incorporation of fatty acids in the uterus in response to
diets with differing n3 and n6 fatty acid contents is investigated
in chapters 3 and 4. Specificity of incorporation of fatty acids
into phospholipids with particular types of linkages has been
observed. Analysis of the uptake and stimulated release of
arachidonic acid from human platelets demonstrated preferential
uptake into the di-acyl class compared with the alkyl-acyl class and
preferential release from the diacyl class when stimulated by
thrombin but equal release with the alkyl-acyl class when stimulated
with calcium ionophore A23187 (Purdon & Smith, 1985). Preferential
incorporation of docosahexaenoic acid into the alkenyl-acyl
(plasmalogen) class of phospholipid above that of the alkyl-acyl
class has been reported in P388Di cells (Blank et al., 1989)
cultured in medium containing a 22:6n3 supplement, suggesting a
higher turnover rate of the plasmalogens. Further evidence for this
comes from studies on the incorporation of the fish oil fatty acids,
eicosapentaenoic acid and docosahexaenoic acid, into PE of human
platelets. Greater incorporation and replacement of arachidonic
acid and adrenic acid was found in the alkenyl-acyl class than the
diacyl class (Aukema & Holub, 1989).
The formation of fatty acid - CoA esters may play a role in specific
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incorporation. In human platelets a fatty acid - CoA synthetase
enzyme specific for arachidonic acid has been identified (Neufeld et
al., 1983). In a mutant strain of the mouse fibrosarcoma cell line
lacking this enzyme less arachidonic acid was found and
prostaglandin synthesis was lower than in the normal cell line which
contains the enzyme (Neufeld et al., 1984). Whether this enzyme
plays a similar role in other cell types is unknown.
1.4 The Enzymic Release of Phospholipid Bound Essential Fatty Acids
The turnover of fatty acids in phospholipid molecules requires the
release of fatty acids from the phospholipid molecule. The enzymes
that catalyse this reaction are known as phospholipases and include
the following enzymes; phospholipase Al, A2, B, C and D.
Phospholipase As and phospholipase C are the phospholipases most
involved in fatty acid release for prostaglandin synthesis. Two of
the major functions of phospholipases are to regulate the
composition of membrane lipids and to release fatty acids for
conversion to prostaglandins, thromboxanes, and leukotrienes (known
as the eicosanoids). Prostanoids do not occur in stored form in
tissues and the availability of the free acid precursors is thought
to be the limiting factor in their formation. This will be
discussed further in section 1.5. The levels of free fatty acids in
resting cells are usually very low (Bills et al., 1977; Marcus et
al., 1969) due to their rapid reacylation or metabolism.
Phospholipase A2 is the phospholipase upon which most interest has
centred and is usually a membrane bound enzyme, (Victoria et al.,
1971; Newkirk & Waite, 1973) although it can be found in soluble
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form (De Haas et al., 1968). Phospholipases A= release the -fatty
acid molecules -from position 2 o-f phospholipids. Fatty acids in
position 2 are predominantly unsaturated and are o-f ten eicosanoid
precursors. Therefore phospho lipase A^ activity results in a
release o-f a high proportion o-f -free fatty acids for eicosanoid
synthesis. Phospho1ipase C cleaves between the head group and the
glycerol molecule to release diacylglycerol and the phosphorylated
head group. Free fatty acids may then be released from the
diacylglycerol by diacylglycerol lipase (Bell et al., 1979) and from
the resulting monoacylglycerol by monoacylglycerol lipase (Chan and
Tai, 1981; Okazaki et al., 1981b).
Phospholipase As is largely specific for PC and PE (Jesse and
Franson, 1979; Kanagi and Koizum, 1979; Lagarde et al., 1981),
however, it may also hydrolyse PI (Hong and Deykin, 1981; Hong et
al., 1985; Emilsson and Sundler, 1984; Billah and Lapetina, 1982).
PI is the main substrate of phospholipase C (Banno et al., 1986;
Takenawa and Nagai, 1981; Wilson et al., 1984; Allan and Michell.,
1978; Kamisaka et al., 1986; Rothenberg et al., 1983), although PC
hydrolysing phospho lipases C have also teen identified in canine
myocardium (Wolf and Grass, 1985) and rabbit platelets (Hwang,
1988). Arachidonic acid may also be released from the
quantitatively minor, but metabolically active lipids
phosphatidyl inositol -4-monophosphate (PIP) and phosphatidyl inositol
-4,5-biphosphate (PIP2). These have been shown to be hydrolysed by
phospholipase C (Berridge, 1983, Downes & Wusteman, 1983). However,
these polyphosphoinositides are minor cell constituents and the
extent of the role they play in releasing arachidonic acid and other
eicosanoid precursors is unknown.
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Radiotracer studies with H1"^! and C^Hi labelled arachidonic acid
have shown that the main phospholipid sources of arachidonic acid
released on agonist stimulation vary between different species and
different tissues. In MC5-5 mouse fibroblasts the main sources
were PC and PI (Hong & Deykin, 1979), this was also true for human
platelets, (Bills et al., 1977; Bills et al., 1976; Rittenhouse-
Simmons et al., 1976) human umbilical vein endothelial cells (Hong
et al., 1985; Thomas et al., 1984), and human neutrophils (Walsh et
al., 1981). However, in porcine aortic endothelial cells (Hong &
Deykin, 1981) the main source was PE and PI, in MDCK cells it was
PC, PI, PE and PS (Daniel et al., 1981), and in human lymphocytes it
was PI (Parker et al., 1979). In human foetal membrane at term PE
and PI were found to be the main sources of arachidonic acid (Qkita
et al, 1982), whereas, in the guinea pig uterus, radiotracer studies
suggested PC, PE and triglyceride were the major sources of free
arachidonic acid (Ning et al., 1983). In chapter 4 the arachidonic
acid content of major lipids in the rat uterus has been
investigated.
Phospholipases A= specificity for fatty acids in phospholipids has
been observed. Bills et al. (1977), using human platelets found
that phosphatidylcholine hydrolysis occurred only in arachidonic
acid containing molecules and Qkazaki et al. (1978) identified
phospholipase A^ specific for PE with arachidonic acid in the sn-2
position in human foetal membranes. Evidence of specificity for
ether or diacyl phospholipids has also been found. Jesse and Cohen
(1976) analysed the lysophophatidylethanolamine produced from PE in
human platelets along with fatty acid release and found it to
contain virtually no fatty aldehydes. This led the authors to
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believe that phospholipase was specific for diacyl phospholipids
and not plasmalogens. Rittenhouse-Simmons et al. (1976) reported a
rise in C^HD radioactivity in alkenyl PE after thrombin activation
in human platelets prelabelled with C^HIl arachidanic acid. They
suggested that arachidanic acid might be transferred to the alkenyl
PE from other phospholipids and that the alkenyl PE serves as the
donor of arachidonic acid for eicosanoid synthesis. However, such
transfer has not been observed in other types of cells (Hong &
Deykin, 1979; Weithman et al., 1989; Schremmer et al., 1979).
The disintegration of membrane structure observed in necrotic and
other autolytic processes (including parturition) involving the
activation of tissue phospholipases indicates the importance of
control of phospholipase activity. Factors involved in activation
and control of phospholipase activity include; association with 6-
proteins (Billah and Siege1, 1987; Nakashima et al., 1989), platelet
activating factor (Nakashima et al., 1989), protein kinase C
(Emilsson et al., 1986) regulation by Car2- concentration,
diacylglycerol and phorbol myristate acetate (Emilsson et al., 1986;
Emilsson and Sundler, 1986), influence of hormones, and regulation
by changes in membrane structure (Vogt, 1978). Phospholipase A2 can
be activated by addition of calcium to isolated membranes (Derksen &
Cohen, 1975), or by the addition of calcium ionophore to platelets
(Pickett et al., 1977) and uterus (Leaver and Richmond, 1984).
Stimulation of prostaglandin production in the rat uterus by the
calcium ionophore A23187 is discussed in chapter 5. Hormones have
also been shown to stimulate some phospho1ipases A2 (Haye et al.,
1973). In the uterus, steroid hormones are known to regulate
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prostaglandin release (Leaver and Seawright, 1982; Roberts et al.,
1975), however, it is not known whether or not this is through
control of phospholipase activity. Oxytocin, calcium ionophore
A23187, endotoxin, and mechanical stimulation of the uterus have
also been found to increase prostaglandin release from the uterus
(Leaver and Seawright, 1982; Roberts et al., 1975), however, only in
the case of A23187 has evidence suggested that this is achieved
through the release of substrate for prostaglandin synthesis (the
control of prostaglandin release in the uterus is discussed in
section 1.8). The hydrolysis of PI-4,5-P= by phospholipase C has
been suggested to be the initial event in phospholipase activation
in stimulated cells (Hong, 1988). This may occur through the
activation of phospholipase C by G-proteins (Cockcroft and Gomperts,
1985; Uhing et al., 1985), with the phospholipase C releasing
diacylglycerol and inositol phosphates that will in turn increase
calcium levels (Berridge, 1983). The calcium and diacylglycerol
could then act synergistically to activate phospholipase A2.
1.5 The Prostaglandins : Synthesis and Functions
Prostaglandins were first isolated by Bergstrom and Sjovall in 1957,
who isolated PGEi, and PGF1o< in crystalline form. Prostaglandins
are synthesised from three different essential fatty acids, giving
rise to three distinct series of prostaglandins, depending on the
number of double bonds in the molecule. One-series prostaglandins
are synthesised from dihomo-gamma-linolenic acid (20:3n6), two-
series from arachidonic acid (20:4n6) and three-series from
eicosapentaenoic acid <20:5n3). It is also now known that the 22C
fatty acids docosatetraenoic acid (22:4n6> and docosahexaenoic acid
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(22:6n3> can be converted to prostaglandins (Sprecher et al., 1982;
Ferretti and Flanagan, 1986; Mai et al., 1981), however, little is
yet known about the activity of these prostaglandins.
The fatty acids are converted to prostaglandins by cyclooxygenase
enzymes (Van Dorp et al., 1964; Ferretti and Flanagan, 1986; Weber
et al., 1986). Figure 1.4 shows the structure of the 1, 2, and 3
series E and F prostaglandins produced from the three different
precursor fatty acids. PGE and PGF are necessary for the induction
of uterine contractions during parturition (Embrey, 1969; Liggins et
al., 1973) and impaired prostaglandin production may delay or
prevent normal parturition (Mitchell, 1980; Leaver et al., 1986;
Olsen et al., 1986).
Eicosanoids are involved in the activity of blood cells such as
platelets (Marcus, 1978), monocytes, macrophages, and neutrophils
and they have effects on aspects such as vasal tone (Needleman et
al., 1979; Knapp et al., 1986), inflammation (Pelus and Strausser,
1977; Burton, 1989; Tate et al., 1989; Kremer et al., 1987; Leslie
et al., 1985), and immunosuppression (Erickson, 1986). Many of the
effects of the 1,2 and 3-series prostaglandins oppose each other and
this principle has been used to try and cure or alleviate the
symptoms of a number of diseases partly or wholly caused by
imbalanced prostaglandin production.
The n3 fatty acids will inhibit the desaturation and elongation and
the uptake into phospholipids of n6 fatty acids (see sections 1.2
and 1.3). This is also true with the production of prostaglandins,
where the three different fatty acid precursors will compete with
each other for the cyclooxygenase enzymes. The non-essential fatty
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FIGURE 1.4





















acid, 20:3 n9, which accumulates in essential tatty acid deficiency,
is also known to block prostaglandin production (Okazaki & Araki,
1974; Okazaki & Araki, 1978).
Eicosapentaenoic acid has been shown to block oxidation of
arachidonic acid by the cyclooxygenase enzymes in human platelets
(Culp et al., 1979; Morita et al., 1983b), cultured vascular smooth
muscle cells (Morita et al., 1983a) and uterus (Leaver et al.,
1986). Species difference in the inhibition caused by EPA have also
been observed (Morita et al., 1983b), with much greater inhibition
in human platelets than in rat platelets. There are also species
differences in the ability to convert EPA to 3-series
prostaglandins. In human and rabbit smooth muscle cells and bovine
endothelial cells EPA was converted to 3-series PG, but in murine
and porcine smooth muscle cells, and rat platelets no conversion to
3-series prostaglandins was observed (Morita et al., 1983a). In
view of the inhibitory effects of the n3 fatty acids on parturition
it is important to know to what extent the uterus will produce the
3-series prostaglandins as this may be one of the causes of the
inhibition. In chapter 5, 3-series prostaglandin production by the
uteri of rats maintained an diets with varying n3 and n6 fatty acid
contents has been analysed.
1.6 The Role of Essential Fatty Acids in Parturition
The metabolism of arachidonic acid during early parturition is shown
in figure 1.5. The importance of EFA and their metabolites in
parturition has been illustrated by the inability of EFA deficient
rats to undergo normal parturition (Deuel et al., 1964, Houtsmuller,
1981). The major role of fatty acids in parturition is probably in
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Figure 1.5
The metabolism of arachidonic acid during early parturition,
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prostaglandin synthesis, demonstrated by the inhibition of
parturition caused by eyelooxygenase inhibiting drugs such as
indomethacin. This demonstrates that even in the presence of normal
cellular levels and normal release of free fatty acids from
intracellular stores, if prostaglandin synthesis is inhibited,
normal parturition will not occur. Columbinic acid (18:3; 5 trans,
9 cis, 12 cis) is not converted to prostaglandins but it will
alleviate many of the symptoms of EFA deficiency, however rats
maintained on an EFA deficient diet supplemented with columbinic
acid are unable to undergo normal parturition (Houtsmuller, 1981).
The effects of the n3 fatty acids on parturition were first
demonstrated by Quackenbush et al. in 1942, who found that linoleic
acid and arachidanic acid would support normal parturition.
However, if a-linolenic acid was given as the only source of
essential fatty acid the rats had major difficulties in initiating
and sustaining labour, despite only slight abnormalities in weight,
implantation and gestation being observed in the rats. The uteri of
the n3 fed rats were found to be thin, flacid and lacking tone, and
vaginal bleeding was observed. Foetal mortality was high in n3 fed
animals, but if Caesarian section was carried out early in labour
live animals were delivered (Leat & Northrop, 1980). Leat and
Northrop (1979) suggested that the inhibitory effect of a-linolenic
acid on parturition was due to inhibition of conversion of linoleic
acid to arachidonic acid, thus inhibiting production of the
prostaglandin initiators of parturition, PGE= and PGF^-,. Qlsen et
al. (1986) have suggested that the high intake of marine fat by
Faroese women inhibits 2-series prostaglandin production, resulting
in increased gestation time compared to women from Denmark. Fish
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oil diets have also been found to inhibit parturition in rats
(Leaver et al., 1986; Leaver et al., 1989) and will cause prolonged
gestation, foetal death, extended duration of labour and vaginal
bleeding. Showing that even when n6 fatty acids are present,
inhibition of their metabolism by high levels of the n3 fatty acids
will still prevent normal birth, this was found in a fish oil diet
having an n3/n6 ratio of 6.28 (Leaver et al., 1989). PGE=
measurements made on intrauterine tissues obtained during
parturition showed significantly lower levels (P <0.05) in fish oil
fed rats compared to those fed on evening primrose oil or a control
pelleted diet (Leaver et al., 1986). The inhibition caused by the
fish - oil diet suggested that the n3 inhibition was not due to the
total loss of n6 fatty acids but was more likely to be due to
inhibition of processes such as incorporation into phospholipids,
desaturation, elongation, release from esterified stores, and
prostaglandin formation by the n6 fatty acids. These studies
indicate the importance of studying replacement of n6 fatty acids by
n3 fatty acids in uterine tissue in relation to dietary fatty acid
content and parturition.
Mating, pregnancy rate and number of pups per litter were unaffected
by a fish oil diet (Leaver et al., 1986), despite the fact that
prostaglandins are thought to play a role in ovulation and
implantation (Poyser, 1981). The fact that the n3 fatty acids did
not affect these processes may suggest that they required lower
levels of 2-series prostaglandins for their normal functioning or
that 3-series prostaglandins produced from the n3 fatty acids were
able to substitute for the 2-series prostaglandins in regulating
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these processes. Arachidonic acid and prostaglandins are released
in quantities 2 to 3 times greater at parturition than at ovulation,
implantation or lactation (MacDonald et al., 1974; Poyser, 1981;
Bussman & Deis, 1979; Ogburn et al., 1980; Leaver et al., 1987).
Measurements of 3-series prostaglandins have not previously been
made in the uterus of the rat, however, renal tissue in the rat is
known to synthesise 3-series prostaglandins (Kivits and Nugteren,
1988; Gallon and Barcelli, 1986). Their activity in stimulating
uterine contractions and other processes necessary for normal
parturition are unknown. The profound effects of the n3 fatty acids
on parturition illustrate the importance of studying their
incorporation into the uterus and their effect on levels of n6 fatty
acids, and in particular arachidonic acid.
Essential fatty acids may have further roles to play in parturition
apart from acting as precursors for prostaglandin synthesis (see
table 1.2). Large amounts of arachidonic acid are released at
parturition and these quantities are far in excess of the quantities
required for prostaglandin production. Protein kinase C is known to
control certain contractile proteins and enzyme activities (Preiss
et al., 1987; Bell, 1986) and arachidonic acid and diacylglycerols
can activate protein kinase C (Sekiguchi et al., 1987). The lyso-
phospholipid, platelet activating factor (PAF), has potent
contractile effects on smooth muscle (Findlay et al., 1981) and an
increase in PAF in human amniotic fluid at parturition has been
reported (Billah & Johnston, 1983). PAF availability is regulated
by a phospholipase A^ with arachidonate selectivity (Hanahan, 1986).
PAF can also stimulate Ins-1,4,5-P3 release in platelets and
leucocytes (Shukla et al., 1987), and if it has a similar effect on
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Thorburn (1979); Leat (1981).
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Nishizuka (1988)
Okazaki (1981); Ning (1983); Leaver
(1983); MacDonaId (1987)
DiRenzo (1981); Leaver (1981, 1985)
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uterine tissue, the Ins-1,4,5-P3 induced release o-f calcium may in
turn activate phospholipases, resulting in increased prostaglandin
production.
1.7 Control of Prostaglandin Production in the Uterus of the Sheep,
the Rat and the Woman.
During pregnancy the uterus synthesises increased quantities of
prostaglandins from precursor fatty acids (Dray and Friedman, 1976;
Keirse et al., 1983). Two prostaglandins have been identified to
have an important role in the control of parturition, these are
prostaglandin E2 and prostaglandin (Dray and Friedman, 1976).
In the sheep, the rat and man increased levels of PGE= and PGF-^.-, are
thought to be the main stimulus for the initiation of parturition,
but in each case the mechanisms controlling prostaglandin production
differ.
1.7.1 Control of Prostaglandin Production in the Uterus of the Sheep
In the sheep the main sites of prostaglandin production are maternal
cotyledons, where production is thought to be under the control of
the steroid hormones; progesterone and oestrogen, oxytocin may also
exert its effect on parturition through prostaglandins (Roberts et
al, 1975). Oestrogen is thought to stimulate prostaglandin
synthesis (Roberts et al, 1975), whereas progesterone is thought to
inhibit its release (Liggins et al, 1973). Oestrogen levels
increase sharply at term (Challis, 1971), whereas progesterone
levels decline towards term (Thorburn et al, 1972).
The key role of prostaglandins in mediating the action of oestrogen
and progesterone has been illustrated by Mitchell and Flint (1978).
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The administration of meclofenamate, an inhibitor of prostaglandin
synthesis, to pregnant sheep prevented the premature delivery of a
live foetus in response to intrafoetal dexamethasone infusion.
Despite the anticipated rise in oestradiol and fall in progesterone,
no increase in uterine activity occurred, indicating that changes
in steroid hormones are inadequate to cause delivery if
prostaglandin synthesis is blocked.
In a reciprocal study, PGF^ infused into the aorta of pregnant
sheep, at rates comparable to the production rates at term,
stimulated uterine contractions similar to those normally seen at
term (Liggins et al., 1973). Maternal plasma progesterone and
oestradiol levels were unaltered during the infusion, again
indicating that the major role of the steroids is to modulate
prostaglandin synthesis, and that this role can be bypassed with
exogenous PGF^. The ability of oxytocin to stimulate uterine
contractions is also thought to be mediated through prostaglandins.
Oxytocin has been shown to stimulate prostaglandin production (Flint
et al, 1975; Roberts et al, 1975).
In conclusion, progesterone, oestrogen and oxytocin, in the sheep,
control levels of prostaglandins during parturition, and either an
increase in oestrogen or a decrease in progesterone can initiate
parturition through stimulation of prostaglandin production.
However, it seems most likely that the stimulus required to induce
production of sufficient levels of prostaglandin to initiate
parturition is a lowering of the progesterone: oestrogen ratio below
a critical level and possibly also for a critical period of time
(Taylor et al, 1982; Mitchell et al, 1983; Roberts et al, 1975).
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However, little is yet known about the cellular mechanisms by which
the hormones control ovine prostaglandin release.
1.7.2 Control of Prostaglandin Production in the Uterus of the Rat
In the rat uterus the major site o-f prostaglandin synthesis is the
endometrium (Williams et al., 1974). The control o-f prostaglandin
production in the uterus of the rat resembles that of the sheep in
its oestradiol and progesterone dependence (Thorburn, 1979 for
review). As in the sheep, oestradiol stimulates prostaglandin
production in the uterus, whereas progesterone prevents this
stimulation (Ham et al., 1975; Castracane & Jordan, 1976). However,
in contrast to the sheep, progesterone does not appear to inhibit
prostaglandin release or myometrium stimulation (Fuchs, 1974). The
mechanism of action of oestrogen and progesterone on prostaglandin
synthesis and release in the rat uterus is unknown, however, an
inhibitory effect of oestrogen and a stimulatory effect of
progesterone on prostaglandin degradation by 15-hydroxyprostaglandin
dehydrogenase (PGDH) has been observed (Flower, 1977). Little
information is, as yet, available on phospholipase activity in the
uterus of the rat. Evidence has suggested that prostaglandin
synthetase may play a role in controlling the level of
prostaglandins in the rat uterus, with increasing prostaglandin
synthetase activity being observed with advancing pregnancy
(Williams et al., 1974; Williams & Vane, 1975). It has been
suggested that lysosomal lability may be increased by the newly
formed prostaglandins, leading to a rise in phospholipase A2
activity. Therefore, increasing the synthesis of prostaglandins may
initiate a positive feedback system stimulating a further increase
28
in prostaglandin release (Thorburn and Challis, 1979).
Oxytocin will also stimulate prostaglandin production in the rat
uterus, however, as with oestrogen and progesterone little is known
about the mode of stimulation. The role of phospholipase and
cyclooxygenase activity in control of prostaglandin production in
the rat uterus requires investigation. In chapter 5 the effect of
phospholipase activation by intracellular calcium on rat uterine
prostaglandin production has been investigated.
1.7,3 Control of Prostaglandin Production in the Uterus of the Woman
Although much research has been carried out on the control of
prostaglandin production in the uterus of the woman, it is
possibly the least understood of the three species discussed here.
Progesterone and oestrogen appear to play a lesser part in
controlling prostaglandin production in humans than in the rat and
the sheep. No abrupt changes of either progesterone or oestrogen
are observed at the onset of labour (Turnbull et al., 1974), and
human labour cannot be induced by oestrogen treatment (Pinto et al.,
1967; Larsen et al., 1973). There is evidence that prostaglandins
have an important place in the physiology of human labour, both PGE=
and PGF^ will stimulate uterine contractions and they are also
known to soften and ripen the cervix prior to parturition (Liggins
et al., 1977).
In humans the main sites of prostaglandin synthesis are thought to
be the foetal membranes and the deciduum and the main control
mechanisms appear to be local mechanisms acting on these tissues.
The foetal membranes and decidua contain glycerophospholipids that
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are highly enriched with arachidonic acid (Olund and Lunell, 1979;
□kita et al., 1982; Okazaki et al., 1978; Okazaki et al. , 1981b) and
the specific incorporation of arachidonic acid into the foetal
membranes has been detected late in pregnancy (Das et al, 1975),
increasing the potential for prostaglandin synthesis.
The release of the fatty acid prostaglandin precursors from cellular
stores (mainly membrane phospholipids) is thought to be the major
controlling factor in prostaglandin synthesis (section 1.5). This
is probably also true of prostaglandin synthesis by uterine and
foetal tissues. MacDonald et al (1974) found that women injected
with arachidonic acid into the amniotic sac underwent abortion,
suggesting that the major control of prostaglandin synthesis was
not at the level of the cyclooxygenase, at least during late
gestation.
In many tissues, phospholipases are lysosomal enzymes and their
activity depends on release from the lysosome. This led Gustavii
(1972) to propose a 'lysosomal theory' of parturition in which a key
role in the initiation of parturition is attributed to lysosomes of
the deciduum. According to Gustavii, the deciduum becomes rich in
lysosomes which are maintained in a stable state by the presence of
stabilisers, particularly progesterone. The onset of labour is
precipitated by labilising influences that cause leakage of
lysosomal enzymes, including phospholipase A2, into the cytoplasm.
The increased activity of phospholipase A2 causes accelerated
deacylation of phospholipids at the sn-2 position which leads in
turn to the release of fatty acids, including arachidonic acid
resulting in increased prostaglandin production. In support of this
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hypothesis, Brunk and Gustavii (1973) found that the lysosomes of
decidual cells are unusually fragile and leak their contents when
subjected, in vitro, to slight physical stress that has no
discernable effect on other tissues. Also, decidual cells obtained
at elective Caesarian section at term showed marked degenerative
changes and signs of release of the lysosomal enzyme, acid
phosphatase into the cytoplasm (Gustavii, 1975).
The Gustavii theory was further extended by Schwarz et al., (1974)
who found a progesterone binding protein in the cytosol of foetal
membranes, the concentration of which increased towards term. This
led to the proposal that a specific progesterone binding protein
appears in the cytosol of foetal membranes near term and competes
with lysosomes for progesterone. As a consequence, the lysosomes
become more unstable and their contents leak out. The cause for the
rapid accumulation of progesterone binding protein is unknown.
Phospholipase A2 activity with specificity for arachidonic acid in
human foetal membranes has been identified by Qkazaki et al (1978).
Phosphatidylinositol specific phospholipase C activity has also been
demonstrated in human foetal memranes and decidua vera (Di Renzo et
al, 1981) and diacylglycerol lipase and monoacylglycerol lipase
enzymes with specificity for glycerol with arachidonate in the sn-2
position have also been found (Okazaki et al, 1981b). These results
are consistent with those of Okita et al (1982), who found that at
term, arachidonic acid was specifically released from PE and PI.
The specificity of these enzymes for arachidonate containing lipids
may account for the increases in arachidonic acid concentration
observed in amniotic fluid of women during labour (MacDonald et al,
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1974), which coincided with increases in PGF^ concentrations.
Other -fatty acids were -found to increase less strikingly.
There is some evidence tor control of prostaglandin production at
other levels than the phospholipase. A prostaglandin synthetase
inhibitor has been tound in human amniotic fluid (Saeed et al,
1982). Potency ot the inhibitor was significantly less during
labour than it was at term before the onset of labour. This
suggests that, throughout gestation, substances in amniotic fluid
may suppress the production of prostaglandins by foetal membranes.
The substances may be secreted into the amniotic fluid in foetal
urine (amniotic fluid consists mainly of foetal urine). The
inhibitory activity of these substances may be overcome at term by
the foetus secreting substances into the amniotic fluid that
stimulate prostaglandin synthesis. A substance in human foetal
urine that will stimulate bovine prostaglandin synthetase activity
has been found (Strickland et al., 1983). Samples from foetuses
after spontaneous vaginal delivery were found to have more stimulant
activity than those from foetuses at term before the onset of
labour. These results could explain the decrease of prostaglandin
inhibitory activity in the amniotic fluid observed during labour.
Foetal urine has also been found to stimulate PGE^ synthesis in
cultured human amnion cells, but not in endometrial stromal cells,
glandular epithelium, endometrial carcinoma cells, myometrial cells,
or adipose tissue stromal cells (Casey et al., 1983). This suggests
that the stimulant activity may be specific for tissues involved in
prostaglandin production at parturition. Prostaglandin synthetase
activity has also been found to be significantly higher in amnion
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■from women obtained after the spontaneous onset of labour compared
to amnion from women obtained at elective Caesarian section before
the onset of labour (Okazaki et al., 1981a).
One other possible level at which prostaglandin synthesis may be
controlled is at the level of fatty acid incorporation into
phospholipids. Specific incorporation of arachidonic acid into
phosphatidylethanolamine and phosphatidylcholine has been observed
in human amnion (Schwartz et al., 1977). Arachidonic acid levels
have been observed to increase with gestation in cholesterol esters
of amniotic fluid (Das et al., 1975), and it has been suggested that
the specific incorporation into PE and PC may also occur late in
pregnancy (Liggins et al., 1977). Since these may be major sources
of arachidonic acid released for the stimulation of parturition, the
incorporation of arachidonic acid into these phospholipids in
sufficient levels could be an important factor in the production of
sufficient quantities of prostaglandin for the stimulation of
parturition.
In parturition the prostaglandins must travel a much greater
distance from their sites of synthesis to the target tissues (the
foetal membranes and uterine decidua to the myometrium and uterine
cervix respectively) than in other aspects of placentation (Wickland
et al., 1984; Ellwood, 1980). Therefore, at parturition
prostaglandin E and F appear to act in a more 'hormonal' capacity
than in other prostaglandin mediated processes, diffusing locally
into the myometrium and cervix, and coordinating, and possibly
inducing, labour by an extracellular, rather than an intracellular,
mode of action. This may allow greater diversity in modes of
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control of prostaglandin levels reaching their target tissues than
in other processes involving prostag1 and ins.
1.8 Chlamydia, Infectious Abort ion and Prematura Labour
Microbial infection is a common cause of abortion and premature
labour (Silver et al., 1986) and one of the infectious agents knowi
to cause abortion in a number of species, including sheep (Studdert,
1968; Novilla & Jensen, 1970) and man. (Jolrison et al.. 1985) are
tlte microorganisms of the genus Chlamydia. Cross - species
infectivity from sheep to man can also occur (Roberts et al., 1967).
Ttiere is widespread distribution of Chlamydiae in both slieep (McEwen
et al., 1951; Studdert & Mckercher, 1968) and man (Sweet et al..
1987) and Chlamydiae are now known to be tlie most common sexually
transmitted organism in the USA, with more than three million
infections occurring each year (Scfiachter, 1978). There are two
different species of the genus Chlamydia; C. trachomatis and C.
psittaci. Chlamydiae are spread mainly by three metlTods; by direct
contact by uninfected persons with eye secretions from infected
carriers, sexual intercourse, or by infection of an infant during
passage through an infected mothers birth canal. Hosts can be
infected by Chlamydiae for long periods of time witliout any apparent
ill effects. The Chlamydiae also have a remarkable ability to evade
the hosts' immune system.
Chlamydiae are intracellular parasites that have two distinct forms
during their life cycle; tlie elementary and reticulate bodies. The
elementary body is spherical and surrounded by a rigid trilaminar
cell envelope similar in composition to tttose of gram-negative
bacteria, except that the cell walls do not exhibit characteristic
endotoxic properties. The elementary body is specially adapted to
extracellular survival and is the infectious form of the organism,
entering new cells by phagocytosis. The elementary bodies remain
within the phagosome where they somehow manage to prevent lysosome
fusion. Within 6 to 8 hours after phagosome formation, the
elementary bodies undergo a conversion to the second form of the
organism, the reticulate body. After 12 hours, binary fision of
reticulate bodies begins and from 20 to 24 hours reticulate bodies
begin to convert back into elementary bodies. After about 40 hours
the host cells begin to die and host cell lysis occurs, releasing
the Chlamydiae. It has been suggested that host cell lysosomes
release into the cytoplasm hydrolytic enzymes that digest host cell
constituents with consequent membrane lysis and release of
Chlamydiae (Todd & Storz, 1975).
Although cell envelopes of the elementary bodies do not have
endotoxic properties, live elementary bodies exhibit toxicity, the
source of which is unknown. The reticulate body is non-toxic, and
this may account for the organisms ability to live for long periods
in the host without causing any apparent ill effects. Signs of
infection often only manifest themselves when the host organism is
subjected to stress, nutritional deprivation, or other traumatic
events, indicating a delicate balance between host defence and
chlamydial pathogenicity. This is also observed during pregnancy,
Chlamydiae being latent until late pregnancy. Treatment of
chlamydial infection is usually with the drugs chloramphenicol,
tetracyc1ine, and rifamein.
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Although infection by Chlamydiae is now known to cause abortion
(Studdert, 1968; Studdert and Mckercher, 1968; Aitken, 1986; Johnson
et al., 1985) little is known about how it causes this. One likely
route is by altering the balance of hormones, such as progesterone,
oestrogen, oxytocin, and prostaglandins, which control the onset of
parturition under normal conditions. However, very little research
has, as yet, been conducted on the effect of chlamydial infection on
these hormones (Martel et al., 1983; Rank et al., 1982), although a
recent report suggested elevated PGF^, metabolite concentrations in
the plasma of four sheep infected with C^_ psittaci (Fredriksson et
al., 1988). In chapter 6 the effects of infection by psittaci on
PG£3, progesterone and oestradiol 17fl production in pregnant ewes
has been investigated.
1.9 Aims of the Project
The project attempted to answer the following questions:
a) What effects do dietary n3 and n6 fatty acids have on the fatty
acid composition of the uterus?
b) To what extent will n3 fatty acids replace n6 fatty acids in
uterine tissue when given as the predominant dietary fatty acid
source?
c) Do the 20C and 22C n3 fatty acids replace arachidonic acid in
the uterus?
d) How quickly does the uterine fatty acid composition respond to
changes in dietary fatty acid content and do rats of different
ages have different fatty acid composition and metabolism?
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e) Is there selective incorporation of fatty acids into specific
lipid pools?
f) Does the uterus specifically incorporate, and/or synthesise
arachidonic acid?
g) Does the uterine fatty acid composition and response to dietary
fatty acid intake change with age?
h) Does the uterus produce the 3-series prostaglandins?
i) What effect does infection by an ovine abortion strain of
Chlamydia psittaci have on the release of prostaglandins and





2.1 Rats and Diet
Female Sprague - Dawley rats were used in all experiments. Animals
were fed either a normal pelleted rat diet (CRM Diet, BSS Ness,
Edinburgh, Scotland) or a semisynthetic diet supplemented with one
of five different essential fatty acid preparations, which were
administered orally at a dose of 1.5 pl/g body wt/day. Animals were
divided into different age groups. Adult rats were maintained on
the diet from weaning (21 days) until they were between 151 and 586
days old. Young rats were maintained on the diet from weaning to
42-49 days old. The normal pelleted control diet consisted of fat,
8 en'/.; protein, 20 en'/.; carbohydrate, 72 en'/.. The essential fatty
acid content of the control pelleted diet consisted of approximately
0.8 en'/, of n6 fatty acids and 0.01 en'/, of n3 fatty acids as a
proportion of the total calorific value of the diet. The semi¬
synthetic diet had the following composition: fat approximately
16.5 en"/., of which 13.5 en"/, was saturated fat (hydrogenated coconut
oil, Pilsbury's, Birmingham, UK) and approximately 3 en'/, was
essential fatty acid supplement; protein 15.7 en'/, (fat-free casein,
BDH, Poole, UK); Carbohydrate 68.7 en"/, (sucrose; British Sugar PLC,
Peterborough, England) with non-digestible fibre (cellulose 11.02
g/kcal, kaolin 5.5 g/kcal; both Special Diet Services, Cambridge,
UK); DL-methionine (2.6 g/kcal; BDH, Poole, England); Vitamin premix
(2.76 g/kcal) and mineral premix (12.9 g/kcal) (both Special Diet
Services, Cambridge, UK). The percentage fatty acid composition of
the hydrogenated coconut oil was C12:0, 55.0"/.; C14:0, 18.9"/.; C14:l,
0.17'/.; C16:0, 7.94"/.; C16:l, 0.32Z/.; C18:0, 7.0'/.; C18:l, 2.4'/.;
C18:2n6, 0.76'/.; C18:3n3 , 0.034'/.; C18:3n6, <0.017.; C18:4n3, <0.017.;
C20:0, 0.016'/.; C20:l, 0.058'/.; C20:4n6 , 0.058'/.; C20:5n3, <0.017.;
C22:0, <0.01"/.; C22:5n3, <0.017.; C22:6n3, <0.017..
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The five different essential fatty acid supplements were; MaxEPA
(Seven Seas Health Care Ltd, llarfleet, Hull), Hi-EPA, evening
primrose oil (both Efamol Ltd, Guildford, Surrey), linoleic acid
ethyl ester and a-linolenic acid ethyl ester (both >79"/. pure,
supplied by Nu-Chek Prep, Elysian, MN, USA). Supplements were
stored under nitrogen to avoid oxidation. Energy content of EFA in
the different diets were as follows: Linoleic ethyl ester
supplemented diet contained 3.11 en"/. n6 fatty acids and 0.006 en"/. n3
fatty acid; linolenic ethyl ester supplemented diet contained 0.11
en"/. n6 fatty acid and 3.006 en"/. n3 fatty acid. Fish oil (F0) and
evening primrose oil (EP0) supplemented diets contained
approximately 3 en"/, essential fatty acids.
The growth rate and consumption of diet was not significantly
different in rats fed the semisynthetic diets with different EFA
supplements. There was also no significant difference in weight
between rats on the control and the semisynthetic diets.
2-2 Killing of Rats and Uterus Excision
After being on a diet for the required time, rats were killed by
cervical dislocation. One of two procedures was then adopted. If
the uteri were to be used for measurements of prostaglandin
production they were excised under sterile conditions (care being
taken to remove any adipose tissue from the uterus) and placed
separately into pre-weighed vials containing 5 mis of sterile medium
199 with Hanks salts (Flow Laboratories, Irvine, Scotland) and
uterine weights were recorded. If uteri were only to be used for
fatty acid analysis then sterile conditions were not used for
uterine excision and excised uteri were placed in a pre—weighed vial
39
containing 5 mis analar methanol (BDH Ltd, Poole, England) and
sealed under nitrogen and stared at -30"C. The weight of each uterus
was recorded by weighing the uterus in the pre—weighed vial then
subtracting the weight of the vial.
2.5 Tissue Culture
Excised uteri in medium 199 (as described above) were transferred to
60 x 15 mm sterile culture dishes (Sterilin, Feltham, UK) containing
3 mis of sterile medium 199 and the tissue cut into 2 mm slices
under sterile conditions. Some of the uteri were also incubated
with culture medium containing 5 ug/ml of the calcium ionophore
A23187 (Sigma Chemical Co., Poole, England). Tissue explants were
cultured in a CQ^ incubator at 37*C for 15 hours with the medium
renewed at 30 mins, 3 h and 15 h.
2.4 Extraction, F\irification and Separation of Prostaglandins
The prostaglandins released into the medium were extracted
immediately by adjusting the agueous phase to pH4 and extracting the
acidic prostanoids into ethyl acetate (4 fold volume) (Rathburn
Chemicals, Walkerburn, Scotland). The extraction was carried out
three times and the ethyl acetate was evaporated. The prostaglandin
extract was resuspended in water:methanol (20:1, v:v) and absorbed
on C18 Sep-Pak columns (Waters, Millford, Mass., U.S.A.) pre-washed
with 20 mis of methanol, then 20 mis distilled water. Polar
material was eluted using 10 mis of ethanol:water (15:ICO, v:v).
Prostaglandins were eluted with 5 mis of ethyl acetate. Samples were
taken to dryness under a vacuum and resuspended in a mixture of
analar chloroform (BDH Ltd, Poole, England):methanol (2:1, v:v) and
applied in a line to 20x20 cm thin layer chromatography (t.l.c.)
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aluminium sheets coated with silica gel 60 (E. Merck, Darmstadt,
West Germany). Prostaglandin standards were also suspended in
chloroformzmethanol <2:1, v:v) and were applied as spots on one side
o-f the t.l.c. plate. PGE3 and F3,.-< standards were from Upjohn Ltd,
Crawley, England, Et and F^, standards were from Cayman Chemical
Co., Ann Arbor, Michigan, U.S.A. The solvent system used was
Acetone : Ethyl Acetate: Acetic Acid (75:25:1, v:v). The solvent
was allowed to move up the plate until it almost reached the top
(approximately 1 hour).
The strip of the t.l.c. plate containing the standards was cut from
the plate and developed in iodine vapour. fV values were calculated
for the standards (E^/Et, 0.81; F 0.69). Areas corresponding
to these FV values on the part of the t.l.c. plate containing the
sample were scraped into glass vials containing 6 mis chloroform-
methanol (2:1, v:v), the vials shaken thoroughly and then
centrifuged at 300 xg for 5 mins in an M.S.E. benchtop centrifuge
(Fisons Scientific Equipment, Crawley, England). The supernatants
were decanted into pear shape flasks and the procedure repeated
twice more. Extracted prostaglandins were sealed under nitrogen and
stored at —30*C.
2.5 Conversion of PGE to RGB
Conversion of PGE samples and standards to PGB was carried out by
incubation at room temperature with 2 mis of aqueous 1M K0H (BDH,
Poole, England) for 45 mins (Bergstrom et al., 1963). The reaction
mixture was then adjusted to pH 3-4 using acetate buffer and the PGB
extracted twice with glass distilled grade diethyl ether (Rathburn
Chemicals Ltd, Walkerburn, Scotland). To ensure that the E to B
conversion was taking place the reaction was monitored using a Cary
model 118 U.V. spectrophotometer (Palo Alto , California, USA) at
280 nm absorption. Maximum conversion of E to B was observed after
45 mins of reaction time.
2.6 t-RjC of FOB
Some of the PGE samples, after conversion to PGB, were further
purified by high pressure liquid chromatograohy (HPLC). The HPLC
used was a Gilson model 303 pump and Gilson model 802 manometric
module controlled by an Apple II E computer (Apple Comp. Ltd,
Cupertino, CA, USA), with a Partisil Px5 10/25 PAC column (Whatman
Inc, . Clifton, New Jersey, USA), equilibrated overnight with HPLC
grade dichloroethane (Rathburn Chemical Co., Walkerburn, Scotland):
methanol (100:1, v:v) at a flow rate of 0.5 mls/min. PGB samples
were injected and eluted in the same solvent at a flow rate of 1
ml/min. A Perkin Elmer LC55 Spectrophotometer (Beaconsfield,
Bucks, England) at 278 nm was used to detect the elution of the PGB,
along with a Servoscribe Is chart recorder (Belmont Instruments,
Glasgow, Scotland). PGB standards were run prior to samples to
obtain elution times of PGB (figure 2.1 shows HPLC of PGB^).
2.7 Derivatisation of Prostaglandins
(a) Trimethylsilyl (TMS) derivatives
Prostaglandin standards and samples were methylated by addition of a
few drops of diazomethane (generated from "Diazold" - Aldrich
Chemical Co. Ltd, Gillingham, Dorset, England) in ether to the dry
prostaglandin in an eppendorf tube (Brinkmann Instruments Co.,
Westbury, N.Y., U.S.A.). The tube was shaken and the diazomethane-
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Figure 2.1
HPLC of 20 |jg of standard PGB^. Conditions were as
described in section 2-6. Chart paper speed was 0.5
cms/min.
ether evaporated by a stream of nitrogen. Ketone groups of E
prostaglandins were converted to butoxime groups by addition of 5
drops of butoxylamine (prepared by Dr N. H. Wilson by the method of
Fujii et al, 1967) in pyridine (5 mgs/ml) (Aldrich Chemical Co,
Gillingham, Dorset, England) fol lwed by incubation for l'<6 hours at
60*C. Pyridine was then evaporated under a stream of nitrogen. 25
pis of bis-(trimethylsilyl)trifluoroacetamide (BSTFA) (Sigma
Chemical Co., Poole, England) was added to all prostaglandin samples
and standards and incubated for 15 minutes at 60"C. Figure 2.2
shows an outline of the preparation of prostaglandin TMS
derivatives.
(b) Tertbutyldimethylsilyl (TBDMS) Derivatives
TBDMS derivatives were prepared as for TMS derivatives, except that
instead of adding TMS, the TBDMS derivative was created by the
addition of 2 drops of 4M immidazole (Aldrich Chemical Co. Ltd,
Gillingham, Dorset, England) in dimethylformamide (DMF) (Aldrich
Chemical Co. Ltd, Gillingham, Dorset, England), followed by 2 drops
of 2M tertbutyldimethylsilyl chloride (Aldrich Chemical Co. Ltd,
Gillingham, Dorset, England) in DMF and the mixture incubated at
100'C for 1 hour. The derivatised prostaglandin was removed from
the DMF by shaking the solution with 0.5 mis of distilled water and
0.5 mis of glass distilled grade ether (Rathburn Chemicals Ltd,
Walkerburn, Scotland). The top layer of ether, containing the
derivatives, was aspirated and the ether extraction repeated once
more. Before injection into the gas chromatograph (GC), the ether
was evaporated under a stream of and the sample resuspended in 50
mis HPLC grade hexane (Rathburn Chemicals Ltd, Walkerburn,
Scotland). Butylboronate derivatives were formed when using some
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Figure 2.2
Formation of Me,TMS and Me,BuO,TMS Derivatives
It is essential to form a derivative of the prostaglandin which has
the correct volatility and a high thermal stability.
(a) Methylation
The PG is treated with diazomethane to produce the methyl ester.
0 o
» II
r—c—oh + ch2n2 r — c - och3 + n2
(b) Butoxime formation
Prostaglandins with ketone groups (such as PGE) usually have the
ketone group converted to an alkyloxime group prior to mass







(c> Addition of TMS
Diazomethane does not attack hydroxyl groups to form the methyl
ester in the absence of a catalyst. However, a number of compounds
(known as silylating agents) readily form trimethylsilyl esters with
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(d) Addition of TBDMS
The TBDMS creates a heavier derivative than TMS which gives it a
greater retention time in the GC. This may allow for greater
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(e) Formation of Butylboronate Derivatives
F prostaglandins may form very high mass derivatives with TBDMS-C1
due to their having three hydroxy1 groups. This often makes GC
retention times impractically long. If lighter derivatives are
desirable then the two cis-hydroxyl groups of the cyclo-pentane may




CH3b or C4H9B RB + H20
V
PGF samples to reduce the retention time of the sample in the GC.
The boron conjugates were formed by the addition of 5 drops of n-
butyl boronic acid (Aldrich Chemical Co. Ltd, Gillinghamm, Dorset,
England) before addition of TBDMS at a concentration of 5 mgs/ml in
2,2 dimethoxypropane (Aldrich Chemical Company Ltd, Gillingham,
Dorset, England) and the sample incubated at 60*C for 1-2 hours.
Figure 2.2 shows an outline of the preparation of prostaglandin Me,
n-butylboronate TBDMS derivatives.
2.8 Analysis of Prostaglandins by Combined Gas Chromatography -
Mass Spectometry
Analysis was carried out using a Rye Unicam 2000M gas chromatogram
and a VG Analytical Micromass 7070F mass spectrometer (MS). The GC
was fitted with a fused silica DB1 capillary column (J and W
Scientific, Rancho Cordova, California, USA). GC conditions were as
follows: Injector temperature - 250"C; detector temperature, 250*C;
column temperature, 180" - 280*C with 1 min initial time then
rising at 4"C/min. Three different types of detection were used
with the mass spectrometer, these were total ion detection (TID),
single ion monitoring (SIM) and multiple ion detection (MID).
(a) TID
TID monitors all the ions produced in a sample at any one time.
This system is often not sensitive enough for use with biological
samples as the substance for analysis is often lost in contaminating
material eluting at the same time.
(b) SIM
SIM allows the mass spectrometer to monitor for one single ion or a
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small range of ions. This means that the recorder will only show a
peak when the particular ion that the mass spectrometer is set for
is detected, this allows for greater sensistivity. When monitoring
with either TID or SIM, prostaglandin standards were run first to
give a retention time for the different prostaglandins. Samples
were then run and spectra taken when peaks appeared at the correct
time. Spectra were taken as the pen reached the top of the peak.
Ions monitored for under SIM were as follows:
(1) Me,TMS derivatives
PGE= - 512, 295









The MID system allows for very accurate detection of a number of
different single ions simultaneously. It operates by locking a
channel onto a known ion, either produced by one of the samples
being analysed or produced by a standard that may be injected
directly into the M.S. detector. In the case of PGB (Me,TBDMS)
derivatives the 405 PGB^ ion was used in the lock channel, whereas
for PGF (Me,TBDMS) derivatives either the PGF^-, 653 ion or the 614
ion of heptacosafluorotributylamine (Aldrich Chemical Co. Ltd.,
Gillingham, England) was used in the lock channel. Other channels
were then set to monitor ions produced by the sample. As the ions
produced by the sample are detected, the M.S. locks itself onto the
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signal, using the standard substance as a reference, to produce a
very accurate measurement of the quantity of sample present. By
monitoring for more than one ion, ratios of one ion to another can
be obtained to give evidence for the presence of different
substances. For example, the procedure for detecting the presence
of PGF-z,x and PGF-^ was as follows. After setting the channels
appropriately and injecting the standard substance a known quantity
of PGF^ (Me,TBDMS> was injected. The channels were set to monitor
the 653 (Fi,3) and the 651 (F.^) ions. When these ions were detected
a multi-penned chart recorder recorded the size of each signal with
a separate pen for each ion. Although the 653 ion is the major ion
for F^ there is also a small 651 ion produced. A retention time
was obtained for standard F^ (which was the same for F-^) and a
proportion obtained of 651/653 ions taking the 653 ion as 10O*/.. If
the calculated proportion for the 651 ion in the sample was the same
as that for standard F=,^ then this suggests there is no present,
however, if the 651 proportion increased then this provides evidence
for the presence of PGF3,*.
The main advantages of MID above SIM are that more than one ion can
be monitored very accurately without interference from other ions.
The main disadvantage is that full mass spectra cannot be taken when
MID is in operation.
2-9 Uterine Lipid Extraction
Uteri were placed in a mortar and pestel containing C17:0 internal
standard (Sigma Chemical Co.j Poole, Dorset, England) and
chloroform: methanol (2:1, v:v). The uteri were then pulverised and
the chloroform - methanol mixture poured through a glass wool filter
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into a pear-shape flask. The mortar and pestel were washed four
times with chloroform: methanol (2:1, v:v) and filtered into the
f1ask.
2.1Q Neutral Lipid and Phospholipid Separation by Silicic field
Column Chromatography
Glass columns were packed with 4g Unisil silicic acid (Clarksan
Chemical Co. Inc., Williamsport, USA) suspended in ether. Columns
were then dehydrated with 20 mis ether, followed by 20 mis ether :
acetone (1:1, v:v) (glass distilled grade - Rathburn Chemicals Ltd,
Walkerburn, Scotland), followed by a further 60 mis of ether. The
sample was added to the top of the column in 1 ml of ether. The
tube that contained the sample was washed twice with 1 ml of ether
and the ether added to the column. Neutral lipids were washed from
the column with 30 mis of ether, 30 mis of methanol were then used
to wash the phospholipids from the column.
The efficiency of the separation was tested as follows: 20 mgs of
standards of both dioleic PC (approximately 15 mgs of which was
fatty acid) and free oleic acid (both Sigma Chemical Co. Poole,
Dorset, England) were run on separate columns and neutral lipid and
phospholipid fractions collected from both columns. Fractions were
then dried under a vacuum and hydrolysed and methylated as described
in section 2.15. 4 mgs of heptadecanoic acid methyl ester (Sigma
Chemical Co. Poole, Dorset, England) were then added to each
fraction and gas chromatography carried out on the samples by the
method described in section 2.17. The quantity of
phosphatidylcholine recovered was calculated from the quantity of
fatty acid detected by the GC, assuming that 15 mgs of the 20 mgs of
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phosphatidylcholine was fatty acid, and using the C17:0 internal
standard to calculate the total quantity of lipid recovered in each
fraction. The results are shown in table 2.1.
Due to the poor recovery of phospholipid from the column two further
experiments were tried to see if any improvement could be made. The
first involved attempting to wash the phospholipids from the column
with a 0.57. acetic acid (BDH Ltd, Poole, England) - methanol mixture
instead of 1007. methanol. The second experiment involved removing
the silicic acid from the column after the neutral lipid fraction
had been collected and attempting to hydrolyse the phospholipids
from the silicic acid by incubating it in 8 mis 0.5M Aristar grade
KQH (BDH Ltd, Poole, England) in methanol for 1 hour at 60*C.
However, neither of these methods significantly improved
phospholipid recovery.
2.11 Two Phase System -for Separation of Neutral Lipids and
Phospholipids
A two phase system was also used for the separation of neutral
lipids and phospholipids. The two phases were 10 mis 667. HPLC grade
ethanol (Rathburn Chemicals Ltd, Walkerburn, Scotland) in distilled
water with 10 mis hexane, mixed in a pear-shaped flask. The lipids
were added in 1 ml of the ethanol - water mixture and the flasks
shaken thoroughly. The phospholipids separated into the ethanol -
water layer and the neutral lipids into the hexane layer. The
hexane layer was then aspirated into another pear shape flask and a
further 10mIs hexane added to the ethanol - water mixture and the
extraction repeated. The neutral lipids were extracted into hexane
a total of four times.
Lipid Fraction ! mgs f.a. recovered ! 7. of total f.a. !










Oleic acid 18.76 93.8
neutral lipid fraction
Table 2.1
Recovery of phospholipids and neutral lipids after silicic acid
chromatography. 20 mgs of dioleoyl phosphatidylcholine and 20 mgs
of oleic acid were separated in a glass column packed with 4 g of
silicic acid. Oleic acid was eluted with 30 mis of diethyl ether
and phosphatidylcholine was eluted with 30 mis of methanol. Eluted
phosphatidylcholine was hydrolysed with alkali and fatty acids
methylated with boron trifluoride in methanol. Fatty acids
recovered from the column were identified and quantified by GC
analysis using heptadecanoic acid as an internal standard.
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The separation of the neutral lipids and phospholipids was tested
using C1-14C3 stearic acid (neutral lipid) or 1-palmitoyl -2- Cl-
1'^CD palmitoyl phosphatidylcholine (phospholipid). Both were from
Amersham International PLC, Amersham, Bucks, England. 1.85 KBq 1^C
Stearate or 1.16 KBq of phosphatidylcholine (PC) were added to
the two phase system and the extraction completed as described
above. The two phases were then taken to dryness under a vacuum and
resuspended in 4 mis NE266 scintillation fluid (Nuclear Enterprises,
Edinburgh, Scotland) and radioactivity measured in an LKB Wallac
1216 Rackbeta II beta counter (Turku, Finland) (see table 2.2).
The results show that the separation was successful except for
approximately 107. of the phospholipids separating into the hexane
fraction. This would clearly contaminate the fatty acid
measurements made of the neutral lipids so it was decided to repeat
the extraction but this time the ethanol - water phase contained
0.57. analar acetic acid (BDH, Poole, England) to enhance
phospholipid ionisation and so decrease solubility in the hexane
fraction. The results from this experiment are shown in table 2.3.
The acetic acid decreased the quantity of phospholipid in the hexane
fraction to around 87., to further reduce this, silicic acid
chromatography, as described in section 2.1, was used. To test the
purification after silicic acid chromatography, an experiment using
the two phase system was set up as before, except that only 1'*C PC
was used and after separation the hexane layer was evaporated under
a vacuum and resuspended in ether and applied to a column as
previously described. Neutral lipids were then washed from the





cpm ! 7. of total !
! sample recovered!
PC No-1 hexane fraction ! 702 ! 10.4 :
PC No-2 hexane fraction ! 733 : 12 :
PC No-1 ethanol-water fraction ! 5716 : 89.i :
PC No-2 ethanol-water fraction ! 5389 : 88 :
Stearate No-1 hexane fraction ! 17848 ! 98.4 !
Stearate No-2 hexane fraction ! 20892 ! 98.5 !
Stearate No-1 ethanol-water fraction ! 294 I 1.6 !
Stearate No-2 ethanol-water fraction ! 322 : 1.5 !
Table 2.2
Recovery of phospholipids and neutral lipids after two phase
separation. 1.85 KBq of 1"*C stearate and 1.16 KBq 1"VC labelled
phosphatidylcholine were added individually to two phase separation
systems containing 10 mis 667. ethanol in distilled water and 10 mis
hexane. Stearate was extracted into the hexane fraction four times.
Radioactivity in each phase for both samples was measured in a






cpm ot total !
!sample recovered!
PC No—1 hexane traction ! 962 ! 7.5 i
PC No—2 hexane traction ! 1131 ! 7.9 !
PC No—1 ethanol-water traction ! 11867 ! 92.5 :
PC NO-2 ethanol-water traction ! 13164 ; 92.1 :
Stearate No-1 hexane traction ! 16138 ! 99.7 :
Stearate No-2 hexane traction ! 16799 : 99.8 :
Stearate No-1 ethanol-water traction ! 54 : 0.3 :
Stearate No-2 ethanol-water traction ! 31 ! 0.18 :
Table 2.3
As -for table 2.2, except that the ethanol
0.5'/. acetic acid.
- water traction contained
evaporated under a vacuum and the sample resuspended in 4 mis
scintillant and cpm measured. The column removed nearly all the
phospholipid that was present in the hexane -fraction with greater
than 997. of the recovered radio label being in the ethanol-water-
acetic acid fraction (the results are shown in table 2.4).
The recovery of the phospholipid and neutral lipid from the
different fractions was tested by measuring the cpm for 1.16 KBg
PC and 1.85 KBq 1-*C stearate after they had been extracted by the
two phase separation followed by silicic acid chromatography for the
neutral lipid, and comparing this with the same quantities of 14C
stearate and 1"*C PC placed directly into scintillant and counted on
the beta counter. The recovery was found to be 85-907. for the
phospholipid and 90-957. for the neutral lipid.
2.12 Separation of Neutral Lipids by Thin Layer Chromatography
A solvent system of petroleum spirit : ether : acetic acid
<75:25:1, v:v) was used for separating the neutral lipids. Uterine
neutral lipids that had been isolated by the two phase system
followed by silicic acid chromatography were suspended in chloroform
: methanol (2:1, v:v) and applied to 0.2 mm thick silica gel 60
t.l.c. plates in a line as described in section 2.3. Standards of
cholesterol, triglyceride, free fatty acid, diglyceride and
monoglyceride were applied as spots on one side of the plate. After
developing the plate the different neutral lipids were identified
and extracted by the procedure described in section 2.3. Neutral
lipids were separated into the following four fractions; cholesterol
ester and triglyceride, diglyceride, monoglyceride and a free fatty
acid fraction (FV values are shown in table 2.5).
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PC No-1 hexane fraction after
chroma tog raphy
30 0.3
PC No-2 hexane fraction after 37 0.4
chromatography
Table 2.4
Phospholipid recovered in the ethanol water fraction after two phase
separation and in the neutral lipid fraction after silicic acid
chromatography. The two phase separation was carried as described
in the legend for table 2.2. The hexane fraction was dried in a
vacuum and resuspended in ether and added to a glass column
containing 4 g silicic acid. The column was then washed with 30 mis
diethyl ether and radioactivity in this fraction measured in a































FV values for monoglycerides, diglycerides, triglycerides, free
fatty acids and cholesterol esters. Lipids were separated on an
aluminium t.l.c. plate coated with silica gel 60 using a solvent
system of petroleum spirit : ether : acetic acid (75:25:1, v:v).
Lipids were visualised with iodine vapour.
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2.15 Separation of Phosphalipids by Thin Layer Chromatography
A solvent system was required that would separate phophatidylcholine
(PC), phosphatidylethanolamine (PE), phosphatidylserine (PS),
phosphatidylinositol (PI), phosphatidylinositol monophosphate (PIP)
and phosphatidyl inositol triphosphate (PIP3). Standards of the above
phospholipids (all from Sigma Chemical Co. Ltd, Poole, Dorset,
England) were run on t.l.c. plates using different solvent systems
to try and obtain the best separation of the phospholipids.
Aluminium backed silica gel 60 high performance t.l.c. (h.p.t.l.c.)
plates (E. Merck, Darmstadt, West Germany) were used for the
phospholipid separation. These were sprayed with a methanol - water
mixture (3:2, v:v) containing 17. 'analar' potassium oxalate (BDH
Chemicals Ltd, Poole, Dorset) then dried overnight in a drying
oven. Standards were spotted onto the plate and separated in a
solvent system of chloroform : acetone : methanol : acetic acid :
water (40:15:13:12:8, v:v, Jolles et al., 1981). When the solvent
front had nearly reached the top of the plate the plate was
removed from the solvent and phospholipids visualised in iodine
vaspour. The solvent system gave a reasonable separation of all the
phospholipids except for PC and PI which ran a similar distance on
the plate. To solve this problem it was decided to try and first
separate the major phospholipids (PC, PE, PI and PS) using a solvent
system of chloroform : methanol : ammonia (Analar; BDH, Poole,
England) (65:35:5, v:v). Then to separate the PIP and PIP^ with a
different solvent system. Normal t.l.c. plates that had not been
treated with the potassium oxalate solution were used for the first
separation and h.p.t.l.c. plates that had been treated with
potassium oxalate were used for the second separation. The
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chloroform-methanol-ammonia solvent system succes-fully separated PC
and PE, however, PS and PI did not separate (FV values are shown in
table 2.6). Therefore, PS and PI would have to be separated on the
2nd t.l.c. along with the PIP and PIP3. A number of slightly
different solvent systems were then tested for their ability to
separate the four phospholipids. The solvent systems are shown in
table 2.7.
K and L were found to adequately separate all the phospholipids,
with K giving slightly better separation than L. It was therefore
decided to use K for the separation of uterine phospholipids (FV
values for phospholipids using solvent system K are shown in table
2.8). The uterine phospholipids were applied to the t.l.c. plates
as previously described and were separated alongside standards as
before, first on the chloroform - methanol - ammonia system, after
which the PC and PE were detected and removed as in section 2.4.
The PI, PS, PIP and PIP3 were then separated, on the h.p.t.l.c.
plates that had been treated with potassium oxalate, using solvent
system K and were extracted from the plates.
2.14 Lipid Hydrolysis and Methylation
All lipid samples (except free fatty acids) that were to be analysed
by gas chromatography were hydrolysed and methylated according to
the procedure of Leaver and Poyser (1981). This was as follows:
Solvents were vacuum evaporated from samples and 3 mis 0.5 M KQH in
methanol added and the flasks purged with nitrogen and stoppered.
Flasks were shaken and incubated at 60"C for 10 mins. Heptadecanoic
acid methyl ester was added at this point as an internal standard in






Phosphatidylinositol Monophosphate ! 0.12




Rp- values for phospholipids separated on an aluminium backed t.l.c.
plate coated with silica gel 60, using a solvent system of
chloroform : methanol : ammonia (65:35:5, v:v>. Phopholipids were
visualised with iodine vapour.
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A ! 25 : 0 : 15 : 4 : 2 :
B ! 40 : 15 ! 13 : 12 : 8 :
C ! 40 : 16 : 8 ! 8 : 4 !
D ! 40 ! 20 ; 10 ! 10 : 6 :
E ! 40 ! 18 ! 10 : 8 : 6 :
F ! 40 : 23 : 10 : 10 : 8 :
G 1 40 : 26 ; 10 ! 12 : 8 :
H : 40 : 20 10 : 10 : 8 !
I ! 40 ! 21 : 10 : 10 : 10 !
J : 40 ! 20 : 10 : 11 : 6 !
K : 40 : 20 ! 12 : 11 : 7 :
L ! 40 : 21 : 13 : 12 : 8 :
Table 2.7
Solvent systems tested tor separation o-f PS, PI, PIP and PIP;* by
t.l.c. Aluminium backed silica gel 60 high performance t.l.c.
plates pretreated with 17. potassium oxalate were used -for
separation. Samples were applied in chloroform - methanol (2:1,









Rr- values for phospholipids separated on aluminium backed silica gel
60 high performance t.l.c. plates, pre-treated with 17. potassium
oxalate in a methanol-water mixture (3:2, v:v), using a solvent
system of chloroform : acetone : methanol : acetic acid : water
(40:20:12:11:7, v:v). Iodine vapour was used to visualise
phospholipids.
lipid, 0.6 mgs; phospholipid, 0.5 mgs; neutral lipid, 0.1 mgs; PE,
0.2 mgs; PC, 0.2 mgs; PI, 0.05 mgs; triglyceride-cholesterol ester,
0.1 mgs; diglyceride, 0.05 mgs; monoglyceride, 0.05 mgs; -free -fatty
acid, 0.01 mgs. 3.5 mis boron tri-Fluoride (BDH, Poole, England) was
then added, the flasks purged with nitrogen again and stoppered and
shaken. After incubation at 60*C for a further 5 mins, 3 mis
saturated sodium chloride solution and 10 mis 40-60* petroleum
spirit (glass distilled grade, Rathburn Chemicals Ltd, Walkerburn,
Scotland) were added. The flasks were shaken thoroughly and the
petroleum spirit, containing the fatty acids, aspirated into pear
shape flasks. Petroleum spirit extraction was repeated a further
three times. Samples were then taken to dryness in a vacuum and
resuspended in a small volume (approximately 250 pi) of h.p.l.c.
grade hexane (Rathburn Chemicals Ltd, Walkerburn, Scotland).
2.15 Free Fatty Acid Methylation
Free fatty acid samples were placed in small glass test tubes
(volume 5 mis) and taken to dryness under a stream of nitrogen and
five drops of diazomethane added. The tubes were gently shaken for
approximately 20 seconds and the diazomethane evaporated under a
stream of nitrogen. The samples were then resuspended in 250 pi of
hexane.
2.16 Gas Chromatography
Samples in hexane were injected into a Pye 204 gas chromatograph
with flame ionisation detector fitted with a 15 metre DB wax bonded
carbowax capillary column (J and W. Scientific, Rancho Cordova,
California, USA). Helium (British Oxygen Corporation, Guildford,
England) was used as a carrier gas (5 ml/min). Injector and
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detector temperatures were 175 and 250*C respectively. Oven temperature
was programmed at 180"C -for 1 min, then rising to 230*C at 4*/min, where
the temperature was maintained until the sample, was -fully eluted. Fatty
acids detected were recorded on a Venture Servoscribe Is chart recorder
(Belmont Instruments, Glasgow) and a supergrator 1A integrator (Kentronix
UK Ltd, Compton, Berkshire, England). Fatty acid methyl esters -from
samples were identified by comparison with retention times of standards
(some short chain fatty acids that were commercially unobtainable as
standards were tentatively identified by extrapolation from graphs of
carbon number against log retention time of standard fatty acids). Each
sample was analysed in duplicate and fatty acid percentages and quantities
taken as the mean of the two results obtained. The mean variation for a
large peak (6-1Z/.) measured ten times in duplicate was 0.87. + 0.6, the
mean variation for a small peak (0.1-17) was 10.57. + 6. Figure 2.3 shows
the GC separation of fatty acid standards.
2.17 Experimental Infection of Sheep
Twenty-two Scottish Blackface ewes were infected by subcutaneous
innoculation with between 0.45 x 10<fa and 0.5 x 104* egg LD-so(ELD30) of an
ovine abortion strain (no. S26/3) of psittaci between day 90 to 115 of
pregnancy. Uninfected pregnant ewes were used as controls. The number of
foetuses was determined in all animals between day 60 to 80 of gestation
using ultrasonography, and at birth. Infection and sampling of sheep was
carried out by I.D. Aitken, B.W. Appleyard, I.E. Anderson, G. Jones, L.A.
Hay, G.E. Williams and D. Buxton of the Moredun Research Institute.
2.18 Amniotic, Allantoic and Utero-Ovarian Vein Samples for PGE^> Assays
Twelve Scottish Blackface ewes were implanted with indwelling
catheters into the amniotic and allantoic cavities and into the
utero-ovarian vein on day 113 of gestation (Mel lor DJ, 1970;
Mellor DJ, 1980). Amniotic and allantoic sacs of each foetus were





Separation of methyl ester fatty acid standards by gas
chromatography. See section 2.16 for GC conditions. Chart
speed was 0.5 cms/ min.
Peaks numbered in A and B correspond to the following fatty
acids:
A- peak 1, 16:0; peak 2, 18:0; peak 3, 18:ln9; peak 4,
18;2n6; peak 5, 18:3n3.
B- peak 1, 18:4n3; peak 2, 20:4n6; peak 3, 20:5n3; peak 4,
22:6n3.
Column number of theoretical plates = 58774.
fob
30-40 ml balloon; Eschmann, Sussex, England). A utero-ovarian vein
was also catheterised using 1.4 mm external diameter vinyl tubing
(Portex Ltd, Kent, England). A two-way luer stopcock was attached
to each catheter. Vascular catheters were sampled daily and flushed
with a heparin saline solution (SO I.U. ml-1 preservative-free
heparin; Evans Medical, IXinstable, Beds) twice daily. Blood was
placed into tubes containing 2 I.U.ml-1 preservative-free heparin,
and plasma was prepared by centrifugation of the heparinised sample
at 2000xg for 10 minutes. All plasma samples were stored at -40"C.
Peripheral plasma samples were taken from the jugular vein and
prepared and stored as for the utero—ovarian vein samples. Small
samples (0.5-2 ml) of amniotic and allantoic fluids were withdrawn
using minimal suction. Sterility within each 2-way tap was
maintained by twice daily flushing with thiomersal solution,
consisting of thiomersal 0.1"/. alcohol (British Drug Houses, Poole,
Dorset): acetone: ethanol (1:500:500, v:v). On day 115 of
gestation, six ewes were infected by subcutaneous injection of 4.5
x 1055 ELDso of an ovine abortion strain of psittaci, and six
controls injected with sterile saline. Single samples of amniotic
fluid, allantoic fluid or utero-ovarian vein were taken from each
sheep on alternate days up to day 130 of gestation, and daily from
day 130 until parturition. Occasionally, it was not possible to
withdraw samples on the required day, particularly from the
allantoic cavity, due to catheter blockage. Amniotic fluid and
allantoic fluid was placed immediately into 10 mis of analytical
reagent grade methanol, and stored at -40*C. Samples which were
stained with blood or meconium (Leaver et al., 1988) were discarded.
Utero-ovarian plasma (0.2 mis) was immediately extracted using 2 mis
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of redistilled diethyl ether, vortex mixed, then immersed in
acetone/dry ice until the aqueous layer was frozen. The organic
layer was decanted, and the extraction was repeated three times.
The extraction of PGEs; was 94-99"/. using this technique. Samples
were stored at -40 *C before radioimmunoassay. The mean duration of
gestation was 144.5 +1.1 days in the control group, and 141.3 +1.8
days in the infected group, and the difference between these
gestation periods was not significant. In the control group, three
of the ewes had twins and three had single lambs, and in the
infected group, four of the ewes bore twins and two bore single
lambs. In the Chlamydia-infected group, two out of ten lambs were
born . dead: one of twin lambs was dead on delivery, and another,
single lamb, died of asphyxia during delivery. In the control
group, all nine lambs survived.
2.19 Peripheral Plasma for Progesterone Assays
Six ewes were infected on day 90 of gestation by subcutaneous
injection with 5 x 10= ELDso of C^_ psittaci strain no. 26/3, and six
control ewes were injected with sterile saline. The mean duration
of gestation + SE in control sheep was 144.7 + 1.08 d (n=6), range
144-149 d, and in psittaci-infected sheep, 137 + 1.6 d (n=6),
range 132-142 d. Only sheep with single lambs were used, as twin
pregnancies are associated with higher progesterone levels, which
are not directly proportional to the number of lambs (Bedford et
al ., 1972; H.A. Leaver, unpublished observations). Blood was
withdrawn at 3 day intervals from the jugular vein of infected and
control sheep up to day 110 of gestation and at 2 day intervals
after day 110, and placed into tubes containing 2 I.U. ml-1
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preservative—free heparin (Evans Medical, Dunstable, Beds). Plasma
was prepared by centrifugation of the heparinized sample at 5000
r.p.m. for 10 min. All plasma samples were stored at -40*C.
Progesterone concentrations were expressed as the means ± SE in
samples of plasma taken from 3 to 6 individual control or infected
sheep on the same day of gestation.
2.20 Peripheral Plasma Samples for □estradiol 17B Assays
Oestradiol 17(3 was analysed in peripheral plasma samples collected
from sheep used for progesterone and PGE^ samples (see above). In
the sheep used for PGE= sampling, blood was withdrawn from the
jugular vein at 24 h intervals during the last three days of
gestation, and placed into tubes containing 2 I.U. ml-1
preservative-free heparin (Evans Medical, Dunstable, Beds). Plasma
was prepared by centrifugation (see above) and stored at -40*C.
Oestradiol 1713 concentrations were expressed as pg ml-1 + SE in the
plasma of control or infected sheep, sampled on separate days before
parturition.
2.21 Utero-Ovarian Venous Plasma. Amniotic Fluid and Allantoic Fluid
Samples from Gatheterised Animals for Oestradiol 17(3 Assays
The intrauterine distribution of oestradiol 17(3 during chlamydial
infection was analysed in the six control sheep injected with
saline, and in the six sheep infected with 5x10= ELD^o of C.
psittaci strain S26/3 on day 115 of gestation that were used for
PGE2 samples (see section 2.19).
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2.22 Prostaglandin E= Radioimmunoassay
A double antibody radioimmunoassay was used, the procedure -for which
was as -follows. Standard PGE= (Upjohn, Crawley, England) was
prepared in HEPES buffer <pH 7.4) in triplicate at doubling
concentrations from 0.0025 ng/ml to 2.56 ng/ml. These standards
were used for production of the standard curve. Samples suspended
in solvent (methanol for amniotic and allantoic samples, ethyl
acetate for utero ovarian vein) were added in triplicate to 3 ml
plastic tubes (Sarstedt, Numbrecht, West Germany - also used for
standards) and the solvent dried under a stream of nitrogen. The
sample was resuspended in 250 pi of buffer. To each, tube was added
50 pT of rabbit anti-PGE= antibody (Institut Pasteur, Paris)
followed by 50pl of PGE= tracer [5,6,8,11,12,14,15 (n)-3HD
(Amersham International PLC, Buchinghamshire, England) which had
been diluted in buffer to give a concentration that would provide
approximately 1500 cpm per 50 pi aliquot in 3 mis scintillation
fluid. The tubes were vortexed and left to incubate at room
temperature. After 2 hours incubation 50 pi of a 1/140 dilution of
normal rabbit serum (Scottish Antibody Production Unit, Law
Hospital, Carluke, Scotland) and 50 pi of donkey anti-rabbit serum
(also Scottish Antibody Production Unit) were added. After
overnight incubation at 4*C the tubes were centrifuged at 4*C for 30
mins at 1800xg in an M.S.E. Coolspin Centrifuge (Fisons Scientific
Equipment, Crawley, England), the supernatant discarded and the
pellet resuspended in 3 mis NE 266 scintillation fluid (Nuclear
Enterprises, Edinburgh, Scotland). Each tube was counted for 10
minutes in an LKB Wallac Rackbeta II beta counter (Turku, Finland).
In addition to tine Pasteur anti-PGE^ antibody one other anti-PGE^
antibody was tried in the assay, which was a monoclonal antibody
donated by Dr Ivanyi, Wellcome Laboratories. However, this antibody
was -found to have very high cross reactivity and produced very high
estimates o-f PGE= in the samples so it was decided only to use the
Pasteur antibody (Cross reactivity o-f the Pasteur antibody is shown
in table 2.9). Problems also arose, however, with the Pasteur
antibody. Different batches o-f the Pasteur antibody were found to
have widely differing binding activities with twice the quantity of
antibody being required from some batches compared to others to
maintain a 507. bound figure for the assay zero standard. Of the
different batches of lyophilised Pasteur PGE= antibody used, lots D;>
and Dt- were suspended in 11 mis buffer and lots D12 and D13, due to
reduced binding activity, were suspended in only 5.5 mis buffer.
Different dilutions of donkey anti-rabbit serum (DARS) were tested
to find the concentration that gave approximately 507. binding of ^H
PGE;* in the zero standard, again of two different batches used
different activities were observed, as shown in table 2.10. A 1/10
dilution was used for batch 0907J and a 1/8 dilution for batch
5104L.
Two different buffers, HEPES and phosphate, both at pH 7.4 were
tested. 100 mis HEPES buffer contained 0.48 g HEPES powder (947.
pure; Aldrich Chemical Co. Gillingham, England), 0.01 g analar
sodium azide (BDH Chemicals Ltd, Poole, England) and O.lg gelatin.
100 mis phosphate buffer contained 0.69 g disodium
hydrogenorthophosphate, 0.17 g sodium dihydrogen orthophosphate
(both analar grade; BDH Chemicals Ltd, Poole, Dorset, England), 0.01







PGAi 0.04'/. PGAs; 0.37.
PGBi <0.017. PGB= <0.017.
PGDi <0.017. PGD= <0.017.
PGEx 6.57. PGE= 1007.
DH PGEi 0.017. DH PGErs 2.17.
K PGEi 0.167. K 13.27.
DHK PGEi 0.037. DHK E= 0.67.
PGFi,;, 0.017. PGF=* 0.117.
K PGFla, <0.017. DH PGF^ <0.017.
DHK PGFi,^ <0.017. K PGF»« <0.017.
19QH PGE1 <0.017. DHK PGFa« <0.017.
6 keto PGFt,* <0.017. 190H PG 0.0197.
Thromboxane B^ <0.017.
6, 15 diketo PGES <0.017.
Table 2.9
Cross reactivity for B/Bo = 0.5 of rabbit anti-PGE3 antibody.
(DH = 13, 14 Dihydro; K = 15 keto)




! 1/5 1/6 1/8 ! 1/10 : 1/15 :
DARS Batch 0907J ! 307.-407. - - ! 407.-507. ! 407.-507.I
DARS Batch 5104L 1l 507.-607. 507.-607. ! 457.-557. : 357.-407.:
Table 2.1Q
The effect of different donkey anti — rabbit serum (DARS) batches
and dilutions on the percentage of 3HPGE= bound in the PGE=
radioimmunoassay zero standard. HEPES buffer was used for dilution
of antibody stock solutions.
7*
one would provide the highest '/. bound figures for zero standards,
HEPES was found generally to give better results and so was used in
the assays (see table 2.11).
Included in each assay were three tubes to measure non-specific
binding (NSB) of tracer in the assay. These tubes contained all the
normal ingredients of the assay except for the anti-PGE3 antibody.
An extra 50 pi of buffer was added to make up the volume. The
addition of an extra 0.5 mis of buffer to some non-specific binding
tubes was tested to see if a greater total volume would reduce non¬
specific binding, however, no significant difference was observed
(see table 2.12).
Intra-assay variability was measured by repeating standards from the
middle of the standard curve (10-40 pg/tube) at the end of the assay
and comparing cpm with the standards from the beginning of the
assay. Inter—assay variability was monitored by repeating the assay
of two samples that had been assayed previously and the estimates
from the different assays compared. The mean inter—assay
coefficient of variation was 13.9"/. + 1.98 (n=7) and the mean intra-
assay coefficient of variation was 10.87. + 1.04 (n=15). The
sensitivity of the assay was 0.28 pg PGE3 ml-1 of plasma in utero-
ovarian vein samples and 0.401 pg PGE^ ml-1 in amniotic and
allantoic samples.
2.23 Progesterone Radioimmunoassay
Peripheral plasma progesterone was extracted using ethyl acetate
(efficiency 71 + 3"/.). Progesterone was determined by a
radioimmunoassay using the antiserum and technigue of Scaramuzzi et
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: HEPES ! Phosphate !
RIA No—1 ! 69+1.4 ! 62+1.5 :
RIA No—2 ! 38+5 : 50+3 :
RIA No—3 : 50+3 : 52+2 :
RIA No—4 ! 66+1 { 41+13 !
Table 2.11
Comparison o-f percentage 3HPGE= bound in zero standards of the PGE=
radioimmunoassay. Rabbit anti-PGE= antibody, donkey anti-rabbit
serum, normal rabbit serum, and :3HPGE3 were diluted in HEPES or
phosphate buffers at pH 7.4 and the percentage 3HPGE= bound in zero
standards for four different radioimmunoassays was determined.
Results are expressed as means + standard deviation for three
determinations.
15
! 0.5 ml buffer added
! 7. bound + S.D.
! 0.5 ml buffer not added !
! 7. bound + S.D. !
RIA 1 ! 6.2+4 ! 4.6+0.2 !
RIA 2 ! 3.6+0.7 ! 3.4+0.8 !
RIA 3 1 2.0+0.3 ! 3.3+0.3 !
RIA 4 ! 2.9+1.3 ! 5.2+0 :
RIA 5 ! 2.2+0.6 ! 4.5+2.8 !
Table 2.12
The effect of adding 0.5 mis of buffer to reaction tubes prior to
centrifugation on non-specific binding in the PGE^ radioimmunoassay.
Non-specific binding was tested by adding all the normal ingredients
of the radioimmunoassay with the exception of the anti-PGE^
antibody. Therefore any residual radioactivity after centrifugation
and removal of the supernatant was a result of non-specific binding.
Results show the mean percentage of ^fHPGE^ bound + standard
deviation for three determinations in five radioimmunoassays.
7*>
al. (1974), and (1,2,6,7,16,17—"=H> progesterone radiotracer
(Amersham, Bucks, batch no. 10/H/4723). Antibody-bound progesterone
was precipitated using dextran charcoal. The precision of
progesterone determination was 10.27. for within-assay duplication
(intra-assay coefficient of variation), and 9.67. for between-assay
replication (inter-assay coefficient of variation), for two plasma
samples analysed six times within the same assay (n=6), and two
plasma samples analysed in six different assays (n=6), respectively
(Hunter, 1978). The progesterone radioimmunoassay was carried out
by Dr H.A. Leaver.
2.24 Oestradiol 1713 Extraction from Plasma
Prior to assay of some of the samples, oestradiol was extracted and
concentrated five times by the following method: 250 mis of plasma
was placed in a glass tube and 2 mis of glass distilled grade ether
added. The tubes were shaken for 5 minutes to extract the
oestradiol into the ether and the agueous and organic layers allowed
to separate. Card-ice and acetone were mixed in egual guantities
and the agueous layer frozen by touching the bottom of the tube in
the card-ice-acetone mixture for a few seconds. The organic layer
(containing the oestradiol 17f3) was then poured off into another
glass test tube, the ether blown off with a stream of air and the
oestradiol 17(3 resuspended in 50 pi of zero standard plasma.
The efficiency of extraction of oestradiol was measured using
tritiated oestradiol 17f3 as follows, 50 pi of tritiated oestradiol
(Amersham International PLC, Amersham, Bucks, England) in analytical
grade methanol was dried under a stream of air and resuspended in
250 pi of sheep plasma. The extraction was then carried out as
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above and the extracted oestradiol resuspended in scintillant and
cpm measured in a beta counter. 10 separate extractions were
carried out and the cpm obtained compared with that tor two 50pl
tritiated oestradiol samples that had not undergone the extraction
procedure. The results are shown in Table 2.13. The (mean
extraction efficiency was 80.01 + 0.5Z/. (S.E. ) .
2.25 Oestradiol 17B Radioimmunoassay
Utero-ovarian vein plasma, peripheral plasma, and amniotic fluid
samples were all assayed for oestradiol 170. Utero-ovarian vein and
peripheral plasma samples were either assayed directly or extracted
and concentrated as described. Amniotic and allantoic samples were
in methanol so they were taken to dryness under a stream of air and
resuspended in 50 pi zero standard plasma. The assay involved a
solid phase double antibody method and was supplied as a kit from
Steranti Research Ltd, St. Albans, Herts, England. Each assay
included both intra- and inter—assay quality controls. Intra-assay
variability was tested by assaying the same sample both at the
beginning and at the end of the assay and comparing the results.
The same sample was then assayed in the next assay for inter-assay
precision. Assay accuracy was also measured by assaying three
samples taken from three different pools of plasma of known
oestradiol concentration. The pools were low (32.4 pg
oestradiol/ml), medium (84.5 pg/ml) and high (244.1 pg/ml). Inter-
assay and intra-assay coefficient of variation were 11.47. and 6.837.
respectively (n=6). Assay sensitivity was 3.1 pg oestradiol ml-1
at 2.5 standard deviations from the zero standard value. Figure 2.4
shows an oestradiol 17(3 radioimmunoassay standard curve.
Tube Contents
! !Oestradiol recovery





Extracted ^H-Oestradiol No-1 17360.31 82.6 80.01+0.52!
Extracted ^H-Oestrad io 1 No-2 17343.71 82.4 I1
Extracted ^Tl-Oestradiol No—3 16955.71 78.1 li
Extracted ^^H-Oestradiol No—4 17084.7! 79.5 II
Extracted ^H-Oestrad io 1 No—5 17044.71 79.1 I(
Extracted ^H-Oestradio1 No—6 17270.31 81.6 tI
Ex trac ted 3H-0estrad io 1 No—7 17033.3! 78.9 Il
Extracted 3H-0estradio1 No—8 !7048.0! 79.1 l1
Extracted ^H-Oestradio1 No—9 17160.0! 80.4 l»























Extraction efficiency of ^ oestradiol 17(3 into diethyl ether. 3,H
oestradiol 17(3 in 250 pi of sheep plasma was shaken with 2 mis of
acetone and the mixture allowed to separate into two layers. The
aqueous layer was frozen in an acetone - card-ice mixture and the
acetone poured off. 3H oestradiol 17(3 present in the acetone layer
was measured in a liquid scintillation counter.
COUNT
PLOT OF COUNTS v LOG(DOSE)













































[ LOG DOSE —3
734.35 157?.97 3399.32
Figure 2.4
Standard curve -for oestradiol 17(3 radioimmunoassay. See
section 2.25 for description of assay technique.
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Chapter 3
The Influence of Dietary n5 and rwb Fatty Acids an the Uterine Fatty
Acid Composition of Rats of Different Ages
3.1 Introduction
Arachidonic acid and prostaglandins are released from the uterus at
parturition (Leaver et al., 1987; MacDonald et al., 1974; Ogburn et
al., 1980; Olund & Lunell, 1980). Arachidonic acid is the precursor
of PGF^.-. and PGE= which have a crucial role in the initiation of
parturition (Thorburn & Challis, 1979). Inhibitors of prostaglandin
production will block parturition in almost every species tested to
date, whereas infusions of PGF^ and PGEs will initiate it (Aitken,
1972; Lewis & Schulman, 1973; Thorburn & Challis, 1979).
Quackenbush et al., (1942) were the first to demonstrate the role of
the n6 EFA in parturition, it was found that a diet high in n3 fatty
acids caused inhibition of the initiation of parturition
(Quackenbush et al., 1942; Leaver et al., 1986). However, in
animals fed a diet high in n3 fatty acids, normal foetal development
was observed, and if Caesarian section was carried out early in
labour live animals were delivered (Leat & Northrop, 1981),
suggesting that only labour was inhibited by high n3 fatty acid
con ten t.
In the rat the main site of fatty acid elongation and desaturation
is the liver. Studies on this tissue have illustrated a competetive
inhibition between n3 and n6 EFA for the desaturase and elongase
enzymes (Aitken, 1972; Bernert & Sprecher, 1975; Brenner & Peluffo,
1966: Brenner & Peluffo, 1967; Brenner, 1974; Nassar et al., 1986;
Rahm & Holman, 1964). A similar competition has been observed in
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the production of prostaglandins from n3 and n6 EFA by enzymes of
the cyclooxygenase system (Magrum & Johnston, 1983; Lokesh &
Kinsella, 1987; Hwang & Carrol, 1980; Hwang et al., 1988; Corey et
al., 1983). n3 fatty acids are not readily converted to
prostaglandins by cyclooxygenase enzymes, so in a diet containing
high quantities of n3 fatty acids there may be low prostaglandin
production resulting in impairment of parturition.
The rate determining step of the essential fatty acid elongase -
desaturase enzyme system is the D6 desaturase step, which in n6
fatty acids converts linoleic acid to gamma-linolenic acid. Evening
primrose oil contains relatively high quantities of gamma-1inolenic
acid- which may form a good source for production of arachidonic
acid in the uterus due to the rate determining D6 desaturase step
not being required for arachidonate production.
D5 desaturase activity is equally important for arachidonic
acid production. A number of tissues of different species have also
been shown to accumulate 20:3n6, suggesting low D5 desaturase
activity, including the testes (Ayala et al., 1973), thymus
(Horrobin, 1980), vesicular glands (Lands & Samuelsson, 1968) and
adrenals (Willis, 1981; Moore & Williams, 1966, Takayasu et al,
1970). It has also been suggested that although some cells, such as
platelets, contain far greater quantities of arachidonic acid than
20:3n6, in the free fatty acid fraction, the difference may be much
less (Marcus et al., 1969), suggesting that, at least in the resting
state, much of the arachidonic acid is not available for
prostaglandin synthesis.
The uterine production of PGE^ and PGF=.;, from arachidonic acid is
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very important at the time of parturition (Leaver et al., 1987;
Lewis & Schulman, 1973; Ogburn et al., 1980; Olund & Lunell, 1980).
Inhibition of either arachidonic acid synthesis or conversion to
prostaglandins by high n3 concentrations in the uterus could cause
impairment of parturition. Also, if levels of 20:3n6 accumulate
in the uterus this may cause competition between 20:3n6 and
arachidonic acid for cyclooxygenase enzymes, although PGEi formed
from 20:3n6 will induce uterine contractions (Villar et al., 1985).
Cellular lipid composition and enzymes involved in lipid metabolism
have been shown to change with age. In the liver of rats HMG-CoA
reductase activity decreases with age (Choi & Sugano, 1988) and in
rabbit alveolar macrophages increases in unsaturated to saturated
fatty acid ratios were observed as well as increases in the neutral
lipid fatty acid pool, during the first month of life. After this
no further changes were observed up to 150 days of life (Ricardo et
al., 1986). Plasma membranes of the macrophages were also found to
be more fluid in rabbits of 1 to 14 days old compared to older
animals and during the first 30 days of life increases in membrane
content of cholesterol and sphingomyelin were observed (Ricardo et
al., 1986). These increases may account at least in part for the
observed decreases in fluidity.
Differences in fatty acid desaturase activity in rats of different
ages have also been observed. In the rat foetus and placenta low D6
desaturase or D5 desaturase activity has been reported, and there is
evidence that young animals seem to aquire their long chain
essential fatty acids by transport from the maternal circulation
(Mercuri et al., 1979). In the rat foetal brain some D6 desaturase
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activity has been detected, which increased rapidly after birth, but this
fell to very low levels by 4 weeks of age and remained very low in the
adult (Cook, 1978). In the liver, however, the opposite was found. Low
levels of D6 desaturase were detected at birth, rising sharply on weaning
(Cook, 1978), but even in the liver levels were very low by one year of
age, Choi and Sugano (1988) also reported a reduction in liver D6
desaturase activity from 8 week old rats to adults fed on an EPO
containing diet. In the testes D6 desaturase activity has also been found
to decline rapidly at 3-6 weeks after birth in the young rat (Peluffo et
al., 1970; Ayala et al., 1973). Reductions in D6 desaturase activity have
been suggested to be one of the causes of ageing (Horrobin, 1981).
We studied the effect of diet and age on the metabolism of fatty acids in
the uterus of the rat, using rats of three different ages; newly weaned,
young, and adult, fed on three different diets; a control diet, a
semisynthetic diet supplemented with evening primrose oil (EPO) and a
semisynthetic diet supplemented with fish oil (F0).
3.2 Materials and Methods
Female Sprague - Dawley rats were divided into three age groups; Adult
(151 - 586 days, mean age 231 days, n=39), young (42 - 49 days, n=15) and
newly weaned (21 - 25 days, n=10). Rats from adult and young groups were
randomly divided into three diet groups and were fed either a pelleted
diet, or a semisynthetic diet supplemented with evening primrose oil or
fish oil (see section 2.1 for composition of pelleted and semi-synthetic
diets). Adult rats were used for further experiments not reported here,
this resulted in my having no control over rat age or number in diet
groups. There was no significant difference between rats aged 181
days, 290-368 days and 568-586 days within diet groups. Adult rats
were not grouped according to stage of oestrous cycle. The effect
of the oestrous cycle on rat uterine fatty acid is not yet
known. Young rats had not yet entered the oestrous cycle. Numbers in
adult rat groups were; control n=14, evening primrose oil n=4, fish
84
oil n=21. Numbers in young rat groups were; control n=4, evening
primrose oil n=5, -fish oil n=6. Adult rats received Maxepa as a
fish oil supplement whereas young rats were given Hi-EPA. This was
used in preference to Maxepa because of its high eicosapentaenoic
acid content (21.45"/. in Hi-EPA as compared to 15.6Z/. in Maxepa). An
analysis of the fatty acid intake of rats on each diet is shown in
table 3.1 (taking into account presence of coconut oil in semi¬
synthetic diets). 90-93"/. of EFA in the EPO supplemented diets was
provided by the EPO supplement and 80-82"/. of EFA in the F0
supplemented diets was provided by the FO supplement. The essential
fatty acid composition of the EPO diet consisted of 99.57. n6 and
0.57. of n3 fatty acid; the pelleted diet, 84"/. n6 and 16"/. n3; and the
FO diet, 257. n6 and 757. n3 fatty acid. Administration of oil
supplements to adult rats was carried out by Dr H.A. Leaver. Rats
of the newly weaned group were born from mothers of the three
different diet grops (pelleted, evening primrose oil and fish oil).
Rats were killed and uteri removed by the method described in
section 2.2, lipids were extracted and separated into neutral and
phospholipid fractions by the two phase separation system described
in section 2.11 followed by silicic acid column chromatography
described in sections 2.10 and 2.11. Lipid hydrolysis and fatty
acid methylation was carried out as described in section 2.14. GC
analysis of fatty acid methyl esters was as described in section
2.16. Significance of differences between groups was analysed using
the Wilcoxon Rank Sum Test for unpaired data (Cohen and Holliday,
1984).
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F.A. Control Adult Young Maxepa Hi-EPA
EFO EFO
u 2.86 2.72 2.8 2.84
12:0 51.7 49.18 50.4 51.35
13:0 0.23 0.28 0.21 0.16
13:1 0.14 0.18 0.14 0.09
14:0 0.4 17.84 17.02 18.72 19.1
14:1 0.31 0.38 0.34 0.21
14:2 0.08 0.07 0.08 0.1
15:0 0.06 0.06 0.06 0.1
15:1 0.06 0.06 0.06 0.09
16:0 17 8.19 8.16 9.51 8.98




18:0 2.1 6.8 6.59 6.8 6.86
18:ln9 20.6 3.03 3.27 3.91 3.33
18:2n6 45.6 7.23 10.19 0.98 0.8
18:3n6 0.8 0.84 1.22
18:3n3 2.0 0.12 0.08
18:4n3 0.24 0.14
20:0 0.4 0.12
20:ln9 0.5 0.05 0.05 0.25 0.15
20:4n6 0.1 0.05 0.05 0.11 0.08
20:4n3 0.06





22:5n3 0.06 0.18 0.21
22:6n3 4.1 0.77 0.42
Table 5.1
Percentage -fatty acid intake of rats on control pelleted diets or
semi-synthetic diets supplemented with evening primrose oil or fish
oil. Calculations for rats on semi-synthetic diets included both
fatty acid intake from oil supplements and from coconut oil. Fatty
acids at <0.05*/. are not shown.
"B>(>
3.3 Results
3.3.1 The effect o-f dietary fatty acids on uterine fatty acid
compos!tian in adult rats
The effect of dietary evening primrose oil, fish oil and a normal
pelleted diet on the uterine fatty acid composition of the adult
rats is shown in tables 3.2 and 3.3. The major differences between
diet groups arose in the essential fatty acids. The proportion of
n6 EFA in uteri of the EPO and control groups was higher than in
the FQ group. 20:3 n6, arachidonic acid, 22:4 n6 and 22:5 n6 were
all significantly higher in the EPO group than in the F0 group (all
P<0.05, except 22:5 n6 which was P<0.001> and 18:2 n6, 20:2 n6, 22:4
n6 and 22:5 n6 were significantly higher in the control group than
in the FO group (P<0.05, PC0.05, P<0.001 and P<0.001 respectively).
The n3 fatty acids 20:5 n3, 22:5 n3 and 22:6 n3 were all
significantly higher in the FO groups than in both the control
(P<0.001, P<0.01 and P<0.05 respectively) and EPO groups (P<0.05,
P<0.05 and P<0.001 respectively). a-linolenic acid, however, was
significantly higher in the control group than the FO group
(PCO.OOl).
3.3.2 The effect of dietary fatty acids on the neutral lipid and
phospholipid fatty acid composition of the uterus in young rats
The effect of dietary evening primrose oil, fish oil and a normal
pelleted diet on the uterine fatty acid composition of young rats is
shown in tables 3.4, 3.5 and 3.6. The fatty acid proportions of the
phospholipids of young rats were similar to those of the adult total
lipids, although fewer significant differences were detected this
may be due to the smaller sample size of this group (table 3.3).
Arachidonic acid and 22:4 n6 were significantly higher in the EPO
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F.A. Control
12:0 0.578 + 0.502-*=
13:0 0.39 + 0.112
13:1 0.144 + 0.052
14:0 2.683 + 1.087-'=
14:1 0.382 + 0.137
14:2 0.164 + 0.576
15:0 0.358 + 0.096
15:1 0.182 + 0.056-
15:2 0.157 + 0.107
U 1.232 -t- 0.253-*=
16:0 27.634 + 1.082-
16:1 3.621 + 0.871-
16:2 0.058 + 0.008
17:1 0.174 + 0.043
17:2n6 0.088 + 0.018-
U 0.917 + 0.162
18:0 11.712 + 1.296
18:ln9 23.027 + 1.422
18:2 n6 11.122 + 1.307-'=
U 0.052 + 0.002
18:3n6
U
18:3n3 0.327 + 0.071-
U 0.101 + 0.051
20:0.
20:ln9 0.49 + 0.132
20:3n9 0.555 + 0.115
20:2n6 0.227 + 0.042-*=
20:3n6 0.527 + 0.089
20:4n6 7.724 + 1.338
20:3n3 0.136 + 0.056
U 0.168 + 0.091
20:5n3 0.428 + 0.122-
22:0 0.31 + 0.186
U 0.181 + 0.114
22:ln9 0.208 + 0. Ill
U 0.324 + 0.118
U
22:4n6 1.952 + 0.519-
22:5n6 0.108 + 0.028-
22:5n3 0.592 + 0.176-
22:6n3 1.542 + 0.318-
EP0 Maxepa
2.53 + 0.696*= 2.165 + 0.399-
0.596 + 0.34 0.559 + 0.116
0.083 + 0.033 0.154 0.039
4.636 + 0.729'= 4.224 + 0.537-
0.559 + 0.16 0.474 + 0.113
0.456 + 0.312 0.16 + 0.0056
0.088 + 0.038 0.142 + 0.03
0.531 + 0.118- 0.487 + 0.084
0.073 + 0.021
1.82 + 0.069to 1.712 + 0.195-
23.71 + 1.178 24.724 + 0.506-
4.178 + 0.419 5.059 + 0.537-
0.073 + 0.023 0.147 + 0.032
0.085 + 0.083 0.158 + 0.021-
1.068 + 0.075 0.859 + 0.118
10.214 + 0.657 11.382 + 0.763
23.808 + 2.467 25.802 + 0.96




0.094 + 0.004 0.056 + 0.005
0.092 + 0.034
0.32 + 0.198 0.467 + 0.116
0.839 + 0.064 0.75 + 0.136
0.781 0.088"= 0.954 + 0.149-
0.762 + 0.038- 0.453 + 0.074-
9.924 0.772- 4.//5 + 0.7-
0.101 + 0.035
0.396 + 0.238 0.14 + 0.048
0.156 + 0.017*= 2.615 + 0.376-*=
0.11 + 0.057
0.202 + 0.102 0.508 + 0.114
1.64 + 0.931 0.153 -t- 0.075
3.454 + 0.222*= 0.903 + 0.307-*=
0.909 + 0.27-
0.501 + 0.208*= 1.89 + 0.238-*=
0.48 + 0.126*= 3.059 + 0.471-*=
Table 3-2
Percentage -fatty acid content of uterine total lipid in adult rats
(151-586 days old), ted on either a control pelleted diet or a
semisynthetic diet supplemented with fish oil or evening primrose
oil. Figures are presented as mean + standard error. n=14 for
control rats, n=4 for EPO rats,and n=21 for FO rats. Like
superscript indicates a significant different of at least P<0.05
between diet groups. Fatty acids at less than 0.057. are not shown.
U indicates an unidentified fatty acid. SEM are expressed for
interest, despite non-parametric statistics being used for diet
group comparisons. Results are expressed as obtained from the
integrator and do not reflect sensitivity of analysis. Refer to
methods section 2.16 for variance of peak size measurements from
duplicate injections.
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The C20 and C22 tatty acid content (mg fatty acid per g wet weight
uterus) of adult rats (mean age 231 days) detected by gas
chromatography using C17:0 as internal standard in 14 rats fed
control diet, 21 rats fed fish oil diet, and 4 rats fed evening
primrose oil diet. Results are the mean mg fatty acid/g uterus +
SEM, and significantly different (p<0.01) results are denoted by the
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Control Fish Oil Evening Primrose Oil
PL PL PL
C20:ln9 0.028 + 0.004 0.055 + 0.015 0.039 + 0.018
C20:3n9 <0.001 0.001 + 0.003 <0.001
C20:2n6 0.015 + 0.008- 0.057 + 0.023 0.072 + 0.025-
C20:3n6 0.051 + 0.016== 0.005 + 0.003= 0.022 + 0.013=
C20:4n6 0.88 + 0.139 0.299 + 0.055-= 0.699 + 0.118=
C20:3n3 <0.001 <0.001 <0.001
C20:4n3 0.009 + 0.008 <0.001 <0.001
C20:5n3 0.013 + 0.008- 0.221 + 0.042-= 0.009 + 0.008=
C22:3n6 <0.001 0.016 + 0.007 0.054 + 0.045
C22:4n6 0.215 ± 0.039- 0.014 ± 0.012-= 0.129 + 0.031-=
C22:5n6 0.016 + 0.009 <0.001 0.034 + 0.020
C22:3n3 <0.001 <0.001 <0.001
C22:5n3 0.008 + 0.007- 0.068 + 0.031- <0.001-
C22:6n3 0.248 + 0.07 0.549 + 0.322= 0.54 + 0.026=
NL NL NL
C20:ln9 0.037 ± 0.018 0.013 + 0.005 0.055 + 0.022
C20:3n9 <0.001 0.001 + 0.003 <0.001
C20:2n6 <0.001 <0.001 <0.001
C20:3n6 <0.001 0.001 <0.001
C20:4n6 0.069 + 0.035 0.011 + 0.006 0.075 + 0.025
C20:3n3 <0.001 0.001 <0.001
C20:4n3 <0.001 0.009 + 0.005 0.023 + 0.017
C20:5n3 0.007 + 0.006 0.008 + 0.008 0.001
C22:3n6 <0.001 <0.001 <0.001
C22:4n6 <0.001 <0.001 <0.001
C22:5n6 <0.001 0.011 + 0.008 0.037 + 0.016
C22:3n3 <0.001 <0.001 <0.001
C22:5n3 <0.001 <0.001 <0.001
C22:6n3 0.04 + 0.035 <0.001 <0.001
Table 3,6
The C20 and C22 fatty acid content of the uteri of young 42-49d rats
(mgs fatty acid per g wet weight uterus) detected by gas
chromatography using C17:0 internal standard in 4 rats fed control
diet, 6 rats fed fish oil diet and 5 rats fed evening primrose oil
diet. Results are mean mg fatty acid/g uterus + SEM, in neutral
lipid (NL) and phospholipid (PL). Significantly different results
are denoted by the superscripts - = (P<0.01), and = = (P<0.05).
group than in the FO group (both P<0.05) and linoleic acid,
arachidonic acid and 22:4 n6 were significantly higher (P<0.05> in
the control than the FO group. The FO group had significantly
higher levels of 20:5 n3 than the control and EPO groups (P<0.05).
In both the adult rats and the phospholipid of young rats, levels of
gamma-linolenic acid were very low if detected at all and no
significant differences were found between the three dietary groups.
Levels of 20:3n6 were also found to be low and no significant
differences between diet groups were found.
In the neutral lipid fraction of the young rats many more of the
nan-essential fatty acids were found to be significantly different
between diet groups (table 3.5), than in the adult rats or the young
rats phospholipid fraction. The control group had significantly
higher levels of linoleic acid, a-linolenic acid and arachidonic
acid than the EPO (all P<0.05) and the FO group (all P<0.01), and
the EPO group had significantly higher proportions of gamma-
linolenic acid than both the control (P<0.05)and FO (P<0.001) groups
and linoleic acid than the FO group (P<0.001). Significantly higher
proportons of n3 fatty acids in the FO group compared to the other
groups were not found in the neutral lipid fatty acids.
3.3.3 The effect of dietary fatty acids on uterine tissue/diet
fatty acid ratios
Table 3.7 and figure 3.1 show tissue/diet fatty acid ratios in total
lipid in adult rats and table 3.8 and figure 3.2 show ratios in the
phospholipid fraction of young rats. In both adult rats and
phospholipid in young rats, arachidonic acid had by far the highest
tissue/diet ratio in all three diet groups, with ratios of 77.24 ±
93
F.A. Control Ratios EFQ Ratios FO Ratios
18:2n6 0.24 + 0.03-"= 0.38 + O.OS^ 2.46 + 0.4—=
18:3n6 2.55 + 1.3
18:3n3 0.12 + 0.02-= 1.3 0.37*= 0.49 + 0.05-
20:4n6 77.24 + 13.38= 198.48 + 15.45—b 38.9 + 5.34"=
20:5n3 0.18 + 0.05- 1.53 + 0.21-
22:4n6 18.82 + 5.34
22:5n6 0.36 + 0.09
22:5n3 1.92 + 0.59
22:6n3 0.38 + 0.08- 7.56 + 1.3-
Table 3.7
Adult rat (mean age 231 days) uterine total lipid essential fatty
acid to dietary essential fatty acid ratios. Where a ratio is not
given the fatty acid was undetected in tissue and/or diet. Figures
are means + standard errors for fourteen determinations in control
rats, four determinations in EPO rats, and twenty one determinations
in FO rats. A significant difference of at least P<0.05 between
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Adult rat (mean age 231 days) total lipid fatty acid to
dietary fatty acid ratios. Ratios were calculated for all
fatty acids detected in both diet and tissue in rats fed
either a control pelleted diet (n = 14) or a semisynthetic
diet supplemented with fish oil (n =21) or evening primrose
oi1 (n = 4).
FA. Control Ratios EPD Ratios FD Ratios
18:2n6 0.15 + 0.02*b 5.01 + DID■»—4 3.42 + 0.49*
18:3n6 0.02 + 0.002
18:3n3 0.07 + 0.03 3.5 + 1.83
20:4n6 81.62 + 7.03* 190.75 + 30.38*13 44.95 + 3.4to
20:5n3 0.06 + 0.03* 1.2 + 0.12*
22:4n6 19.87 + 2.36
22:5n6 2.32 + 1.95
22:5n3 0.32 + 0.16 4.75 + 1.96
22:6n3 0.56 + 0.13 7.81 + 1.96
Table 3.8
Young rat (42-49 days) uterine phospholipid essential fatty acid to
dietary essental fatty acid ratios. Where a ratio is not given the
fatty acid was undetected in tissue and/or diet. Figures are means
+ standard errors for four determinations in control rats, four
determinations in EPO rats, and six determinations in FO rats. A
significant difference of at least P<0.05 between ratios of a fatty











Young rat (mean age 44 days) phospholipid fatty acid to
dietary fatty acid ratios. Ratios were calculated for all
fatty acids that were detected in both diet and tissue in
rats fed either a control pelleted diet (n = 4) or a
semisynthetic diet supplemented with fish oil (n = 6) or
evening primrose oil (n = 5).
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13.38, 198.48 + 15.45 and 38.9 + 5.34 being recorded in the control,
EPO and FO groups respectively, of the adult rats, and ratios of
81.62 + 7.03, 190.75 + 30.38 and 44.95 + 3.4 being recorded in the
same groups of the young rats. The ratios for arachidonic acid were
significantly higher in the EPO group than in both the control
(P<0.01 adult, P<0.05 young) and the FO groups (P<0.001 adult,
P<0.05 young). Control rats also had high 22:4 n6 ratios (18.82 in
adult and 19.87 in young) and fish oil rats high 22:6 n3 fatty acid
ratios (7.56 in adult and 7.81 in young). In the neutral lipid
fatty acids the highest ratio was found in palmitoleic acid with
ratios of 14.32 + 0.88, 37.68 + 5.55 and 10.32 + 0.67 being found in
control, EPO and F0 groups respectively, but the arachidonic acid
ratio was very low (5.08 + 1.3, 2.64 + 0.84 and 0.74 + 0.07 in the
control, EPO and F0 groups respectively) compared to the levels in
the phospholipid fraction and in the adult rats (see figure 3.3).
3.3.4 The effect of dietary fatty acids on uterine n3/n6 fatty acid
ratios
Diet and tissue n3/n6 ratios are illustrated in table 3.9. Adult
and young rat phospholipid values were very similar to each other.
The ratios in F0 groups in both adult rats (0.901) and young rats
phospholipid fraction (0.992) were more than 10 times that of the
EPO fed rats (0.071 and 0.074 respectively). The control rats had
intermediary ratios (0.147 in adult and 0.166 in young rats
phospholipid fraction). The difference in ratios in the tissue
between the different diet groups was, however, far less than the
differences in the diet itself, where the F0 diets had n3/n6 ratios
700-800 times higher than the EPO diet. The control dietary n3/n6
ratio (0.183), however, was very close to that found in the control
98
Fig 3.3
Young rat (mean age 44 days) neutral lipid fatty acid to
dietary fatty acid ratios. Ratios were calculated for all
fatty acids that were detected in both diet and tissue in
rats fed either a control pelleted diet (n = 4) or a
semisynthetic diet supplemented with fish oil <n = 6) or
evening primrose oil (n = 5).
Control (n) EPO (n) FO (n)
Adult 0.147 (14) 0.071 (4) 0.901 (21)
Young PL 0.166 (4) 0.074 (4) 0.992 (6)
Young NL 0.08 (4) 0.028 (5) 0.171 (6)
Diet 0.183 <0.004 2.899* 3.522b
a-Maxepa b-Hi-EPA
Table 3.9
n3/n6 tatty acid ratios of uterine tissue in control, EPO, and FO
fed rats and diet n3/n6 ratios in control, EPO, and FO diets.
Ratios for EPO and FO diets take into account fatty acid
contribution from coconut oil.
too
rat uterus o-f the adult rats (0.147) and the phospholipid of the
young rats (0.166). In the EPO fed rats there was a more than 10
fold increase in n3/n6 ratio over that of the EPO diet in adult rats
and both phospholipid and neutral lipid in young rats, whereas the
F0 group exhibited at least a 4.5 fold decrease in adult rats and
both phospholipid and neutral lipid in young rats compared to that
of the F0 diet. The young rat neutral lipid ratios showed a similar
trend to the other groups, with the F0 group having the highest
n3/n6 ratio and the EPO group the lowest, however the differences
were less pronounced. The neutral lipid ratios in the control and
F0 groups were both considerably lower than those in the
corresponding diets, 0.08 and 0.171 compared to 0.187 and 3.522
respectively, whereas the EPO, as with the adult and phospholipid
groups, was considerably higher, 0.028 in the tissue compared to
<0.004 in the diet.
The proportion of n3 and n6 EFA in the uterus of each diet group was
very similar in control and EPO groups of total lipid in adult rats
and phospholipid and neutral lipid in young rats (see table 3.7).
However, the F0 fed rats had very much lower n6 and higher n3
proportions, except in the neutral lipid of the young rats where the
F0 diet did not have much effect on the n6-n3 proportions. In the
total lipid of the adult rats and phospholipid of the young rats,
the control diet groups contained the highest proportion of EFA as a
percentage of total fatty acid (237. and 20.47. respectively), and the
F0 groups the lowest (18.27. and 14.37. respectively). The proportion
of EFA compared to other fatty acids is shown in table 3.10. In
neutral lipid the proportion of EFA was low in both the EPO and F0
fed rats (3.69 and 1.64 7. respectively), compared with the EFA in
101
Adult Rats Young Phospholipid Young Neutral Lipid

















Mean n6 and n3 fatty acids as percentages of total essential fatty
acids and mean essential fatty acid as percentage of total fatty
acid in uterine total lipid of adult rats and phospholipid of young
rats. Rats were fed either a control pelleted diet or a
semisynthetic diet supplemented with evening primrose oil or fish
oil.
the phospholipid of young rats and total lipid of adult rats.
However, the neutral lipids in the control rats had a high EFA
content (18.79"/.), 897. of which was linoleic acid.
The 20:3n9/20:4n6 ratio was not greater than 0.2 in any of the rats
(a ratio of greater than 0.4 indicates fatty acid deficiency,
Holman, 1960).
5.5.5 Age-related changes in uterine fatty acid composition and
essential fatty acid content
Table 5.11 shows total uterine fatty acid and <C18 and >C18 fatty
acid content of rats in the three different age groups. The total
uterine fatty acid content was significantly higher (p<0.001) in
newly weaned rats (199.59 + 46.65 mg fatty acid/g tissue), compared
with adult rats (14.02 +2.47 mg fatty acid/g tissue). The
proportion of short chain fatty acids (<C18) was also significantly
greater (P<0.01) in newly weaned rats, at 52.927. + 8.94, compared to
55.877. + 1.59 in adult rats.
5.4 Discussion
Dietary evening primrose oil and fish oil induced significant
changes in the fatty acid content of the uterus of rats in all three
age groups. In adult rats and phospholipids of young rats the
major differences between diet groups were found in the essential
fatty acids. The proportion of tissue n6 EFA was higher in the
control and EPO groups than in the F0 groups. The uteri of control
rats had significantly higher proportions of linoleic acid than the
adult and young neutral lipid EPO groups (both PC0.05) and F0






















Total fatty acid (mg/g wet weight tissue), <C18 fatty acid (7FA) and
>C18 fatty acid (7. FA) of rat uteri from different age groups,
expressed as mean mgs fatty acid/g wet weight of uterus of n
determinations + standard error of mean. Newly weaned rats were 21-
25 days old (22.6 + 0.6), young rats were 42-49 days old (44.4 +
0.8) and adult rats were 151-586 days old (230.6 + 16.9).
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FO group (PC0.05). This corresponds with the high levels of
linoleic acid in the control diet. However, the uterine lipids of
rats fed EPO contained the highest concentration of arachidonic acid
from a diet that contained the least arachidonic acid. This
suggests that large guantities of the linoleic acid in the control
groups was not being converted to arachidonic acid, indicating low
D6 desaturase activity in the uterus. Also, competetive inhibition
of the n6 desaturase by relatively high levels of a-linolenic acid
in the tissue of control rats may be inhibiting the D6 desaturase.
This also suggests that the guantities of arachidonic acid found in
the EPO groups were being considerably increased by the presence of
high levels of gamma-linolenic acid in the EPO diet. This may be
more readily converted to arachidanic acid than linoleic acid
because of the omission of the D6 desaturase rate determining step
which converts linoleic acid to gamma-linolenic acid. The fact that
no gamma-linolenic acid was detected in the uteri of the EPO fed
rats suggests that it was all converted to 20:3n6 and arachidonic
acid rather than it was not incorporated into the tissue.
The FO rats had similar uterine tissue proportions of linoleic acid
to the EPO rats, despite the fish oil diet containing less linoleic
acid (0.987. compared to 10.197. in adult rats and 0.87. compared to
10.197. in young rats), this was probably due to inhibition of the
conversion of linoleic acid to gamma-linolenic acid due to the high
concentrations of n3 fatty acids in the FD diet. Arachidonic acid
levels in the uterine lipid of rats fed fish oil were significantly
lower than those in the EPO groups (P<0.05) in both adult rats and
young rat phospholipids, despite the presence of higher
concentrations of arachidonic acid in the FO diet. This was
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probably due to increased arachidonic acid production -from gamma-
linolenic acid in the EPO groups, and competetive inhibition of the
D5 and D6 desaturase by n3 fatty acids in the FO group (Nasser et
al., 1986).
Proportions of 20:3n6 in the EPO groups of both the phospholipid
fraction of young rats and the total lipid fraction of adult rats
were very low compared to proportions of arachidonic acid. This,
together with the low proportions of gamma-linolenic acid found in
this group, despite the high dietary level, suggests very active D5
desaturase activity in the uterus and suggests that 20:3n6 will not
accumulate in the uterus as has been observed in other tissues
(Ayala et al., 1973; Horrobin, 1980; Lands & Samuelsson, 1968;
Willis, 1981; Moore & Williams, 1966; Takayasu et al., 1970). The
levels of gamma-linolenic acid in the EPO diet of the young and
adult rats were only slightly higher than those in the control diet
(0.847. and 1.227. compared to 0.87. respectively) but the control diet
contained far greater quantities of linoleic acid than the young and
adult EPO diets <45.67. compared to 7.237. and 10.197. respectively),
despite this the levels of 20:3n6 in young rat phospholipids and
adult rat total lipids were very similar between EPO and control
groups, again suggesting low D6 desaturase activity and conversion
of linoleic acid to arachidonic acid in the uterus. The fish oil
groups had by far the lowest levels of 20:3n6 precursors available
to them (see table 3.1), but despite this proportions of 20:3n6 in
the fish oil fed rats were relatively high (tables 3.2 and 3.4).
This suggested that the high levels of n3 fatty acids in the uterine
lipids of rats fed fish oil inhibited the D5 desaturase. There was
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also higher levels of linoleic acid in the FO fed rats than in the
FO diet, suggesting there was inhibition of the D6 desaturase.
Consequently, the accumulation of 20:3n6 was detected in uterine
lipid of the rats fed the fish oil diet. A similar result was
reported by Nasser et al. (1786) who observed increasing 20:3 n6
proportions in rat liver and plasma fatty acids with increasing
proportions of fish oil in a fish oil-EPO diet mixture. There is
evidence that 20:5n3 is more effective at competing with arachidonic
acid for cyclooxygenase enzymes than with 20:3n6 (Boukhchache &
Lagarde, 1982), thus possibly resulting in a proportional increase
of PGEi compared to PGE= in the FO fed rats.
The "dietary proportions of arachidonic acid were very much lower
than the corresponding tissue levels in all three diet groups, this
suggests that the major source of arachidonic acid in the tissue was
from precursors rather than from arachidonic acid in the diet. The
proportions of arachidonic acid and linoleic acid found in the
uterus in this study were relatively low compared to proportions of
these fatty acids found in other tissues of animals fed on diets
containing similar fatty acid contents, including; rat liver (Hwang
and Carrol, 1980; Hwang, 1988; Nasser, 1986), heart (Charnock,
1983), serum (Hwang, 1980), plasma (Nasser, 1986), and human
platelets (Sanders et al., 1981). Due to the profound effects of 2—
series prostaglandins, and possibly of free arachidonic acid itself,
on the uterus, as seen at parturition, it may be beneficial for the
uterus to maintain low levels of arachidonic acid when
prostaglandins are not required for parturition. Arachidonic acid
incorporation in human amnion has been found to increase during
labour (Schwartz et al., 1977) and arachidonic acid composition of
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cholesterol esters in amniotic fluid have been found to increase
with gestational age (Das et al., 1975), so a possiblity exists of
extra incorporation of arachidonic acid into uterine tissues during
gestation. Specific tissues thought to be involved in arachidonic
acid release and prostaglandin production at parturition, such as
human uterine decidua and foetal membranes have also been shown to
contain high arachidonic acid concentrations (Schwarz et al., 1975).
The fish oil diet groups in total lipid in adult rats and
phospholipid in young rats had significantly greater quantities of
eicosapentaenoic acid than both control (P<0.001 in adult and P<0.05
in young) and EPO groups (P<0.05 in both adult and young). This was
despite the fact that the control diet had a higher percentage
20:5n3 content than the FO diet. This suggests that the uterus will
only incorporate large quantities of n3 fatty acids when sufficient
quantities of n6 fatty acids are not available, as is the case with
the FO diet but not the pelleted diet. Similar results have been
observed in rat plasma and liver (Huang et al., 1987). The 22
carbon EFA show a similar trend to that of the 20C EFA with control
and EPO groups having significantly higher levels of the n6 FA and
significantly lower of the n3 FA. In both the phospholipids of
young rats and the total lipid of adult rats there was relatively
low tissue proportions of adrenic acid and 22:5n6 compared to
arachidonic acid, despite levels of all three free fatty acids in
the diet being very low. In the FO groups the relative quantitites
of adrenic acid and 22:5n6 compared to arachidonic acid were lower
than those in the control and EPO groups, this was probably due to
inhibition of the D4 desaturase by high levels of 20:5n3, 22:5n3 and
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22:6n3 in the FD fed rats. The n3 22C fatty acids, however, were
present in higher levels than 20:5n3, especially in the EPO and
control groups. This suggests that either D4 desaturase has greater
specificity for the n3 fatty acids than the n6 fatty acids or that
the 22C n3 fatty acids are preferentially incorporated compared to
the 20C n3 fatty acids. Preferential incorporation in platelets
after fish oil feeding has been reported (Simonsen et al., 1987).
The results suggest that the uterus may compensate for deficiencies
of arachidonic acid by incorporating available n3 C20 and C22 EFA.
Figures 3.4 and 3.5 show the combined arachidonic acid, 20:5n3 and
22:6n3 contents of the 3 diet groups of adult rats and young rat
phospholipids respectively. This illustrates clearly how the
combined arachidonic acid, 20:5n3 and 22:6n3 levels are very close
in the three diet groups despite widely differing individual
proportions of the three fatty acids. However, this compensation
was structural rather than functional, as a number of studies have
illustrated the difficulties encountered at parturition in animals
receiving a diet with a high n3 fatty acid content. The tissue/diet
ratios shown in tables 3.7 and 3.8 and figures 3.1 and 3.2
illustrate the importance of high arachidonic acid content in the
uterus. Even in the FO groups where only low levels of arachidonic
acid precursors were available arachidonic acid still had by far the
highest ratio. In the control groups, adrenic acid (22:4n6) also
had a relatively high ratio, suggesting that it may also play a role
in uterine functions (22:4n6 was not detected in the EPO or the FO
diet and so ratios could not be calculated). Little is known about







Proportions o-f arachidonic acid, eicosapentaenoic acid, and
docosahexaenoic acid in total lipid o-f adult rats (mean age
231 days) fed control pelleted diet (n = 14), semi-synthetic
diet with evening primrose oil (EPO, n = 4), and semi¬
synthetic diet with fish oil (FO, n = 21). Proportions are







Proportions of arachidonic acid, eicosapentaenoic acid, and
docosahexaenoic acid in phospholipids of young rats (mean
age 44 days) fed control pelleted diet (n = 4), semi¬
synthetic diet with evening primrose oil (EPO, n =5),' and
semi-synthetic diet with fish oil (FO, n = 6). Proportions
are expressed as percentages of total fatty acid detected
III
The n3/n6 ratios of the total lipid in the adult rats and the
phospholipid in the young rats showed considerable di-fferences from
the n3/n6 ratios detected in the corresponding diets. The control
diet groups had n3/n6 ratios similar to the control diet ratio,
however, the EPO rats had much higher ratios than the EPO diet and
the FO rats had much lower ratios than the FO diet. This suggests
that some compensation for the high n6 content in the EPO diet and
high n3 content in the FO diet was taking place within the rats, and
suggests a requirement for the presence of both n3 and n6 fatty
acids in the uterus. However, despite any compensation taking place
within the uterus the FO diet resulted in a far higher n3/n6 ratio
than either the EPO or control diets. Since little difference in
n3/n6 fatty acid ratio was seen between the control diet and the
control rats this may suggest that the n3 and n6 fatty acid content
of this diet was close to the balance required in the uterus.
The FO diet resulted in a decrease of the proportion of n6 EFA by
approximately 30"/., from around 807. in the control groups to nearer
507. in the FO groups in both total lipid of adult rats and
phospholipid of young rats (table 3.10). These changes, however,
were quantitatively smaller than the observed changes in the
efficacy of parturition in fish oil fed rats, which has teen shown
to decrease by 807., or the uterine content of prostaglandin E= which
decreases by over 807. in uterine wall and foetal membranes of rats
fed F0 diets compared to those on control diets (Leaver et al.,
1986). However, the fatty acid that increased the most in this
study in relation to levels in the control rats was 20:5n3, which
increased by 6107. in adult rats and by 16667. in the phospholipid of
young rats. These very large increases could clearly have a marked
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effect on prostaglandin production from arachidonic acid.
Differences in n3 and n6 content of different lipid pools could also
have to be considered in relation to localisation, metabolic
turnover, and their physiological role in parturition (see chapter
4) .
The phospholipid fatty acids in the young rats illustrated the same
trends as the total fatty acid in the adult rats. Only 3 weeks were
therefore necessary for significant dietary induced changes to
result. The fatty acid content of the neutral lipid in the three
diet groups also demonstrated a number of significant differences,
however, in the neutral lipid only a very few of the differences
were seen in the essential fatty acids. In the tissue/diet ratios
of the neutral lipid pool the highest ratios were found in
palmitoleic and oleic acids, as compared to arachidonic acid in the
phospholipid. This suggests the neutral lipid pool is a
quantitatively minor source of the eicosanoid precursor fatty acids.
The levels of all the EFA, except linoleic acid and gamma-linolenic
acid, were very much lower in the neutral lipid than the
phospholipid fraction. There was little evidence of active
elongation or desaturation of EFA in the neutral lipids as the
relatively high levels of linoleic acid and gamma-linolenic acid
corresponded to low levels of arachidonic acid and 22:4 n6. In the
FO group the quantities of n3 EFA were very much lower than those
in the phospholipid fraction, with the exception of a-linolenic
acid. These results suggest that the major part of the neutral
lipid pool in the uterus does not store or metabolise EFA to any
extent. However, the metabolism of these EFA in quantitatively
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minor neutral lipid constituents such as diacylglycerol and
monoacylglycerol would require further analysis (this has been
investigated in chapter 4).
Significant differences were detected in the fatty acid composition
of the uteri of newly weaned rats compared to adult rats. The newly
weaned rats had a significantly higher total fatty acid content
(P<0.001), and a significantly higher proportion of short chain
fatty acids of less than 18C (P<0.01), but a significantly lower
proportion of fatty acids of 18 carbons or more (P<0.01>. The
increased proportion of short chain fatty acids in the newly weaned
rats may be a result of high quantities of these fatty acids in the
mothers' milk (Ross et al., 1985). However, it seems unlikely that
adult rats would incorporate this level of short chain fatty acids
even if the diet contained large quantities of these fatty acids.
This is supported by a comparison of the adult rats fed the pelleted
diet to those fed the semi—synthetic diet as the semi-synthetic
diets contained approximately four times the quantity of short chain
fatty acids of the pelleted diet, however, there was little
difference between uterine proportions of short chain fatty acids of
rats fed pelleted diet or semi-synthetic diets. It therefore seems
likely that this difference was due to age rather than diet.
In conclusion, we demonstrated both a diet induced and an age
related change in the fatty acid composition of the rat uterus. The
diet induced change took place after only three weeks of feeding and
little further changes were observed when feeding was continued for
up to 18 months. Conservation of arachidonic acid by the uterus was
also seen, even in rats on the FO diet. The levels of EFA in the
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uterus suggest low D6 desaturase and high D5 desaturase activity.
There was also evidence for structural replacement of n6 EFA by n3
EFA in the FO fed rats and to some extent in the control rats.
Differences in EFA content of neutral lipid and phospholipid
fractions were also observed, suggesting that phospholipids were the
major source of EFA in the uterus.
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Chapter 4
The Effects of Dietary n3 and n6 Fatty fields on the Fatty Acid
Composition of the Major Lipid Classes of the Rat Uterus
4.1 Introduction
The release of fatty acid prostaglandin precursors from specific
lipid species has been observed in a number of tissues, including
the uterus and in intrauterine tissues thought to be involved in
prostaglandin production during parturition such as the foetal
membranes. In the guinea pig uterus, Leaver and Poyser (1981)
observed release of arachidonic acid from PC and triglyceride and
Ning et al. (1983) observed specific release of tritiated
arachidonic acid from PC, PE and triglyceride from guinea pig
endometrium in culture. In human foetal membranes, specific release
of arachidonic acid from PE and PI was detected during early labour
(Okita et al, 1982). Phospholipase with a preference for PE with
arachidonic acid in the sn-2 position, and phospholipase C specific
for PI have been identified in human foetal membranes (Okazaki et
al., 1978; Di Renzo et al., 1981).
The essential fatty acids may also be incorporated preferentially
into specific lipid species. In the guinea pig uterus, 937. of total
arachidonic acid was esterified to phospholipids of which 807. was
esterified to PE and PC (Leaver and Poyser, 1981) and in the guinea-
pig endometrium exogenous tritiated arachidonic acid was
incorporated predominantly into PE, PC and triglyceride (Ning et
al, 1983). Human amnion at term, also incorporated exogenous
arachidonic acid primarily into PC and PE and a high rate of
turnover of arachidonic acid relative to palmitic acid was detected
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in PC (Schwartz et al., 1977).
The effects of diets with different n3 fatty acid contents on n6
fatty acid incorporation into specific lipid groups was investigated
in rat myocardium, and a greater displacement of arachidonic acid by
n3 fatty acids was detected in PE compared with other phospholipids
(Abeywardena et al., 1987). Huang et al., (1987) also reported
preferential incorporation of n6 above n3 fatty acids into liver and
plasma phospholipids and cholesterol esters compared to
triglyceride. However, no investigation of this sort has yet been
conducted in uterine tissue. Knowledge of the relative distribution
of the n3 fatty acids and n6 fatty acids in the lipid pools
involved in the release of eicosanoid precursor fatty acids is
important if a better understanding of the inhibitory effect of n3
fatty acids on parturition is to be gained. We therefore studied
the effect of three different diets, containing different levels of
n3 and n6 fatty acids, on the incorporation and metabolism of fatty
acids in the monoglyceride, diglyceride, triglyceride, cholesterol
ester, free fatty acid, PI, PE and PC lipid fractions in the rat
uterus.
In chapter 3, evidence for significant changes in uterine fatty acid
composition after only three weeks of feeding diets containing
different proportions of n3 and n6 fatty acids was presented. In
the following experiments, purified n3 and n£> fatty acid ethyl
esters, (linoleic acid ethyl ester and a-linolenic acid ethyl ester,
both >997. pure) were used as the main source of EFA for rats on a
semisynthetic diet and the incorporation of EFA into the major lipid
pools in the rat uterus compared with rats fed a control pelleted
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diet. The purified ethyl esters were used in preference to the EPO
and FO used in chapter 3 to minimise the quantity of n6 EFA present
in the n3 diet and n3 EFA present in the n6 diet. This also
clarified identification of the metabolism of the dietary EFA in the
uterus as the only source of EFA was either linoleic acid or a-
linolenic acid, whereas the FO and EPO provided a range of different
n3 and n6 EFA. The 2- and 3- series PGE and PGF released by these
uteri were analysed using mass spectroscopy (see chapter 5).
4.2 Methods
Nine newly weaned female Sprague-Dawley rats were randomly divided
into three groups and fed either a control pelleted diet or a diet
supplemented with linoleic acid or a-linolenic acid ethyl esters
(both >99"/. pure). Section 2.1 describes the fatty acid content of
the control and semi-synthetic diets. Rats were killed after three
weeks on the diets and uteri removed as described in section 2.2.
Uterine lipid extraction, separation, methylation and analysis were
as described in sections 2.9, 2.11, 2.12, 2.13, 2.14, 2.15, and
2.16. Due to the small number of rats in each group (n=3), it was
not possible to show statistically significant differences between
diet groups.
4.3 Results
The body weights and uterine weights at time of sacrifice were not
significantly different between diet groups. Fur and skin condition
indicated no signs of EFA deficiency and 20:3n9/20:4n6 ratio was
never greater than 0.2 in any of the lipid fractions from any of the
diet groups (a ratio of greater than 0.4 indicates fatty acid
deficiency; Holman, 1960). Tables 4.1-4.7 show the mean percentage
of each fatty acid detected in the three diet groups in the seven
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different lipid -fractions. In the major saturated fatty acids (16:0
and 18:0) there was no clear trends in dietary effects on the
proportions of these fatty acids common to all the lipid groups, and
in most of the lipid groups the different diets had little effect on
the proportions of these fatty acids, however, some differences
could be seen. Proportions of palmitic acid in the triglyceride -
cholesterol ester (table 4.7) and PC (table 4.2) fractions were
higher in linoleic and linolenic diet groups than in the control
diet group (30.0Z/. + 1.62 and 27.717. + 2.68 compared to 21.197. + 2
respectively in the triglyceride-cholesterol ester fraction, and
33.617. + 5.45 and 31.937. + 4.48 compared to 16.687. + 4.82
respectively in the PC fraction), and in the PE fraction (table 4.3)
levels in the linolenic group were higher than in the other two
groups (40.277. + 1.56 compared to 33.927. + 2.71 in control and
28.687. + 3.43 in linoleic groups). Proportions of stearic acid in
PI (table 4.1) were higher in the linoleic and linolenic groups than
in the control group (14.787. + 1.35 and 17.867. + 4.35 compared to
3.337. + 2.23 respectively) and in the free fatty acid fraction
stearic acid proportions were higher in the linoleic group than in
the other two groups (table 4.4) (19.887. + 2.96 compared to 10.287. +
3.82 in the control group and 12.617. + 1.26 in the linolenic group).
There was little difference in proportions of palmitic acid between
the different lipid fractions, however, stearic acid was present in
considerably lower proportions in the triglyceride - cholesterol
ester lipid fraction (table 4.7) than in all the other lipid
fractions.
The monounsaturated fatty acids present in the highest proportions
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were 16:1 and 18:1. Palmitoleic acid (16:1) proportions in the
linoleic and linolenic groups in the triglyceride - cholesterol
lipid fraction (table 4.7) were slightly higher than in the control
group (12.017. + 0.4 and 10.257. + 0.41 compared to 6.467. + 0.57
respectively) and proportions of this fatty acid were also higher in
the linolenic acid fed rats in the diglyceride lipid fraction than
in the rats fed the control or linoleic acid supplemented diets
(7.857. + 0.46 compared to 3.487. + 1.75 and 4.837. + 0.29
respectively). Apart from this there was little evidence of dietary
effect on the proportions of palmitoleic acid. However, a dietary
effect was detected in the proportion of oleic acid which was higher
in the linolenic acid diet groups of the diglyceride, monoglyceride,
free fatty acid, PC and PI lipid fractions than in both tine control
or the linoleic acid diet groups (tables 4.2, 4.3, 4.4, 4.6 and
4.7). Both palmitoleic and oleic acid were incorporated to a
greater extent into the triglyceride - cholesterol ester fraction
than the other lipid fractions (tables 4.1 - 4.7).
Arachidonic acid proportions were higher in linoleic and control
rats than in linolenic fed rats in all lipid fractions except PC and
PI, where proportions were similar in all three diet groups (tables
4.1 - 4.7). The free fatty acid fraction contained the highest
proportion of arachidonic acid of all the lipid fractions in the
control and linolenic diet groups, with mean percentages of 8.477. +
2.58 and 6.787. + 2.63 respectively, being recorded. The proportion
of arachidonic acid in the linoleic diet group, however, was highest
in the PE lipid fraction with a level of 11.357. + 2.24 compared to
10.57 + 0.42 in the free fatty acid fraction. Proportions of
arachidonic acid were lowest in the triglyceride - cholesterol ester
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F.ft. Control PI Linoleic PI Linolenic PI
12:0 1.03 + 0.47 <0.1 <0.1
12:1 2.07 + 1.97 <0.1 <0.1
13:0 2.92 + 1.94 2.75 + 1.32 1.081 + 0.98
13:1 0.18 + 0.08 0.41 + 0.31 <0.1
14:0 2.42 + 1.58 2.95 + 1.18 <0.1
14:1 0.41 + 0.31 <0.1 <0.1
14:2 <0.1 <0.1 <0.1
15:0 0.41 + 0.2 0.48 + 0.22 2.63 + 2.53
15:1 4.22 + 2.12 3.69 + 1.53 1.28 + 1.69
15:2 0.2 + 0.1 0.49 + 0.39 <0.1
16:0 16.79 + 5.03 16.74 + 3.46 17.92 + 3.96
16:1 0.75 + 0.65 3.22 + 1.89 1.45 + 1.36
16:2 <0.1 <0.1 <0.1
17:1 <0.1 <0.1 <0.1
17:2 <0.1 5.22 + 2.22 3.8 + 0.3
18:0 3.33 + 2.23 14.78 + 1.35 17.86 + 4.35
18:ln9 10.41 + 5.98 9.52 + 1.46 11.8 + 1.94
18:2n6 2.03 + 1.22 2.56 + 0.85 2.1 + 0.66
18:3n6 <0.1 <0.1 <0.1
U 1.58 + 0.86 1.84 + 0.94 2.67 + 1.32
18:3n3 0.19 + 0.09 0.73 + 0.37 0.64 + 0.54
18:4n3 <0.1 <0.1 <0.1
20:0 <0.1 0.52 + 0.42 0.34 + 0.17
20:ln9 0.24 + 0.1 2.41 + 1.5 0.15 + 0.05
U <0.1 <0.1 <0.1
20:3n9 <0.1 0.71 + 0.61 <0.1
20:2n6 7.05 + rHHIT—< 9.47 + 2.41 10.74 + 2.6
20:3n6 <0.1 0.16 + 0.06 0.51 + 0.29
20:4n6 4.25 + 3.3 7.29 + 2.02 6.78 + 2.49
20:3n3 1.04 + 0.94 0.44 + 0.34 0.67 + 0.31
20:5n3 0.28 + 0.18 0.41 +■ 0.22 2.09 + 0.66
U <0.1 <0.1 <0.1
22:4n6 0.74 + 0.64 2.41 + 1.8 <0.1
22:5n6 0.75 + 0.41 <0.1 <0.1
22:5n3 <0.1 <0.1 0.4 + 0.24
22:6n3 2.55 + 1.54 3.56 + 2.85 0.46 + 0.2
Table 4.1
Fatty acid content of uterine phosphatidylinositol in rats fed for
three weeks on either a control pelleted diet or a semisynthetic
diet supplemented with linoleic acid ethyl ester or a-linolenic acid
ethyl ester. Fatty acids are shown as a mean percentage of total
fatty acid present in PI + standard error (n = 3 in each diet
group). U indicates an unidentified fatty acid.
12.1
F.A. Control PC Linoleic PC Linolenic PC
12:0 <0.1 2.2 + 1.48 0.31 + 0.12
12:1 <0.1 2.07 + 1.97 <0.1
13:0 <0.1 1.64 + 1.56 0.17 + 0.07
13:1 <0.1 1.05 + 0.95 <0.1
14:0 0.44 + 0.34 2.69 + 0.04 1.72 + 0.82
14:1 <0.1 <0.1 <0.1
14:2 <0.1 <0.1 0.66 + 0.58
15:0 <0.1 0.32 + 0.13 0.36 + 0.13
15:1 1.86 + 1.44 <0.1 0.68 + 0.3
15:2 1.85 + 1.43 <0.1 1.02 + 0.44
16:0 16.68 + 4.82 33.11 + 5.45 31.93 + 4.48
16:1 8.33 + 5.11 5.82 + 0.67 9.14 + 4.62
16:2 2.05 + 1.59 <0.1 <0.1
17:1 <0.1 <0.1 0.2 + 0.1
17:2 2.24 + 0.2 3.54 + 2.12 1.24 + 0.72
18:0 9.77 + 0.51 11.06 + 2.03 9.41 + 1.41
18:ln9 15.33 + 5.62 14.84 + 1.86 20.96 + 2.98
18:2n6 6.08 + 2.22 2.44 + 0.37 1.52 + 0.77
18:3n6 <0.1 <0.1 <0.1
U <0.1 <0.1 <0.1
18:3n3 <0.1 <0.1 0.14 + 0.04
18:4n3 <0.1 <0.1 <0. 1
20:0 <0.1 0.4 + 0.16 0. 14 + 0.04
20:ln9 4.05 + 3.23 <0.1 2.39 + 2.04
U <0.1 <0.1 <0.1
20:3n9 <0.1 <0.1 1.26 + 1.48
20:2n6 <0.1 0.92 + 0.41 1.29 + 0.83
20:3n6 <0.1 0.19 + 0.09 0.22 + 0.12
20:4n6 5.3 1.72 4.94 + 0.12 6.2 + 1.16
20:3n3 <0.1 <0.1 <0.1
20:5n3 <0.1 0.46 + 0.36 1.05 0.51
U <0.1 <0.1 <0.1
22:4n6 7.44 + 2.81 3.62 + 2.32 1.0 + 0.82
22:5n6 2.24 + 1.74 <0.1 <0.1
22:5n3 2.05 + 1.59 0.78 + 0.35 0.41 + 0.21
22:6n3 2.8 + 1.31 <0.1 1.3 + 0.68
Table 4.2
Fatty acid content of uterine phosphatidylcholine in rats fed for
three weeks on either a control pelleted diet or a semisynthetic
diet supplemented with linoleic acid ethyl ester or a-linolenic acid
ethyl ester. Fatty acids are shown as a mean percentage of total
fatty acid present in PC + standard error (n = 3 in each diet
group). U indicates an unidentified fatty acid.
IZZ
F.fl. Control PE Linoleic PE Linolenic PE
12:0 2.63 + 1.36 6.64 + 3.4 1.92 + 0.37
12:1 0.77 + 0.41 0.49 + 0.39 <0.1
13:0 <0.1 0.29 + 0.19 <0.1
13:1 0.91 + 0.44 1.86 + 0.9 <0.1
14:0 5.03 + 1.2 5.7 + 0.76 5.19 + 0.44
14:1 0.2 + 0.15 0.2 + 0.1 <0.1
14:2 0.15 + 0.1 0.14 + 0.04 <0.1
15:0 0.16 + 0.06 0.64 + 0.27 0.66 + 0.31
15:1 0.53 + 0.3 0.65 + 0.48 0.81 + 0.41
15:2 0.68 + 0.58 0.95 + 0.85 <0.1
16:0 33.92 + 2.71 28.68 + 3.43 40.27 + 1.56
16:1 3.31 + 1.67 4.03 + 1.04 3.66 + 0.41
16:2 <0.1 <0.1 <0.1
17:1 0.28 + 0.09 0.43 + 0.16 0.61 + 0.08
17:2 0.5 + 0.22 1.24 + 0.32 0.92 + 0.19
18:0 11.13 + 4.06 11.49 + 1.94 15.2 + 0.88
18:ln9 15.59 + 0.93 12.7 + 0.9 15.36 + 2.5
18:2n6 7.68 + 2.57 3.48 + 0.5 2.95 + 0.12
18:3n6 0.1 + 0.001 <0.1 0.14 + 0.04
U <0.1 0.13 + 0.3 0.13 + 0.03
18:3n3 0.34 + 0.14 0.15 + 0.05 0.38 + 0.07
18:4n3 0.18 + 0.08 <0.1 <0.1
20:0 0.13 + 0.03 <0.1 0.18 + 0.06
20:ln9 0.19 + 0.05 0.18 + 0.05 0.2 + 0.1
U 0.23 + 0.13 <0.1 <0.1
20:3n9 <0.1 <0.1 <0.1
20:2n6 1.1 + 0.6 0.45 + 0.07 0.74 + 0.22
20:3n6 0.58 + 0.3 1.36 + 0.7 0.53 + 0.09
20:4n6 6.3 + 1.93 11.35 + 2.24 4.15 + 0.4
20:3n3 0.25 + 0.15 0.47 + 0.34 <0.1
20:5n3 <0.1 <0.1 1.98 + 0.49
U <0.1 <0.1 <0.1
22:4n6 0.94 + 0.34 1.49 + 0.54 0.28 + 0.07
22:5n6 0.36 + 0.2 0.71 + 0.07 0.13 + 0.03
22:5n3 0.25 + 0.13 0.18 + 0.05 0.83 + 0.15
22:6n3 0.65 + 0.19 0.52 + 0.16 0.98 + 0.36
Table 4.5
Fatty acid content of uterine phosphatidylethanolamine in rats fed
for three weeks on either a control pelleted diet or a semisynthetic
diet supplemented with linoleic acid ethyl ester or a-linolenic acid
ethyl ester. Fatty acids are shown as a mean percentage of total
fatty acid present in PE + standard error (n = 3 in each diet
group). U indicates an unidentified fatty acid.
1X2.
F.A. Control FFA Linoleic FFA Linolenic FFA
12:0 2.36 + 1.74 1 .29 + 0.32 0.3 + 0.25
12:1 0.08 + 0.03 <0.1 <0.1
13:0 0.99 + 0.94 0.72 + 0.37 3.62 + 1.32
13:1 1.18 + 0.54 1.15 + 0.67 0.2 + 0.15
14:0 1.1 + 0.95 1.11 0.7 0.96 + 0.47
14:1 0.13 + 0.08 <0.1 0.11 + 0.06
14:2 0.08 + 0.03 <0.1 0.15 + 0.1
15:0 0.9 + 0.81 3 + 2.84 0.17 + 0.12
15:1 0.45 + 0.4 0.18 + 0.13 <0.1
15:2 0.2 + 0.1 0.33 + 0.28 <0.1
16:0 23.32 + 11.69 25.02 + 3.94 21.6 + 2.44
16:1 1.78 + 0.89 1.13 + 0.1 1.07 + 0.54
16:2 3.24 + 1.63 0.72 + 0.39 1.23 + 1.03
17:1 0.15 + 0.1 0.5 + 0.41 <0.1
17:2 1.56 + 1.46 0.15 + 0.1 1.58 + 0.91
18:0 10.28 + 3.82 19.88 + 2.96 12.61 + 1.26
18:ln9 10.58 + 3.56 13.28 + 1.17 17.06 + 1.49
18:2n6 4.94 + 1.23 2.24 + 0.03 2.75 + 0.66
18:3n6 0.15 + 0.06 0.5 + 0.43 <0.1
U 0.26 + 0.16 0.92 + 0.45 0.45 + 0.2
18:3n3 <0.1 <0.1 <0.1
18:4n3 <0.1 <0.1 <0.1
20:0 0.27 + 0.13 0.17 + 0.06 <0.1
20:ln9 0.35 + 0.06 0.52 + 0.05 0.32 + 0.17
U 0.36 + 0.31 0.52 + 0.19 1.45 + 0.45
20:3n9 <0.1 0.87 + 0.6 1.74 + 0.96
20:2n6 1.72 + 0.66 2.79 + 1.14 2.72 + 1.57
20:3n6 0.77 + 0.22 0.73 + 0.11 0.76 + 0.38
20:4n6 8.47 + 2.58 10.57 + 0.42 6.98 + 2.63
20:3n3 <0.1 <0.1 0.43 + 0.38
20:5n3 0.74 + 0.18 0.64 + 0.24 1.24 + 0.64
U 1.55 + 1.42 2.9 + 1.47 5.1 + 2.58
22:4n6 1.04 -t- 1.01 2.74 + 0.44 1.07 + 0.53
22:5n6 0.85 + 0.81 0.51 + 0.14 0.46 + 0.21
22:5n3 0.19 + 0.07 0.18 + 0.11 1.04 + 0.5
22:6n3 0.56 + 0.24 0.29 + 0.12 0.56 + 0.28
Table 4.4
Free -fatty acid content of the uteri of rats fed for three weeks on
either a control pelleted diet or a semisynthetic diet supplemented
with linoleic acid ethyl ester or a-linolenic acid ethyl ester.
Fatty acids are shown as a mean percentage of total uterine free
fatty acid + standard error (n = 3 in each diet group). U indicates
an unidentified fatty acid.
F.A. Control MB Linoleic MB Linalenic MG
12:0 1.11 + 0.25 <0.1 4.34 + 3.03
12:1 0.49 -t- 0.44 <0.1 <0.1
13:0 0.71 + 0.34 0.41 + 0.36 0.55 + 0.49
13:1 0.64 + 0.3 0.41 + 0.36 <0.1
14:0 3.86 + 1 0.82 + 0.77 5.02 + 1.96
14:1 0.61 + 0.28 <0.1 <0.1
14:2 1.38 + 1.09 <0.1 <0.1
15:0 0.39 + 0.34 0.8 + 0.75 <0.1
15:1 1.59 + 0.86 0.59 + 0.54 1.38 + 1.02
15:2 0.65 + 0.6 3.52 + 3.47 <0.1
16:0 23.22 + 5.52 22.08 + 5.31 36.92 + 11.11
16:1 3.89 + 0.9 1.37 + 1.32 3.72 + 2.72
16:2 <0.1 1.98 + 1.94 0.51 + 0.46
17:1 0.48 + 0.44 1.73 + 1.37 <0.1
17:2 0.9 + 0.44 5.37 + 3.29 1.92 + 0.94
18:0 11.96 + 2.08 15.66 + 2.4 14.31 + 3.14
18:ln9 11.6 + 2.06 12.13 + 2.02 14.47 + 4.42
18:2n6 4.2 + 0.85 2.75 + 0.36 2.71 + 1.05
18:3n6 <0.1 <0.1 <0.1
U <0.1 0.3 + 0.25 <0.1
18:3n3 <0.1 0.47 + 0.42 0.13 + 0.08
lS:4n3 <0.1 <0.1 <0.1
20:0 <0.1 0.47 + 0.42 <0.1
20:In? 0.19 + 0.14 0.77 + 0.72 <0.1
U <0.1 <0.1 <0.1
20:3n9 0.34 + 0.3 0.29 + 0.24 <0.1
20:2n6 2.34 + 2.08 7.78 + 5.36 0.38 + 0.26
20:3n6 <0.1 <0.1 <0.1
20:4n6 7.64 + 4.81 3.09 + 1.11 2.53 + 0.41
20:3n3 <0.1 0.4 + 0.35 <0.1
20:5n3 <0.1 <0.1 0.84 + 0.79
U <0.1 <0.1 <0.1
22:4n6 1.57 + 0.24 2.02 + 1.44 0.64 + 0.22
22:5n6 0.46 + 0.3 <0.1 0.23 + 0.18
22:5n3 0.36 + 0.31 0.63 + 0.58 1.54 + 0.98
22:6n3 1.68 + 0.24 0.51 + 0.43 1.53 + 0.79
Table 4.5
Fatty acid content of uterine monoglyceride in rats fed for three
weeks on either a control pelleted diet or a semisynthetic diet
supplemented with linoleic acid ethyl ester or a-linolenic acid
ethyl ester. Fatty acids are shown as a mean percentage of total
fatty acid present in uterine monoglyceride + standard error (n = 3
in each diet group). U indicates an unidentified fatty acid.
I IS
F.A. Central DG Linoleic DG Linalenic DG
12:0 4.2 + 2.55 2.56 + 1.27 4.23 + 3.46
12:1 0.25 + 0.2 <0.1 0.26 + 0.21
13:0 2.19 + 0.83 0.85 + 0.4 0.04 0.00'
13:1 0.79 + 0.62 2.93 + 0.27 0.36 + 0.3
14:0 3.98 + 0.3 4.32 + 0.05 4.21 + 2.27
14:1 0.75 + 0.26 <0.1 0.36 + 0.19
14:2 0.14 + 0.08 <0.1 0.14 + 0.09
15:0 1.21 + 0.38 <0.1 0.16 + 0.11
15:1 1.58 + 0.42 4.1 + 1.16 0.48 + 0.39
15:2 1.63 + 0.74 <0.1 0.16 + 0.11
16:0 23.38 + 1.59 23.29 + 0.38 26.2 + 2.6
16:1 3.46 + 1.75 4.83 + 0.29 7.85 + 0.46
16:2 1.7 + 1.65 6.04 + 3.25 0.25 + 0.2
17:1 0.87 + 0.69 <0.1 0.12 + 0.08
17:2 3.64 + 2.41 6.69 + 1.74 2.72 + 2.67
18:0 8.02 + 0.71 10.58 + 0.77 6.78 + 2.26
18:ln9 13.84 + 1.59 11.52 + 0.55 21.04 + 0.99
18:2n6 5.68 + 0.5 2.64 + 0.15 1.92 + 0.3
18:3n6 0.24 + 0.01 0.24 + 0.19 <0.1
U 1.65 + 1.12 <0.1 <0.1
18:3n3 0.3 + 0.12 <0.1 2.0 + 0.1
18:4n3 0.14 + 0.09 <0.1 0.6 + 0.52
20:0 0.6 + 0.35 <0.1 <0.1
20:ln9 0.81 + 0.76 <0.1 <0.1
U 0.14 + 0.09 <0.1 0.66 + 0.6
20:3n9 <0.1 1.07 + 0.52 <0.1
20:2n6 2.71 + 0.32 <0.1 1.1 0.68
20:3n6 0.14 + 0.09 <0.1 0.49 + 0.34
20:4n6 4.09 + 1.16 4.61 + 2.02 2.28 + 1.29
20:3n3 0.23 + 0.09 0.35 + 0.3 <0.1
20:5n3 0.58 + 0.27 <0.1 0.28 + 0.23
U <0.1 <0.1 <0.1
22:4n6 1.23 + 0.64 <0.1 0.09 + 0.04
22:5n6 0.41 + 0.36 <0.1 0.13 + 0.01
22:5n3 0.46 + 0.12 <0.1 1.11 + 0.86
22:6n3 1.43 + 0.74 <0.1 2.63 + 2.35
Table 4.6
Fatty acid content of uterine diglyceride in rats fed for three
weeks on either a control pelleted diet or a semisynthetic diet
supplemented with linoleic acid ethyl ester or a-linolenic acid
ethyl ester. Fatty acids are shown as a mean percentage of total
fatty acid present in uterine diglyceride ± standard error (n = 3 in
each diet group). U indicates an unidentified fatty acid.
life
F.fl. Con TO. Choi Linoleic TG. Choi Linolenic TB. Choi
12:0 1.744 + 0.716 3.08 + 3.01 13.28 + 2.32
12:1 0.485 + 0.187 0.64 + 0.4 0.63 + 0.11
13:0 0.624 + 0.187 0.39 + 0.19 0.06 + 0.01
13:1 0.213 + 0.048 0.3 + 0.17 0.09 + 0.04
14:0 3.296 + 0.554 10.04 + 2.12 10.03 + 0.94
14:1 0.56 + 0.358 0.87 + 0.18 0.99 + 0.03
14:2 0.22 + 0.06 0.13 + 0.08 <0.1
15:0 0.71 + 0.28 0.34 + 0.15 0.19 + 0.08
15:1 0.3 + 0.1 0.21 + 0.16 0.06 + 0.01
15:2 0.34 + 0.26 <0.1 <0.1
16:0 21.19 2 30.02 + 1.62 27.71 + 2.68
16:1 6.46 + 0.57 12.01 + 0.4 10.24 + 0.41
16:2 0.33 + 0.16 0.39 + 0.34 <0.1
17:1 0.451 + 0.05 0.24 + 0.04 0.09 + 0.04
17:2 0.45 + 0.23 0.78 + 0.34 0.25 + 0.2
18:0 2.74 + 1.18 3.74 + 0.35 2.77 + 0.18
18:ln9 22.85 + 3.9 25.76 + 0.94 22.64 + 0.46
18:2n6 15.0 + 2.96 4.3 + 0.83 1.17 + 0.19
18:3n6 0.265 + 0.21 0.15 + 0.1 <0.1
U <0.1 <0.1 <0.1
18:3n3 0.88 + 0.21 0.27 + 0.19 1.77 + 1
18:4n3 <0.1 0.15 + 0.02 0.08 + 0.04
20:0 0.88 + 0.21 0.32 + 0.28 <0.1
20:ln9 0.27 + 0.12 0.63 + 0.55 0.13 + 0.08
U <0.1 <0.1 0.12 + 0.07
20:3n9 0.06 + 0.01 0.17 + 0.03 0.15 + 0.07
20:2n6 0.45 + 0.13 0.21 + 0.06 0.16 + 0.11
20:3n6 0.1 + 0.05 0.12 + 0.04 <0.1
20:4n6 2.2 + 0.6 1.98 + 0.4 0.64 + 0.39
20:3n3 <0.1 <0.1 <0.1
20:5n3 0.12 + 0.05 <0.1 0.33 + 0.06
U <0.1 <0.1 <0.1
22:4n6 0.6 + 0.12 1.09 0.5 0.08 + 0.02
22:5n6 0.06 + 0.01 0.06 + 0.01 0.08 + 0.03
22:5n3 0.07 + 0.02 0.61 + 0.55 0.33 + 0.12
22:6n3 0.7 + 0.18 0.21 + 0.09 1.2 + 1.0
Table 4-7
Fatty acid content of uterine triglycerides and cholesterol esters
in rats fed for three weeks on either a control pelleted diet or
semisynthetic diet supplemented with linoleic acid ethyl ester or a-
linolenic acid ethyl ester. Fatty acids are shown as a mean
percentage of total fatty acid present in uterine triglycerides and
cholesterol esters + standard error (n = 3 in each diet group). U
indicates an unidentified fatty acid.
m
lipid fraction with mean levels of 2.22"/., 1.98*/. and 0.64"/. in the
control, linoleic and linolenic diet groups respectively. The
proportions of arachidonic acid in the other neutral lipid fractions
(diglyceride and monoglyceride - tables 4.4 and 4.3) were also lower
than those in the free fatty acid and phospholipid fractions (tables
4.4 - 4.7).
Proportions of eicosapentaenoic acid <20:5n3) were highest in the
linolenic acid diet group in all the lipid fractions except
diglyceride where it was highest in the control group (tables 4.1 -
4.7). In the control and linoleic diet groups, the free fatty acid
lipid fraction contained the highest proportion of 20:5n3 (0.747. +
0.18 and 0.647. + 0.24 respectively). However, in the linolenic
group, the highest proportions were found in the PI and PE at 2.097.
+ 0.66 and 1.987. + 0.49 respectively, compared to 1.247. + 0.64 in
the free fatty acids. There was no clear dietary effect on levels
of dihomo-gamma-linolenic acid (20:3n6) in any of the lipid
fractions. The free fatty acid and PE fractions contained the
highest proportions of this fatty acid, with percentages of 0.77 +
0.22, 0.73 + 0.11 and 0.76 + 0.38 in the control, linoleic and
liolenic groups respectively in the free fatty acid fraction, and
proportions 0.587. + 0.3, 1.367. + 0.7 and 0.537. + 0.09 in the
control, linoleic and linolenic groups respectively, in the PE
fraction.
Control proportions of linoleic acid were considerably higher than
those of linoleic and linolenic acid ethyl ester fed rats in all
lipid fractions except PI where proportions were similar in all
three diet groups (tables 4.1 - 4.7). The proportions of linoleic
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acid in the linoleic acid ted rats were slightly higher than those
of the linolenic acid fed rats in all except the free fatty acid
fraction where the linolenic acid fed rats had a higher proportion.
There was a higher proportion of linoleic acid in the triglyceride -
cholesterol ester lipid fraction in both control and linoleic groups
(157. + 2.96 and 4.37. + 0.83 respectively) than in any of the other
lipid fractions in the different diet groups. However, in the
linolenic group there was little difference between lipid fractions,
with proportions of around Z/. being found in all lipid frations,
a-linolenic acid proportions were highest in the diglyceride and
triglyceride - cholesterol ester lipid fractions of the linolenic
acid diet group, with proportions of 2.07. + 0.1 and 1.777. + 1
respectively, being observed. These were also the only lipid groups
where a clear dietary effect on a-linolenic acid levels was
observed, with the linolenic acid fed rats having the highest
percentages and the linoleic the lowest.
The n6 22 carbon fatty acids (22:4n6 and 22:5n6) were present in
considerably lower proportions than arachidonic acid in each of the
diet groups in all of the lipid fractions, with the exception of the
control PC. The 22:4n6 was also generally present in higher
proportions than 22:5n6. This was in contrast to the n3 22 carbon
fatty acids (22:5n3 and 22:6n3> which were present in equal or
greater proportions than 20:5n3 throughout most of the lipid
fractions (with the exception of the free fatty acids). 22:6n3 was
also usually present in higher proportions than 22:5n3. Figures 4.1
- 4.14 illustrate these results. Proportions of 22:4n6 were higher
in linoleic and control rats than in linolenic rats, whereas 22:5n3
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Figure 4.1
Proportions o-f n6 essential -fatty acids in the
phosphatidyl inositol lipid -fraction of uterine tissue from
rats fed for three weeks on either a control pelleted diet
(83.67. n6 and 17.47. n3 EFA) , a semisynthetic diet
supplemented with linoleic acid (99.97. n6 EFA) or a
semisynthetic diet supplemented with a-linolenic acid (97.67.
n3 EFA). n =3 for each diet group. Proportions are
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Figure 4.2
Proportions of n3 essential fatty acids in the
phosphatidylinositol lipid fraction of uterine tissue from
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Figure 4.3
Proportions of n6 essential fatty acids in the
phophatidy1choline lipid fraction of uterine tissue from
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Figure 4.4
Proportions of n3 essential fatty acids in the
phosphatidylcholine lipid fraction of uterine tissue from
rats fed for three weeks on diets as described in figure
4.1.
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Figure 4.5
Proportions o-f n6 essential fatty acids in the
phosphatidylethanolamine lipid fraction of uterine tissue




Proportions of n3 essential fatty acids in the
phosphatidylethanolamine lipid fraction of uterine tissue
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Figure 4.7
Proportions of n6 essential fatty acids in the free fatty
acid lipid fraction of uterine tissue from rats fed for
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Figure 4.8
Proportions of n3 essential fatty acids in the free fatty
acid lipid fraction of uterine tissue from rats fed for
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Figure 4.9
Proportions of n6 essential fatty acids in the monoglyceride
lipid fraction of uterine tissue from rats fed for three
weeks on diets as described in figure 4.1.
I 2,%
Figure 4.1Q
Proportions of n3 essential -fatty acids in the monog 1 yceride
lipid -fraction o-f uterine tissue from rats fed for three
weeks on diets as described in figure 4.1.
Figure 4.11
Proportions of n6 essential fatty acids in the diglyceride
lipid fraction of uterine tissue from rats fed for three
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Figure 4.12
Proportions of n3 essential fatty acids in the diglyceride
lipid fraction of uterine tissue from rats fed for three
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Figure 4.13
Proportions o-f n6 essential -fatty acids in the triglyceride
and cholesterol ester lipid -fraction o-f uterine tissue from
rats fed for three weeks on diets as described in figure
4.1.
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Figure 4.14
Proportions of n3 essential
and cholesterol ester lipid
rats fed for three weeks i
4.1.
fatty acids in the triglyceride
fraction of uterine tissue from
n diets as described in figure
IMS
the linoleic group.
Figure 4.15 shows the n3/n6 ratios of the different diet groups in
each lipid fraction. The ratios were highest in the linolenic fed
rats in the triglyceride - cholesterol ester and diglyceride lipid
fractions (ratios of 1.39 and 1.33 respectively) and lowest in the
linoleic fed rats in the free fatty acid and RE fractions (both
ratios were 0.08). In each lipid fraction the linolenic group had
the highest n3/n6 ratio and the linoleic the lowest, with the
exception of the triglyceride - cholesterol ester fraction where the
control ratio was slightly lower than that of the linoleic. The PI
and free fatty acid lipid fractions were least affected by the
linolenic acid diet with ratios of 0.23 and 0.26 respectively. PE
was the phospholipid group most affected by the linolenic acid diet
with a ratio of 0.47. The dietary n3/n6 ratio of control, linoleic
and linolenic acid diets were 0.18, 0.002 and 17.43 respectively.
The value for the linoleic acid diet was far lower than any of the
tissue values found, whereas the ratio for the linolenic acid diet
was far greater than any of the tissue ratios. This suggests
conservation of both n3 and n6 fatty acids in the uterus and is in
accordance with the results presented in chapter 3, where rats were
fed evening primrose oil and fish oil diets high in n6 and n3 fatty
acids respectively.
4.4 Discussion
The results of this chapter confirm the results described in chapter
3 which indicated that three weeks of feeding diets with high n3 or
n6 fatty acid contents induced significant changes in the fatty acid
composition of uterine tissue of the rat.
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n3/n6 EFA ratios in triglyceride-cholesterol ester,
diglyceride, monoglyceride, tree -Fatty acid, PE, F>C and PI
lipid -Fractions -From uterine tissue of three groups of three
rats fed for three weeks on either a control pelleted diet
or a semisynthetic diet supplemented with linoleic acid
(99.9*/. n6 EFA) or a semisynthetic diet supplemented with a-
linolenic acid (97.67. n3 EFA).
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In the phospholipids, the fatty acid content of PE was more
susceptible to changes in dietary n3 and n6 fatty acid than either
PC or PI (Figure 4.15). In rats fed a-linolenic acid the n3/n6
ratio was higher in PE than in either PC or PI (0.47 compared to 0.3
and 0.23 respectively). The PE 20C essential fatty acids were also
more susceptible to dietary change than those of PC and PI with high
proportions of 20:5n3 (1.987. + 0.49) but low arachidonic acid
(4.157. + 0.4) in the a-linolenic acid fed rats (figures 4.5 and
4.6). Abeywardena et al. (1987) also reported the largest decrease
in arachidonic acid to occur in PE on feeding a diet high in n3
fatty acids in rat cardiac tissue. In the linoleic acid fed rats
the opposite was true (figures 4.5 and 4.6) with low 20:5n3 (<0.17.)
and high arachidonic acid proportions (11.357. + 2.24). In both PC
and PI 20:5n3 levels were higher in the linolenic group than in the
other diet groups, however the difference was less than in the PE
fraction (figures 4.2 and 4.4). The a-linolenic acid diet had no
effect on the arachidonic acid proportion in PI and PC (figures 4.1
and 4.3 respectively). In the PC and PI fractions there were low
levels of 22:4n6 in the linolenic group compared to the control and
linoleic groups. Inhibition of conversion of arachidonic acid to
adrenic acid may be one way in which the uterus conserves
arachidonic acid.
There was a marked difference in the effect of the n3 and n6 diets
on the essential fatty acid composition of individual lipid groups.
Neutral lipids (with the exception of free fatty acids) and in
particular the triglyceride - cholesterol ester and diglyceride
fractions exhibited the largest increase in n3/n6 fatty acid ratio
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in response to the a-linolenic acid diet (figure 4.15). The
essential fatty acid content of the triglyceride - cholesterol ester
fraction consisted mainly of 18C fatty acids and only contained low
proportions of the eicosanoid precursors (table 4.7). In chapter 3
a relatively high accumulation of linoleic and a-linolenic acids in
comparison to the longer chain essential fatty acids was observed in
the neutral lipids. This accumulation of the 18C n3 and n6 fatty
acids was not observed in diglyceride, monoglyceride or free fatty
acid lipid fractions. The arachidonic acid and eicosapentaenoic
acid composition of the diacylglycerol, monacylglycerol and free
fatty acids also differed from that of the triacylglcerol -
cholesterol ester pool, in containing higher proportions of these
fatty acids (tables 4.4-4.6). This suggests the possible actions of
phospholipase C, diacylglycerol lipase and monoacylglycerol lipase
in releasing free fatty acids in uterine tissues. These enzymes
have been identified in human uterine decidua and foetal membranes
(Di Renzo et al., 1981; Okazaki et al., 1981)
In the free fatty acid fraction, arachidonic acid and
eicosapentaenoic acid comprised a large proportion of the essential
fatty acids (figures 4.7 and 4.8), suggesting these fatty acids may
be selectively released. The dietary effect on the proportions of
free fatty acids was not as pronounced as that seen in the PE,
monoglyceride or diglyceride fractions, suggesting that the major
sources of free fatty acid in the non-pregnant rat uterus may be
from PI and PC. Leaver and Poyser (1981) suggested that PC may form
the major source of arachidonic acid for prostaglandin synthesis in
the guinea pig uterus, and further studies using tritiated
arachidonic acid indicated release of arachidonic acid in vitro from
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PC, PE and possibly triglyceride (Ning et al., 1983). In human
-Foetal membranes during labour, PI and diacyl Ft have been
suggested to be the sources of free arachidonic acid (Okita et al.,
1982).
Despite the high dietary levels of linoleic or a-linolenic acids
received by the rats on the semi-synthetic diet (greater than 95"/. of
total unsaturated fatty acid in both cases), this did not increase
the tissue levels of these fatty acids compared to those from rats
on the control diet (which contained only 45.67. linoleic acid and
less than 2.87. a-linolenic acid). In most of the lipid fractions,
rats from the control group contained higher tissue levels of
linoleic acid than those from the linoleic group. The high levels
of linoleic acid in the control rats may have resulted from impaired
desaturation and elongation by n3 fatty acids also present in the
control diet. However, there was little overall difference between
arachidonic acid levels in the control and linoleic acid fed rats.
The control levels may, however, have been increased by small
guantities of gamma-linolenic acid and arachidonic acid in the
control diet. One other possibility for the lower levels of
linoleic acid in the linoleic acid fed rats is that the ethyl ester
form of the fatty acid may not have been well absorbed by the rats.
It has been suggested that the ethyl ester forms of fatty acids are
not as well absorbed as the free acid, or other forms such as
triacylglycerols, in humans (El Boustani et al., 1987; Lawson and
Hughes, 1988) and rats (Lawson et al., 1985).
In all of the lipid fractions and dietary groups there were high
proportions of linoleic acid compared to gamma-linolenic and dihomo-
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gamma-linolenic acids. There was no accummulation of either gamma-
or dihomo-gamma-1inolenic acids in any of the lipid groups. This
suggests low D6-desaturase activity but high elongase and D5
desaturase activity. The same results were found in chapter 3. The
high proportions of n3 22C fatty acids compared to n3 20C fatty
acids and the low proportions of n6 22C compared to n6 20C fatty
acids also correlated with results presented in chapter 3. The rats
fed the linoleic and 1inolenic acid diets in this study received no
detectable quantities of 22C fatty acids in the diet, suggesting
that the tissue levels of these fatty acids were a result of
synthesis from precursors. The accummulation of 22C n3 fatty acids
relative to 20C n3 fatty acids has been reported in other studies
(Abeywardena et al., 1987). The considerably greater accummulation
of 22C n3 fatty acids compared to 22C n6 fatty acids suggested that
20:5n3 was a better substrate than 20:4n6 for the elangase enzymes
and that 22:5n3 was a much better substrate than 22:4n6 for D4
desaturase.
In conclusion, the dietary n3 and n6 fatty acids were incorporated
differently in individual lipid fractions of the rat uterus. The
phospholipid fractions of PC and PI conserved arachidonic acid when
rats were fed a diet high in a-linolenic acid and low in n6 fatty
acids. PE was more susceptible to dietary change than
phosphatidylinositol or phosphatidylcholine. Evidence was found for
the selective release of the prostaglandin precursor essential fatty
acids, with the free fatty acid fraction containing high levels of
these fatty acids compared to 18C and 22C essential fatty acids.
Low levels of the eicosanoid precursor fatty acids were detected in
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the triglyceride and the cholesterol ester pools.
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Chapter 5
The Biosynthesis of the 2- and 3-5eries Prostaglandins in Rat Uterus
After Linoleic and g-Linolenic Acid Feeding: Mass Spectroscopy of
Prostaglandin E and F Produced by Rat Uteri in Tissue Culture
5.1 Introduction
The uterine tissues of the human responsible for prostaglandin
synthesis are characterised by a high arachidonic acid content and
by increasing arachidonic acid incorporation with gestational age
(Schwarz et al., 1975; Schwartz et al. , 1977). Large quantities of
prostaglandins are released at parturition (Leaver et al., 1989;
Leaver et al., 1987; Leaver & Seawright, 1982; Leaver & Richmond,
1984; Roberts et al., 1975) and the selective esterification of
arachidonic acid by uterine phospholipids has been described
(Leaver & Ning, 1981; Ning et al., 1983; Leaver & Peatty, 1985).
Both arachidonic acid esterification and prostaglandin release are
influenced by endocrine control (Leaver et al., 1989; Leaver &
Poyser, 1981; Leaver & Ning, 1981; Olund & Lunell, 1980; Ning et
al., 1983; Leaver & Seawright, 1982; Leaver & Richmond, 1984;
Roberts et al., 1985; Leaver & Peatty, 1985). The inhibitory effect
of the n3 essential fatty acids on uterine activity at parturition
was identified in rats fed a diet containing a-linolenic acid as the
major essential fatty acid (Quackenbush et al., 1942; Leat &
Northrop, 1979; Leat & Northrop, 1981). These rats showed defects
in initiating and sustaining labour. As a result of the protracted
labour, fetal mortality was high and it was found that if Caesarian
section was carried out early in labour, live animals were
delivered. Similar effects on the initiation of parturition were
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observed when fish oil was given as the major dietary essential
fatty acid (Leaver et al., 1986). In these experiments, an
inhibition of the uterine synthesis of the 2-series prostaglandin,
PGES, was detected in fish oil-fed rats.
The composition of uterine lipid may influence the release and the
activity of a range of stimuli at parturition. These stimuli
include the prostaglandins, platelet-activating factor, cytokines
and other mediators (Leaver et al., 1989; Roberts et al., 1985;
Billah & Johnston, 1983; Romero et al., 1988). The best
characterised of these stimuli are PGF3« and PGE=. The involvement
of PGE= and PGF^ in the excitatory phases of uterine activity has
been established (Wickland et al., 1984), although the control of
their release remains poorly defined. It has been proposed that a
major regulator of cyclooxygenase activity is substrate
availability. The dietary n3 fatty acids are rapidly incorporated
into uterine lipid (chapters 3 and 4), and selective turnover of the
n6 fatty acids in the various lipid pools of the uterus has been
detected (Leaver & Poyser, 1981; Leaver & Ning, 1981; Olund &
Lunell, 1980; Qkita et al., 1982; Ning et al., 1983; Qkazaki et al.,
1978; Leaver & Peatty, 1985). There is also evidence of selective
release of n6 fatty acids during parturition (Ogburn et al., 1980;
□lund & Lunell, 1980; Qkita et al., 1982; Okazaki et al., 1981).
These studies of fatty acid uptake and release indicate that the
enzymes of uterine phospholipid metabolism regulate the release of
n6 fatty acids at parturition. It has been proposed that the n3
effect on parturition may be explained principally in terms of the
competetive inhibition of n6 specific cyclooxygenase metabolism
(Leaver & Poyser, 1981; Leaver & Ning, 1981; Olund & lunell, 1980;
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Ning et ai., 1983; Leaver et al., 1986). However, little is known
about the capacity of the eyelooxygenase enzyme to metabolise the n3
fatty acids in the uterus (Leaver et al., 1989). We therefore
investigated the molecular species of PGF and PGE synthesised by the
uteri of rats after short-term feeding with diets containing either
predominantly n3 fatty acids, predominantly n6 fatty acids or a
normal pelleted diet. The GC-MS fragmentation of a variety of
derivatives of PGF^ct, PGF3O!, PGE^, PGE3, PGB^ and PGB3 were
investigated and compared with the spectra of PGF, PGE and PGB
synthesised by the uteri of rats fed the n3, n6 and control diets.
The uterine prostaglandin synthesis was studied under two
conditions, using either unstimulated uterine explants in tissue
culture, or tissue whose phospholipase As had been maximally
stimulated using the calcium ionophore A23187. The aim of this
study was to determine the capacity of the unstimulated and the
stimulated uterus to release the 3-series prostaglandins and to
define the influence of dietary EFA on uterine prostaglandin
release.
5.2 Materials and Methods
5.2.1 Rats and Diet
Twenty four newly weaned 21 day old female Sprague Dawley rats were
randomly divided into three groups and maintained on different diets
of either a control pelleted diet or a semisynthetic diet
supplemented with linoleic acid or a-linolenic acid (see section 2.1
for diet compositions). After 21 days on the diet, rats were killed
and the uteri removed as described in section 2.3. Rats used in
these experiments were the same as those in chapter 4.
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5.2.2 GC-MS o-f Prostaglandins
A number o-f different methods of purification and derivatisation of
prostaglandins were tested to identify the best method of analysis.
These will be described in the order in which they were carried out.
(a) Analysis of PGF (Me,TMS) and PGE <Me,BuO,TMS) Derivatives.
2 uteri from each diet group were cultured in medium 199 containing
5pg/ml A23187. After culture, the medium from the two uteri of each
diet group was pooled and the prostaglandins extracted into ethyl
acetate (section 2.4). The samples were then purified by passing
them through a Sep-Pak and each sample split into two halfs (section
2.4). PGF (he,TMS) and PGE (Me,BuO,TMS) derivatives were then
prepared from one half of each sample (section 2.7a). These samples
were analysed by total ion monitoring (TIM, see section 2.8a) and
single ion monitoring (SIM, see section 2.8b) for the PGF 423 ion.
The other half of the samples were further purified by t.l.c.
(section 2.4) and were analysed using TIM and SIM for the 510 and
295 ions in the E samples and the 423 ion in the F samples.
Standards of PGE=, PGE3, PGF=,;, and PGF3,^ were run prior to samples
in each case to obtain elution times for the prostaglandins.
(b) Analysis of PGB (Me,TBDMS) Derivatives.
Six uteri from each diet group were divided into two groups of
three, and one group of three from each diet group was cultured in
medium 199 with 5 ug/ml A23187 and the other group of three cultured
in medium 199 without A23187. Prostaglandins from each group were
extracted from the medium and pooled (section 2.4). They were then
purified by passing through a Sep-Pak, followed by t.l.c.. PGE was
converted to PGB (section 2.5) and further purified by HPLC (see
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section 2.6). Me,TBDMS derivatives were prepared from purified samples (section
2.7b), and standards were injected into the GC to obtain column retention times
and ratios for multiple ion detection. Samples were then analysed using SIM for
the 405 ion and multiple ion detection (MID, see section 2.8c) for the 403
(PGBt.) and 405 (PGB=) ions.
(c) Analysis of PGF (Me,TBDMS) Derivatives.
Samples were prepared as in (b) up to t.l.c., where E and F prostaglandins were
separated. F samples were not purified by HPLC. Standard PGF (Me,TBDMS)
derivatives were used to obtain GC column retention times and ratios for the
MID. Standards were injected at regular intervals during analysis to monitor
retention times. These remained constant provided the column was maintained at
injection temperature between injections. Repeated injections had a range of ±
0.05 minutes from the mean retention time. Samples were analysed by SIM for the
653 ion and MID for the 653 and 651 ions. Deuterated prostaglandin internal
standards were not available for improved quantitation and identification of
prostaglandins in samples
5.3 Results
5.3.1 TIM and SIM of PGE (Me.BuQ.TMS) Derivatives
PGE (Me,BuO,TMS) has syn and anti butoxime isomers that had different GC column
retention times. Standards of PGE^ and PGE3 were found to elute at 19.2 - 19.3
minutes for the first isomer and 20.2 - 20.3 minutes for the second isomer. The
column would not separate 2 and 3 series prostaglandins. TIM analysis of PGE
samples only purified by Sep-Paks did not produce any clear results with the
chromatograms obtained having many unidentified peaks that hid any peaks
appearing from PGE. Spectra taken at the correct time exhibited a large
number of non-prostanoid ions that prevented identification of PGE.
To try and remove some of the contaminating material it was
therefore decided to purify the sample by t.l.c. after purification
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with Sep-Paks. It was also decided to use SIM instead of TIM to
increase the sensitivity o-f the mass spectrometer for PGE specific
ions. SIM was first used for the PGE3 510 ion, thi.s is only found
in PGEt. and so a peak appearing on the chromatogram at a time
corresponding to that of the PGE standards would be evidence for the
presence of PGE3 in the samples. However, this ion is present in
the greatest quantity in the first E isomer which is the minor
isomer and so reduces the chance of detection against the background
noise and ions produced from non-prostanoid substances. SIM for the
510 ion did not produce a peak on the chromatogram at the correct
time in any of the samples, suggesting levels of PGE3 were below the
leveL of detection for this method.
The 295 ion is the major ion of the second isomer of both PGE= and
E3 and so is the ion that would give the largest signal and have the
best chance of detection. However, since it is also present in
PGE3, a peak at the correct time an the chromatogram would only be
evidence for the presence of PGE. Identification of PGE3 would have
to rely on spectra of the samples. Using SIM for the 295 ion clear
peaks were identified in all three samples at the correct time on
the chromatograms, however, interference from other substances on
the spectra again prevented identification of PGE= or PGE3.
5.5.2 SIM of PGB (Me.TBDMS) Derivatives
Due to the problems of contaminating substances masking the
detection of the PGE, a number of measures were taken to further
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purify and concentrate the samples and improve the sensitivity of
detection on the mass spectrometer. To concentrate the samples it
was decided to use three uteri instead of two for prostaglandin
production and to convert PGE into PGB, this eliminates the problem
of the two oxime isomers, meaning that all the E can be detected in
one peak instead of two. To further purify the samples it was
decided to use uteri that had not been stimulated with A23187 in
addition to uteri that had been stimulated with A23187, since the
A23187 may have been causing indiscriminate production of non-
prostanoid substances as well as prostaglandins. It was also
decided to purify the PGB by HPLC, this cannot be done conveniently
with PGE as it does not have an ultraviolet chromophore for ease of
defining retention times. Multiple ion detection was also used for
analysis, this is a more sensitive and accurate method of detection
of selected ions than SIM. One disadvantage of the MID is that
spectra cannot be taken when the mass spectrometer is in this mode
of operation, therefore SIM was also used to obtain spectra from the
samples.
PGB (Me,TBEMS) standards had a GC column retention time of 15
minutes. SIM for the 405 ion was used. This ion is specific for
PGB^, however, the spectrometer was set to cover a range of + 3.5
mass units from the mid—setting so it would also monitor the 403
PGB^ ion. The 405 ion was chosen because it is the largest PGB^ ion
and is also a heavy ion and so is likely to avoid the majority of
the interfering ions. This is also an advantage of the TBDMS
derivative over the TMS derivative. Standard PGB^ and PGB3
(Me,TBDMS) spectra are shown in figures 5.1 and 5.2. The
chromatograms produced using SIM for the 405 ion in the samples not
stimulated with A23187 exhibited very few interfering peaks and a
large peak was produced in each sample at the time corresponding
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exactly to that of the PGB^ and PGBr (Me,TBDMS) standards. Spectra
taken also contained few interfering ions and clear identification
of PGB^ could be made in all samples with characteristic ions being
easily identifiable. In the control sample PGB^ ions were
identified at 462, 405, 391, 363, 300, 248 and 216. In the linoleic
sample ions were identified at 462, 405, 391, 373, 363, 300, 248 and
216, and in the linolenic sample, 462, 405, 391, 373, 363 and 216
ions could be seen. The ions were all present in approximately the
correct proportions for PGBs, except for the 391 ion in the
linolenic sample which was higher than in B^, since this is the
major ion in PGB^ and has a far higher abundance than in PGBs, this
may suggest the presence of some Br.. However, no exclusive PGB3
ions could be observed in the spectra.
In the samples stimulated with A23187, the chromatograms from the
linoleic and linolenic samples produced clear peaks at the correct
time of 15 mins. Spectra taken had a large nunber of interfering
ions present, however, identification of RGBs could be made with the
462, 448, 405, 391, 363 and 300 ions being visible in both samples.
The chromatogram from the control sample, however, had many
contaminating substances present which prevented identification of
PGB ions.
Estimates of the quantity of PGB in the samples were made by
comparison of heights of peaks produced on the chromatograms from
known quantities of standards with those produced from the samples.
These estimates are shown in table 5.1.
5.3.3 MID of PGB (Me.TBDMS) Derivatives
In MID measurements, peak heights were measured from the mid-point
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! PGB ug/g Tissue ! PGF ug/g Tissue !
!Control ILinoleic ILinolenic !Control ILinoleic ILinolenic!
Normal ! 3 I 8 I 3 I ~0.1 I ~0.1 ! ~0.1
tissue ! ! ! ! !
A23187 : 1 : 13 ! 12 ! 1 ! 1 ! X>.3
induced ! ! ! ! ! !
tissue ! ! ! ill
Table 5.1
Estimated uterine production of prostaglandins E and F in rats fed
either a control pelleted diet or a semisynthetic diet supplemented
with linoleic or a-linolenic acid ethyl esters <n = 3 for each diet
group in normal and A23187 stimulated tissue). Incubating medium
was replaced after 30 minutes, 3 hours and 15 hours and the
prostaglandins immediately extracted from the medium after each
incubation. Prostaglandins were identified by gas chromatography.
Results are expressed as pg prostaglandin produced per g wet weight
uterus from three uteri in each group. Quantitation of PGF in
unstimulated uteri was innacurate due to small peak sizes produced
in the chromatograms. Results are estimates based on one
chromatographic peak.
If?
of noise at the bottom of the peak to the mid-point of noise at the
top of the peak. Cross channel interference was expressed as a
percentage of the peak height in the blank channel compared to the
peak height in the sample channel, where the peak height in the
sample channel was equal to 100"/.. Noise was expressed as a ratio of
the noise height to the peak height for each ion in each sample.
The 405 PGB^ and 403 PGEFj ions were monitored. Standard PGB^
(Me,TBDNS) was used to obtain a ratio of the height of the peak
produced in the channel monitoring the 405 ion to that produced in
the channel monitoring the 403 ion. Any reduction in this ratio in
the samples would suggest the presence of the 403 ion and therefore
the presence of PGB3. The results are shown in table 5.2. In the
unstimulated uteri there was no evidence of PGB3 production in
either control or linoleic acid fed rats. In the linolenic acid fed
rats a slight increase in the 403 to 405 ion ratio of 3.3 in the
PGBs standard to 3.5 in the linolenic acid fed rats was detected.
The difference, however, could have arisen from background noise.
In the A23187 stimulated uteri, increased ratios above that of the
PGB^ standard were observed in all three diet groups, indicating
PGBt production in each case. The linolenic acid fed rats gave the
highest ratio of 21.3, compared to 9.7 in the control rats.
5.3.4 TIM and SIM of PGF (Ne.TNS) Derivatives
PGF (Ne,TNS) standards eluted at 16.3 - 16.4 minutes and spectra
were taken. These are illustrated in figures 5.3 and 5.4. Samples
before t.l.c. analysed by TIN and SIN for the 423 ion exhibited a
large number of unidentified peaks that masked the identification of
PGF on the chromatograms. TIN after t.l.c. of the control sample
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Proportion of 403 to 405















MID analysis of PGB (Me,TBDMS) derivatives from standard PGB^ and
PGB produced by uteri from eighteen rats (n = 3 for each diet group
for normal and A23187 stimulated tissue) fed either a control
pelleted diet or a semisynthetic diet supplemented with either
linoleic or a-linolenic acid ethyl esters. Proportions are
expressed as percentages of the 403 ion to 405 ion taking the 405
ion as 1007.. Signal to noise ratios are expressed for each ion in
brackets after each measurement with the first figure representing
the 405 ion and the second the 403 ion.
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gave a clear peak at the correct time on the chromatogram, however,
the spectrum taken still contained a high level of contaminating
material and only the large PGF 191 ion was clearly visible. SIM
■for the 423 ion in the linoleic and linolenic samples was used.
This gave very clear results on the chromatograms with clear peaks
appearing at the time corresponding to that of the PGF standard.
The spectrum from the linoleic sample contained a large number of
interfering ions present which prevented identification of PGF ions.
In the linolenic sample, however, PGF^ was clearly identified by
the presence of the 191, 397, 423, 494 and 513 ions. These were
also in the correct ratio for PGF^. A 492 ion was identified in
the spectrum, this is the largest of the PGF.^ exclusive ions and so
could indicate the presence of PGF,^.
5.3.5 SIM of PGF (Me,TBDMS) Derivatives
The TBDMS derivatives produced from F prostaglandins have a very
high molecular weight due to the presence of three hydroxyl groups
in the F molecule. This increases the chance of identification of
PGF due to the formation of high molecular weight ions that can be
identified above the majority of the lower molecular weight
interfering ions.
Standard PGF (Me,TBDMS) had a retention time of 22.5 minutes.
Spectra taken of PGF3,;< (Me, TBDMS) and PGF3,* (Me, TBDMS) are
illustrated in figures 5.5 and 5.6. SIM for the 653 ion was used in
both standards and samples. Samples from uteri not stimulated with
A23187 only produced very small peaks of PGF on the chromatograms.
These, unfortunately, were not identified at the time of elution and
so no spectra were taken. The peaks in the chromatograms from the
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Figures 5.1-5.6
Fragmentation patterns of B and F« Me,TBDMS and Me,TMS
derivatives. A VG Analytical Micromass 7070F mass
spectrometer was used. Ion source temperature was 250°C and



























































































































































































































A23187 - induced samples were also very small but spectra were taken
at the time of sample elution. However, the spectra contained a
number of interfering ions and only the PGF^,., 653 ion was
identified. In the linolenic sample the 651 PGF3,* ion was also
identified.
5.3.6 MID of PGF (Me.TBDMS) Derivatives
The 653 and 651 ions were monitored. The results are shown in table
5.3. There was no evidence of PGF-r^< production in the unstimulated
uteri of either the control or linoleic acid fed rats, however, the
linolenic acid fed rats exhibited an increased 653 to 651 ion ratio
of 19.2 compared to 12.9 in the standard PGF^. In the A23187
stimulated uteri there was evidence for substancial PGF3.^ production
in both control and linolenic acid fed rats with proportions of 18.2
and 90.9 being recorded respectively, compared to 1.9 in the
standard PCF^.
Discussion
The prostaglandin-producing tissues of the uterus play a major role
in regulating cyclical endometrial receptivity, the prolonged
suppression of uterine activity during pregnancy, and perhaps most
importantly, in the rapid and coordinated myometrial excitation of
parturition. A functional requirement for the n6 essential fatty
acids during normal parturition was established in a series of
dietary studies in which n3 EFA were substituted for the n6 EFA
(Quackenbush et al., 1942; Leaver et al., 1989; Leat & Northrop,
1979; Leat & Northrop, 1981; Leaver et al., 1986). It has been
postulated that the "n3" effect inhibited prostaglandin synthesis
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! Proportion of 653 to 651
l
l
! Standard F^.- ! Control ! Linoleic ! Linolenic
Normal 112.97.(99,13.5) ! 13.27.(78,14.7) ! 12.87.(7,2.6) ! 19.27.(33,15.8) !
tissue ! ! ! ! !
Tissue 11.97. (228,9.2 !18.Z/. (14.7,5) !57.( 14.7,1.4) 190.97. (9,10.5)1
+ A23187 : ! : : :
Table 5.3
MID analysis of PGF (Me,TBDMS) derivatives from standard PGF^ and
PGF produced from uteri of eighteen rats (n = 3 for each group for
normal and A23187 stimulated tissue) fed either a control pelleted
diet or a semisynthetic diet supplemented with linoleic or a-
linolenic acid ethyl esters. Proportions are expressed as
percentages of the 651 ion to the 653 ion taking the 653 ion as
1007.. Signal to noise ratios are expressed in brackets after each
measurement, with the first figure representing the 653 ion and the
second the 651 ion. The two different proportions given for the F^a
standard are due to the PGF^ 653 ion being used for the lock
channel in the normal tissue analysis, whereas for the A23187
treated sample the 614 peak of perfluorotributylamine (Heptacosa-
Aldrich Chemical Co., Poole, England) was used for the lock channel.
I?l
(Leaver et al., 1989; Leat & Northrop, 1979; Leat & Northrop, 1981;
Leaver et al., 1986). However, little information about the
metabolism o-f the n3 essential fatty acids by uterine tissue is
available to indicate whether the postulated competitive inhibition
of n6 metabolism occurs at the level of incorporation into uterine
lipid precursor pools, release from such pools, or at the level of
the cyclooxygenase enzymes. In terms of EFA uptake into the uterus,
it is known that the essential fatty acid composition of the uterus
responds rapidly to changes in dietary essential fatty acid intake
(chapters 3 and 4). However, at the same time, 4O-507. of the
uterine arachidonic acid pool is conserved in rats fed 80"/. n3 EFA
diets, indicating selectivity at the level of n3 EFA incorporation
into uterine PC and PI (chapter 4). The release of EFA at
parturition may be triggered by progesterone withdrawal, oestradiol
release, and oxytocin in species-dependent patterns, in a sequence
leading to the activation of phospholipases A^ and C, and the
release of large pg/ml quantities of arachidonic acid and
prostaglandins (Ogburn et al., 1980; Olund & Lunel, 1979; Okita et
al., 1982; Okazaki et al., 1978; Okazaki et al., 1981; Leaver et
al., 1987). However, the EFA specificity of the uterine
phospholipases involved has not been reported. Similarly, little is
known about the selectivity of uterine cyclooxygenase, although
there is some evidence that dietary n3 EFA inhibit the uterine
synthesis of PGE= (Leaver et al., 1986).
In this study, the activity of uterine cyclooxygenase was studied
under two conditions. Firstly in the absence of stimuli thought to
release prostaglandins, and secondly in the presence of high (1.8
mM) calcium concentrations which activate tissue phospholipases A^
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and C activity. The synthesis of the 2- and 3-series PGE and PGF,.-,
was analysed using total ion monitoring and multiple ion detection
of a variety of derivatives of PGF and PGE. The Me,TMS and Me,TBDMS
derivatives of PGF, the Me,BuO,TMS derivative of PGE, and the
Me,TBDMS derivative of PGB were fragmented under high electron
impact to yield a series of high molecular weight ions, which could
contain the n3 double bond, thereby allowing the 2-series
prostaglandins to be distinguished from the 3-series.
TIM and SIM of PGE (Me,BuQ,TMS) derivatives provided no evidence for
the presence of 3-series prostaglandins, although the chromatograms
did show the presence of E prostaglandins in all the samples. The
spectra taken provided little evidence of the presence of B3 in the
samples with only the linolenic sample from the uteri not treated
with A23187 exhibiting a large 391 peak indicating the presence of
PGB3. Estimates made of PGB produced shown in table 5.1 clearly
indicate the stimulatory effect of the A23187 on prostaglandin
production, however, the low level found in the control A23187
sample is inconsistent with the linoleic and linolenic samples. The
fact that this sample had a far greater quantity of contaminating
peaks present than either the linoleic or linolenic samples suggests
something may have gone wrong with the processing of this sample.
In both the A23187 stimulated uteri and the unstimulated uteri the
linoleic group produced greater quantities of PGE (as PGB) than the
linolenic group, suggesting inhibition of PGE= synthesis by the high
level of dietary n3 fatty acids in the linolenic acid fed rats.
The MID results shown in table 5.2 suggest there may be a low level
of synthesis of PGE3 in the linolenic acid fed rats, indicated by
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the increased proportion of 403 ion from 3.3"/, in the standard PGB^
to 3.5"/. in the linolenic sample, however, this increase may have
been a result of background noise. There was no evidence of PGE3
synthesis in either the control or linoleic acid fed rats. In the
A23187 stimulated uteri, however, there was same suggestion of PGE3
synthesis in all three diet groups, with a low level of synthesis in
the linoleic acid group, indicated by only a slight increase in the
proportion of the 403 ion from 3.37. in the PGEkz standard to 4.87. in
samples, but a high level of synthesis in the uteri of the linolenic
acid fed rats, indicated by the high 403 ion proportion of 21.3"/..
TIM and SIM of the Me,TMS PGF derivatives provided little evidence
of the presence of PGF.^.-, with only the spectra of the linolenic
sample exhibiting the major 492 ion of PGF-j,^. The chromatograms
produced, however, gave clear evidence of the presence of quantities
of PGF in all the samples. The spectra produced from the PGF
(Me,TBDMS) derivatives from A23187 stimulated uteri contained a
number of interfering ions and only the heavy 653 ion could be
identified in all the samples, in the linolenic acid group a clear
691 ion could also be seen, indicating the presence of PGF-»—.
Quantitation of PGF produced in unstimulated uteri was inaccurate
due to the small peak sizes produced in the chromatograms and levels
of production could not be distinguished between the three diet
groups. In the A23187 stimulated uteri, prostaglandin production
was considerably higher than in the unstimulated uteri. In the
A23187 treated uteri evidence could also be seen for the inhibition
of PGF synthesis by the n3 fatty acids in the linolenic acid fed
rats, with this group producing only 0.3 pg PGF/g tissue compared to
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1.16 ug/g and 1.02 pg/g in the control and linoleic groups
respectively. The MID analysis of unstimulated uteri provided some
evidence for PGFn.;, production in the linolenic acid fed rats with
an increased 651 ion proportion from 13'/. in the PGF^ standard to
17"/. in the linolenxc sample. There was no evidence of PGF^
production in the linoleic acid fed rats. As was found with the
PGE2, the A23187 induced considerable production of three series
prostaglandins. By far the greatest quantity was produced by the
linolenic acid rats with a very large increase in the proportion of
the 651 (PGF^) to the 653 (PGF^-,) ion from Z/. in the PGF^ standard
to 917. in the linolenic sample. This result supports the
identification of the large 651 ion identified on the spectrum
produced from this sample. The control rats also synthesised
considerable quantities of PGF^ with a 651 proportion of 18"/.. The
linoleic acid fed rats produced the lowest level with a proportion
of 57. being observed.
The possibility of 3-series prostaglandin production in A23187
stimulated uteri compared to unstimulated uteri suggests that either
two different groups of cells in the uterus are responsible for
prostaglandin synthesis in the unstimulated and stimulated state or
that two different pools of fatty acids and/or phospholipases
are involved. In the uterus, tissue heterogeneity is a
possibility for the difference in prostaglandin production.
Leaver et al. (1981) presented evidence for varying levels of
prostaglandin precursors in the endometrium and myometrium of
guinea pig uterus. In the rabbit kidney evidence has been
presented for the existence of two pools of fatty acids for
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prostaglandin synthesis (Schwartzman and Raz, 1979; Schwartzman and
Raz, 1981), one being hormone sensitive and the other hormone
insensitive. Needleman et al. (1979) have also presented evidence
suggesting that arachidonic acid -from varying sources may be
converted to different prostaglandins in the rabbit kidney.
Evidence for the existence of more than one phospholipase pool that
may be independently activated within one particular cell type also
exists (Hong and Levine, 1976; Hsueh et al, 1981). If different
phospholipase enzymes are involved then they may release fatty acids
from phospholipids with varying n6 - n3 contents (see chapter 4),
with the phospholipase active in the stimulated uterus acting an a
phospholipid group with a higher n3 content than the phospholipid
substrate of the phospholipase active in the unstimulated uterus.
In chapter 4 PI and PC phospholipids were found to be less
susceptible to dietary change than PE, and decreases in 20:4n6 and
increases in 20:5n3 in PI and PC were less than those in PE when a
diet high in a-linolenic acid was fed to rats. It is possible that
in the unstimulated uterus PI and/or PC may form the major source of
free fatty acid for prostaglandin synthesis, whereas on stimulation
by A23187, PE may become the major source, resulting in a higher
level of 20:5n3 being released and converted to 3-series
prostaglandins. Hong and Deykin (1979) found that in mouse
fibroblasts, bradykinin, thrombin and serum caused specific release
of arachidonic and eicosatrienoic acids, however, A23187 stimulation
also caused release of stearic, oleic and linoleic acids. They
suggested that A23187 activated a less specific pool of
phospholipases. This is a possible explanation for the results we
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have observed. The increase in total output of prostaglandins in
response to A23187 reported here has also been observed in other
studies (Leaver et al., 1989; Leaver and Seawright, 1982; Leaver and
Richmond, 1984; Brown et al., 1987).
The increase in 3-series prostaglandin production suggested by the
results obtained after A23187 induced tissue activation indicated
that the uterine cyclooxygenase was capable of producing both PGE3.
and PGF^,;,, and that only a limited degree of substrate specificity
lay at the level of uterine cyclooxygenase. The major control of
uterine PGE3 and PGF^ synthesis appeared to lie at the level of EFA
release. A similar finding has been reported in endothelial cells,
in which the liberation of eicosapentaenoic acid and arachidonic
acid resulted in the formation of substantial amounts of PGI3, PGE3
and PGF^ (Bordet et al., 1986). The increase in 3-series
prostaglandin production observed on A23187 stimulation may explain
why only parturition and not implantation or gestation are affected
by diets containing a high proportion of n3 fatty acids if the
tissue activation at parturition results in similar increases in 3—
series prostaglandin production as those resulting from A23187
stimulation.
In conclusion, the results presented indicate the possible
production of 3—series E and F,^ prostaglandins in the rat uterus.
In unstimulated uteri production of 3-series prostaglandins
was only suggested in rats fed a diet containing a—
linolenic acid as the main dietary EFA source. Upon
stimulation with A23187, there was some suggestion of 3-series
prostaglandin production in rats fed a control pelleted diet
and a diet containing linoleic acid as the major EFA source.
This suggested that A23187 stimulation caused a less specific
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release of fatty acids from the uterus, with higher proportions of
n3 fatty acids being released than in the unstimulated uterus. It
is therefore important to analyse the release of the 3-series
prostaglandins during the changes in phospholipase activity which
occur during tissue stimulation. Our results suggested that in
A23187 stimulated uteri a-linolenic acid fed rats may synthesise
substantially higher proportions of 3-series compared to 2-series
prostaglandins than control or linoleic acid fed rats. Linoleic
acid fed rats also synthesised greater total prostaglandin levels
than a-linolenic acid fed rats, indicating that the diet high in n3
fatty acids suppressed 2-series prostaglandin production. The low
total and high 3-series prostaglandin production may cause the
inhibition of parturition associated with high n3 fatty acid intake.
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Chapter 6
Changes in Prostaglandin E^. Destradiol 17B and Progesterone During
Late Gestaticn in Catheterised Sheep Experimental ly Infected with an
Ovine Abortion Strain of Chlamydia Psittaci
6.1 Introduction
Premature labour and abortion are major complications associated
with Chlamydia psittaci infection of sheep (Studdert & McKercher,
1968; Novilla & Jensen, 1970). Ovine abortion strains of C.
psittaci have been demonstrated to infect women and are associated
with abortion in these subjects (Roberts et al., 1967; Beer et al.,
1982; Johnson et al., 1985). As with the n3 fatty acids, infection
by Cj. psittaci may affect parturition through alterations in
prostaglandin production, or possibly through effects on the steroid
hormones controlling uterine prostaglandin synthesis. In both sheep
and humans, the perinatal complications caused by psittaci appear
to be more severe than those associated with Chlamydia trachomatis
but the pathophysiology of both infections is similar with respect
to the site and timing of infectivity and the effect of initiating
premature labour (Sweet et al., 1987; Studdert, 1968). The
widespread distribution of chlamydial infection in sheep has been
known for many years (McEwen et al., 1951; Studdert & McKercher,
1968). However, recent applications of monoclonal antibodies and
gene probe techniques have indicated a much wider distribution of
chlamydial infection than had been previously suspected in the human
population (Sweet et al., 1987).
The primary focus of chlamydial infection during pregnancy is the
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placenta. Three placental products are important in the control of
parturition; progesterone, oestradiol 173 and PGE^. Progesterone is
important in the maintenance of pregnancy (Bedford et al., 1972;
Taylor et al., 1982), and progesterone synthesis during late
pregnancy in both sheep and women occurs in the placenta (Linzell &
Heap, 1968). The placenta is also a major source of oestrogens in
these species. The secretion and distribution of oestradiol 173
during gestation and its effect on prostaglandin synthesis, have
been characterised (Allen, 1975; Liggins et al., 1972). Plasma
oestradiol 173 concentrations are indicators of the placental
production and secretion of this steroid. The concentrations of
oestradiol 173 in the amniotic fluid and the utero-ovarian vein
reflect the intrauterine production and diffusion of oestradiol 173.
Changes in the concentrations of oestradiol 173 and progesterone
influence the release of PGE2 at parturition (Thorburn & Challis,
1979; Taylor et al., 1982; Olson et al., 1984). The primary site of
placental infection of C;_ psittaci is the chorionic membrane, which
is also a major site of placental PGE= synthesis. PGE3 is also
released in significant quantities by leucocytes, particularly by
inflammatory macrophages (Lewis, 1983). The prostaglandins exert a
range of effects within the uterus at parturition. Prostaglandins
act on the myometrium, where they stimulate and co-ordinate
myometrial contraction (Wickland et al., 1984). In the cervix,
prostaglandins induce ultrastructural changes resulting in an
increase in cervical patency (Keirse et al., 1983). Stimulation of
the chorionic membrane causes release of arachidonic acid and
prostaglandin E= from the foetal membranes (Grieves & Liggins,
1976). A role for prostaglandin in initiating labour has been
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proposed (Bleasdale & Johnston, 1984).
The synthesis of PGE= increases during late gestation in both
sheep and women (Mitchell & Flint, 1977; Olson et al., 1984; Dray &
Frydman, 1976). The inhibition o-f prostaglandin synthesis delays
premature delivery in sheep (Mitchell & Flint, 1978), and infusion
of F'GEs and F'GF^ into the aorta of pregnant sheep stimulates
uterine contractions similar to those detected at term (Thorburn &
Challis, 1979). An increase in uterine FOE^ concentration in
infectious abortion associated with bacterial endotoxin has been
reported in women (Lamont et al., 1985; Romero et al., 1988), and
there has been a recent report of elevated FGF^ metabolite
concentrations in the plasma of four sheep infected with C_^ psittaci
(Fredriksson et al., 1988).
The predominant prostaglandin produced by sheep and human chorion
is PGE3; (Mitchell & Flint, 1977; Mitchell et al., 1977; Olson et
al., 1984; Casey et al., 1983). In contrast to F'GF^,-,, the
concentration of FT3E= increases during late gestation and early
labour, and there is evidence that FtBE^ has a role in the
initiation of labour, while RGF^ is involved in the progression and
the coordination of labour after it has been initiated (Bleasdale &
Johnston, 1984). The FTBE^ synthesised by the fetal membranes is
converted to FtjF^,-,, and both Ft3E^ and FCF^,-, are metabolised, at a
variable rate, to a range of inactive oxygenated metabolites. The
variability of the activities of the enzymes of prostaglandin
metabolism, together with the contribution of blood and vascular
cells to the circulating prostaglandin pool, combine to make the
measurement of peripheral prostaglandin an indirect indicator of
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uterine prostaglandin synthesis (Schweer et al. , 1986). In contrast,
the intrauterine concentrations of PGE= indicate the local
concentrations of biologically active PGE^.
The timing of C^_ psittaci infection has led to investigation of
endocrine factors which might play a role during this period of
gestation. The infection of the placenta by the Chlamydiae does not
begin until a relatively advanced stage of gestation. In the case of
C. psittaci infection of sheep, placental infiltration is detected
between days 100 to 120 of gestation, commencing in the
chorioallantoic membrane, and proceeding to infiltrate the
caruncular region of the placenta (Studdert, 1968; Aitken, 1986).
It has been reported that oestradiol 17f3 acts as a "growth factor"
for the Chlamydiae in several species (Rank et al., 1982; Base &
Goswami, 1986; Sugarman & Agbor, 1986). However, there has been
little investigation of the effects of Chlamydiae on the factors
which play a role in controlling parturition (Martel et al., 1983;
Rank et al., 1982; Fredriksson et al., 1988). This is
surprising, since pathological studies indicate that the
infectivity of Chlamydiae is closely related to the stage of
pregnancy, and disorders in the initiation of parturition
result from this infection.
The endocrinology of infectious abortion has been the subject of
intermittent attention (Smith & Hughes, 1974; Roberts et al., 1975;
Minkoff, 1983; Lamont et al., 1985; Helm et al., 1987). We have
used a catheterised sheep model to study changes in uterine and
peripheral plasma concentrations of PG^s, progesterone and
oestradiol 170 during pregnancy in response to infection by an
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ovxne abortion strain of Chlamydia psittaci.
6.2 Methods
Materials and methods used in the experiments discussed in this
chapter are described in sections 2.18-2.26 of chapter 2.
Results were expressed as mean ± standard error of mean -for n
determinations. Statistical significance of differences between
paired and unpaired data was analysed using the paired and unpaired
Students' t-tests (Cohen and Holliday, 1984). Snedecors' variance
ratio test was used to analyse variances in samples for the paired
t-test. The unpaired t-test incorporated the Behrens Fisher
statistic and, therefore, did not assume that the variances of the
population groups being compared were the same.
6.3 RESULTS
6.3.1 Prostaglandin Es in Amniotic Fluid during Chlamydial Infection
The concentration of PGE= in the amniotic fluid of six catheterised
control sheep is shown in figure 6.1A. Amniotic fluid PGE^
increased during late gestation in the control group. The
concentration of PGE= between 122 to 135 days of gestation in
control animals (2.72 + 0.27, ng/ml, n=29 samples) increased
significantly from day 136 of gestation to the day of parturition
(7.23 + 0.72 ng/ml, n=41 samples), in samples taken from the same
animals, compared using the unpaired Students' t-test for sample
groups with different variances (P<0.01, n=67) (see table 6.1).
In the six sheep infected with C^ psittaci. the concentration of
PGE^ in the amniotic fluid increased earlier in gestation (figure
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Fig. 6.1
Prostaglandin in amniotic -Fluid o-f control and Chlamydia-
infected sheep. Amniotic fluid was withdrawn by catheter
from A. control or B. sheep infected with an ovine abortion
strain of C;_ psittaci (4.5 x 10s F1 .Dgp) on day 115 of
parturition. The arrow indicates the mean date of
parturition. The PGE2 concentrations are the mean of
triplicate determinations carried out on amniotic fluid of







Infected 2.55+0.45(14) 6.42+0.44(21)* 6.40+0.42(21)
Table 6.1
Mean PGE^ concentration in amniotic fluid of six control and six
Chlamydia-infected sheep during late gestation. The mean PGE=
concentrations in sheep whose individual PGE= profiles were shown in
figure 6.1, in ng/ml of amniotic fluid + SEM for n samples of
amniotic fluid, withdrawn from indwelling catheters in control sheep
or sheep infected with 4.5 x 10s ELDso of an ovine abortion strain
of C^. psittaci on the stated days of gestation.
*The concentration of PGE= in the amniotic fluid of Chlamydia-
infeeted sheep, between days 122 to 135 of gestation, was
signficantly greater than that of control sheep, using the unpaired
Students' t-test for sample groups with different variances (PCO.Ol,
n=58>.
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6.IB). A significant increase in PGE3 concentration was observed
after day 122 of gestation in the Chlamydia-infected group, when
samples from the same sheep were compared using the unpaired
Students' t test (P<0.001, n=43). The mean concentration of PGE= was
2.55 + 0.45 ng ml-l(n=14) on days 111 to 121 of gestation, compared
with 6.42 + 0.44 ng ml-:L(n=21) in the same sheep on days 122 to 135
of gestation (see table 6.1). There was no significant increase in
the concentration of PGE= in the amniotic fluid between days 122 to
135 of gestation, compared with day 136 of gestation onwards, in the
Chlamydia-infected group.
6.3.2 Prostaglandin in Utero-ovarian Vein during Chlamydial
Infection
The concentration of PGE= in the utero-ovarian vein of six control
sheep showed a pulsatile release of PGE2, increasing in amplitude
from day 126 of gestation (figure 6.2A). The mean concentration of
PGE3 in utero-ovarian plasma of control sheep between days 122 to
125 of gestation was 1.34 + 0.205 ng ml-1(n=12), and this increased
to a concentration of 2.38 + 0.241 ng ml-1(n=28) in the same sheep
between days 126 to 136 of gestation. This increase in PGE=
concentrations was significant using the unpaired t-test (P<0.01,
n=36). The P(^= concentrations in the utero-ovarian venous plasma
showed a similar pattern of release in Chlamydia-infected sheep
(Fig. 6.2B). The greatest increase in PGE= was observed after day
122 of gestation. The concentration of PGE^ in utero-ovarian plasma
of infected sheep was 0.922 + 0.123 ng ml~1(n=28) between days 110
to 121 of gestation, increasing to 1.52 + 0.153 ng ml-1(n=53) in


















Prostaglandin in utero-ovarian vein of control and
Ch1amydia-in fec ted sheep. Utero—ovarian plasma was
withdrawn by catheter from A. control sheep or B. sheep
infected with an ovine abortion strain of C^_ psittaci (4.5 x
10= F1 rW.,) on day 115 of parturition. The arrow indicates
the mean date of parturition. The PGE= concentrations are
the mean of triplicate determinations, carried out on utero-
ovarian plasma of six individual sheep. Serial results from
individual sheep are joined.
PGE^ was significant using the unpaired t-test for sample groups
with different variances (P<0.01, n=81). The increase in PGE3
concentrations in the utero-ovarian vein of infected sheep (from
1.08 + 0.149 ng ml-1 on days 122 to 125, n=14; to 1.55 + 0.140 ng
ml-1 on days 126 to 136, n=43), was not significant. There was a
further increase in PGE3 concentrations in utero-ovarian vein of
Ch1amydia-in fee ted sheep late in gestation. The concentration of
PGEs from day 137 of gestation in the Chlamydia-infected sheep
increased to 1.96 + 0.228 ng ml-1(n=31> of utero-ovarian venous
plasma. This was significantly greater than the PGE2 concentration
detected in the same ewes between days 122 to 125 of gestation,
using the unpaired t-test for sample groups with different variances
<P<0.01, n=32>.
The increase in utero-ovarian venous PGE3 concentrations in infected
sheep occurred more gradually, over a longer time span, compared
with the increase in utero-ovarian venous plasma PGEcs in control
sheep (see table 6.2). In the utero-ovarian vein, the concentration
of PGE= increased sharply after day 126 of gestation. The mean PGE=
concentration in the utero-ovarian venous plasma of control sheep
increased by 78"/., if samples collected in the period between days
126 to 136 of gestation were compared with samples collected between
days 122 to 125. In contrast, the increase in mean PGE= over the
same period in the infected group (447.) was proportionately lower
than the increase in the control group.
The mean concentrations of PGE= in the utero-ovarian vein of
infected sheep were compared with the mean PGE= concentrations
detected in control sheep on the same day of gestation throughout
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Gestation UO-121 122-125 126-136 137-parturiticn
(days)
Control - 1.34+0.205(12) 2.38+0.241(28) 2.51+0.19(53)
Infected 0.922+0.123(28)1.08+0.149(14) 1.55+0.140(43) 1.96+0.23(31)
Table 6.2
Mean PGE= concentration in utero-ovarian venous plasma of six
Chlamydia-infected and six control sheep during late gestation. The
mean PGE3 concentration in sheep whose individual PGE^ profiles were
shown in figure 6.2, in ng ml-1 of utero-ovarian venous plasma + SEM
for n samples of utero-ovarian venous blood, withdrawn from
indwelling catheters in control sheep or sheep infected with 4.5 x
103 ELDso of an ovine abortion strain of psittaci on the stated
period of gestation.
•M
the period when infected and control sampling overlapped (between
days 122 to 141 of gestation). Over this period, the mean PGE^
concentration in the utero-ovarian vein of infected sheep was 68.8 +
5.Z/. the mean PGE= concentration of control sheep (range 52.6"/. to
96.8"/. for 12 data pairs). The mean PGE3 concentrations in the
utero-ovarian venous plasma of infected sheep were significantly
lower than the mean PGE3 concentrations detected in control sheep,
using the paired t-test for samples with different variances
(P<0.01, n=12). This suggested that the transfer of PGE2 into the
utero-ovarian vein was compromised by chlamydial infection.
6.5.5 Prostaglandin in Allantoic Fluid during Chlamydial
Infection
The sampling of allantoic fuid was infrequent after day 150 of
gestation, due to catheter blockage caused by particulate matter,
and to the increase in allantoic fluid viscosity which occurs during
this period. This problem was most acute during the five days
before parturition, when the allantoic fluid was decreasing in
volume (Mellor, 1980). The concentration of PGE= in the allantoic
fluid of the six control sheep increased during late gestation
(figure 6.5A). The concentration of PGEs in allantoic fluid between
days 122 to 155 of gestation was 5.66 + 0.922 ng ml-1(n=21),
increasing to 8.15 + 2.15 ng ml-1(n=17) in the same sheep between
day 156 and the day of parturition. This increase was significant,
when analysed using the unpaired t-test (P<0.05, n=58> (see table
6.5). The concentration of PGE3 in the allantoic fluid of six sheep
infected with psittaci is shown in figure 6.5B. The increase in
allantoic fluid PGE= occurred earlier in infected sheep than in
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Prosataglandin E= in allantoic fluid of control and
Chlamydia-infected sheep. Allantoic fluid was withdrawn by
catheter from A. control sheep or B. sheep infected with an
oyine abortion strain of C^. psittaci (4.5 x 10= ELQ=0> on
day 115 of parturition. The PC£= concentrations are the
mean of triplicate determinations, carried out on allantoic
fluid of individual sheep. Serial results from individual
sheep are joined. The mean day of parturition is indicated
by an arrow.
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Gestation 111-121 122-126 127-135 136-parturition
(days)
Control - 2.56+0.46(7) 2.68+2.52(7) 8.13+2.15(17)
Infected 2.08+0.22(21) 3.00+0.38(11) 6.04+1.11(30) 9.75+1.61(23)
Table 6.3
Mean PGE3 concentration in allantoic fluid of six Chlamydia-infected
and six control sheep during late gestation. The mean PGE^
concentration in sheep whose individual PGE3 profiles are shown in
figure 6.3, in ng ml-1 of utero-ovarian venous plasma + SEM for n
samples of utero-ovarian venous blood, withdrawn from indwelling
catheters in control sheep or in sheep infected with 4.5 x 10s ELD-,,;,
of an ovine abortion strain of C;_ psittaci during the stated period
of gestation.
m
controls. The concentration of PGE3 in the allantoic fluid of
infected sheep between days 111 to 126 of gestation was 2.33 + 0.196
ng ml~Mn=32>, increasing to 6.04 + 1.12 ng ml~x(n=30) in the same
sheep between days 127 to 135 of gestation. This increase was
significant, P<0.01 (n=62>, using the unpaired t-test. The
concentration of PGE= in the allantoic fluid of the same sheep,
taken between days 136 of gestation and the day of parturition, was
9.75 + 1.61 ng ml_x(n=23). This was not significantly higher than
the PGE3 concentration between days 127 to 135 of gestation in the
same sheep (see table 6.3). The concentration of PG£l= in the
allantoic fluid of the infected sheep between days 127 to 135 of
gestation was 6.04 + 1.11 ng ml~x(n=30), and in the control sheep,
2.68" + 2.52 ng ml_x(n=7>. The difference between these groups was
not significant, due to the increase in PGE= concentrations, during
this period. However, when the PGE3 concentrations in the allantoic
fluid of individual infected and control sheep, taken on the same
day of gestation, between days 127 to 135 were paired and analysed
using the paired t-test, the PGE^ concentrations in infected sheep
were significantly higher than the PGE^ concentrations in the
allantoic fluid of control sheep taken on the same day of gestation
(P<0.02).
6.3.4 Progesterone in Peripheral Plasma during Chlamydial Infection
The mean peripheral plasma progesterone concentrations of six
control sheep and of six sheep experimentally infected with C.
psittaci on day 90 of gestation are shown in figure 6.4.
Parturition was significantly earlier (PC0.05) in the infected
group. The profiles of progesterone release in the two populations
showed the following differences. There was a greater variation in
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Figure 6.4
Progesterone in peripheral plasma of control and C.
psittaci-in-fected sheep. Ewes were infected by subcutaneous
injection on day 90 of gestation with 5 x 10s Pi H-,.-. of C.
psittaci strain S26/3. The filled arrow indicates the mean
day of parturition in infected, and the open arrow, in
control ewes (the mean duration of gestation in control
sheep was 144.7 ± 1.08, n = 6, and in psittaci-infected
sheep, 137 ± 1.6, n = 6). All animals had a single lamb.
Progesterone concentrations are the means of three to six
determinations of plasma progesterone from individual
control (0) or infected (•) sheep on separate days of
gestation.
the concentration of plasma progesterone in infected animals. The
mean plasma progesterone concentration in infected animals, compared
on 8 days between days 100 to 130 of gestation, was 80 + 5.3"/. of the
mean plasma progesterone concentration in control sheep. The
concentration of progesterone in the plasma of control sheep dropped
sharply during the eight days before parturition, while that of
infected sheep showed a more gradual decline, commencing 13 days
before parturition, on day 125 of gestation. The difference between
the mean progesterone concentrations, paired between day 100 and day
144 of gestation and analysed using the paired Student's t-test, was
highly significant (P<0.01, no. of paired concentrations = 22). The
difference between the curves was significant well before delivery;
when plasma progesterone levels from individual infected sheep were
paired randomly with progesterone concentrations in controls on the
same day of gestation, and were compared between day 125 to 135 of
gestation, using the paired t-test, a significant difference was
observed (P<0.05, no. of paired concentrations = 9). The
progesterone concentrations in infected and control sheep were also
analysed in relation to the day of parturition, using the paired t-
test for samples collected between 0 and 8 days before parturition,
and between 9 and 20 days before parturition. There was a
significant <P<0.05> difference in plasma progesterone
concentrations between 16 paired samples from infected and control
sheep in the earlier (day -9 to -20) period. However, there, was no
significant difference in the plasma progesterone of 16 paired
samples from infected and control sheep during the period of
progesterone decline immediately before parturition (day -8 to 0).
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6.5.5 Qestradiol 17f3 in Peripheral Plasma. Utero-Qvarian Vein Plasma
and Amniotic Fluid during Chamydial Infection
In the first group of ewes assayed for oestradiol 17f3, the duration
of gestation in the infected group was 137 +1.6 (n=6), range 132—
142 days and in the control group the mean gestation period was
144.7 + 1.08 days (n=6), range 144-149 days. Parturition was
significantly earlier (PC0.05) in the infected group.
In the psittaci-infected group, a pre-partum increase in plasma
oestradiol 17(3 was detected in the one sheep sampled at 24 h
before parturition (24 pg ml-1, compared with 9.2pg ml-1 and 12.9pg
ml-1 in two control sheep). The five Ch1amydia~infected sheep
sampled on the day of parturition had a mean plasma oestradiol
concentration of 7.2 + 4.8 pg ml-1, which was significantly
(P<0.05> lower than that of control sheep (45 + 7.3 pg ml-1,n=4).
Peripheral plasma oestradiol 17(3 was analysed daily in a second
group of ewes, consisting of four infected and five control sheep
during the two days prior to parturition (table 6.4). The duration
of gestation in the infected group (139.8 + 1.1 d, n=4) was not
significantly different from that of the control group (143.8 + 1.1
d, n=5). Abnormalities in the timing of oestradiol 17(3 release were
observed in the sheep infected with C^_ psittaci compared with
controls. The characteristic rise in plasma oestradiol 17(3, which
was observed on the day of parturition in control animals, was
detected 24 h earlier in Chlamydia-infeeted sheep. In contrast with
the control group, the mean peripheral plasma oestradiol
concentration in the Chlamydia-infeeted group 24 h before
parturition was higher than the mean concentration of oestradiol 17(3
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□estradiol 1713 concentrations







5) 9.15+2.16 21.7 +5.7# 63.1 +10.3
4) 16.6 +0.80 56.3 +7.05* 26.4 +15.9
Utero-ovarian
venous plasma
Control (n = 6)










Infected (n = 6)
5.86+0.86* 5.67+0.87# 9.31+ 0.96
17.6 +5.28* 12.9 +3.07# 24.3 +17.3
Table 6.4
□estradiol 17R in peripheral plasma, utero-ovarian venous plasma and
amniotic fluid of C^ psittaci-infected and control sheep. #
Indicates significant differences between control and infected
groups <P<0.02), using the Student's unpaired t-test.
#The concentrations of oestradiol 17(3 in sheep infected
subcutaneously with C^ psittaci (strain S26/3,5 x 10= ELDso), and of
control ewes injected with sterile saline.
11*
on the day o-f parturition.
As uterine prostaglandin release is controlled by oestradiol 17f3
(Liggins et al. , 1972; Olson et al. , 1984), the effect of chlamydial
infection on the concentration of oestradiol 17f3 within the uterus
of these sheep was analysed by cannulation of the utero-ovarian vein
and amniotic sacs. The oestradiol 17(3 concentrations in the utero-
ovarian plasma and amniotic fluid were determined (table 6.4). The
sheep used for these oestradiol-17(3 measurements were the same as
those used for the PGE= determinations. The oestradiol 17(3
concentrations in utero-ovarian venous plasma of control sheep were
similar to previously reported values (Bedford et al., 1972). There
was no significant difference in the oestradiol 17(3 concentrations
released into the utero-ovarian vein by infected, compared with
control uteri. However, significantly higher local intrauterine
concentrations of oestradiol 17(3 were observed in the amniotic fluid
of Chlamydia-infected animals compared to controls (table 6.4),
indicating that chlamydial infection may have compromised local
intrauterine diffusion barriers.
6.4 Discussion
A characteristic of infection with both C^_ psittaci and C.
trachomatis during pregnancy is a period of latency, followed by the
onset of placental infection of the foetal membranes and placenta
during the last quarter of gestation (Stamp et al., 1950; Studdert,
1968; Novilla & Jensen, 1970; Helm et al., 1987; Aitken, 1986; Sweet
et al., 1987). We have found premature increases in PGE=
concentrations in two intrauterine compartments monitored during
late gestation in sheep infected with an ovine abortion strain of
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C. psittaci. Increases in amniotic -fluid PGE3 associated with C.
psittaci infection were observed from day 122 of gestation, and this
was thirteen days before any changes in PGE3 in amniotic fluid of
control sheep (figure 6.1). In the allantoic fluid, the
concentration of PGE^ increased from day 127 of gestation, nine days
before the increase observed in controls (figure 6.3). It should be
noted that the chlamydial infection established in our catheterised
sheep was relatively mild. The mean (period of gestation of the
infected group (141.3 + 1.8 d) was not significantly different from
the control group (144.5 + 1.1 d) in the animals used for PGE3 and
utero-ovarian vein and amniotic fluid oestradiol-1713 measurements,
and 80"/. of the lambs from infected sheep survived.
The difference between PGE3 profiles in infected and control groups
was greatest in the amniotic fluid. This was the fluid space in
closest contact with the focus of C^. psittaci infection (Mel lor,
1980) which spreads from the chorionic membrane to caruncular tissue
(Studdert, 1968). The amniochorion is also the primary site of
infection of both C^_ psittaci and C^_ trachomatis in humans (Johnson
et al., 1985; Alger et al., 1988). Our studies indicated that the
localised infection of C^_ psittaci was associated with the release
of PGES from the amniochorion. Phospholipase Pfe: with specificity
for arachidonic acid in the sn-2 position of phospholipids has been
observed (Okazaki et al., 1978) in foetal membranes, as well as
arachidonic acid specific diacylglycerol and monoacylglycerol lipase
activity (Qkazaki et al., 1981). Foetal membranes also contain
phosphatidylinositol - specific phospholipase C activity (Di Renzo
et al., 1981) and foetal membrane lysosomes in humans have also been
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found to contain phospho1ipase A2 activity (Schwarz et al. , 1976).
It is possible that the tissue necrosis that occurs during
chlamydial infection may release or activate these enzymes,
resulting in increased PGE3 production which would be evident in the
amniotic fluid.
A comparison of the PGE^ profiles in the utero-ovarian venous
plasma in infected and control sheep suggested that psittaci
infection disrupted the local caruncular exchange of PGE=. The
concentration of PGEa detected in the utero-ovarian vein of infected
sheep was 697. that of control animals. It is possible that the
impaired exchange of metabolites at this site, which is
responsible for approximately 837. of uterine blood flow (Makowski
et al., 1968), may be a cause of the low birth weight associated
with chlamydial infection (Sweet et al., 1987; Studdert, 1968). It
is also possible that impaired vascular function masked the
increase in PGE= release in infected sheep indicated by the amniotic
and allantoic fluid PGE= profiles. The increase in utero-ovarian
venous PGE^ concentrations detected in infected sheep occurred more
gradually, over a longer time span than the increase in control
sheep. Evidence of increased prostaglandin release into the
peripheral circulation was recently reported by Fredriksson et al.,
(1988), who detected a premature increase in peripheral PGF
metabolite concentrations in sheep infected with C^. psittaci.
In the amniotic and allantoic fluid, the concentrations of PGE^
detected during the period of premature PGE;;; release in sheep
infected with psittaci. reached concentrations which were not
significantly different from the concentrations of PGE= released by
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the uteri of control sheep prior to parturition. This indicated
that the PGE^ released during chlamydial infection may be active in
initiating events associated with premature labour. It is possible
that the inflammatory leucocytes infiltrating the uterus at the
sites of C^_ psittaci infection (Stamp et al., 1950; Studdert, 1968;
Johnson et al. , 1985; Aitken, 1986; Leaver et al., 1988) may
contribute to the PGE^ pool in intrauterine fluids of infected
sheep. However, when the magnitude of the premature increases in
PGE= which we detected in intrauterine fluids of infected sheep
(between three and four ng ml-1 of amniotic or allantoic fluid) were
compared with the concentrations of PGE3 synthesised by inflammatory
leucocytes (Kurland & Brockman, 1978; Lewis, 1983), the premature
release of PGE^ in amniotic and allantoic fluids was found to be an
order of magnitude greater than the amount of PGE^ sythesised by
leucocytes. This suggested that most of the PGE= detected in the
fluids of infected sheep was of uterine, rather than of leucocyte,
origin.
The uterine synthesis of prostaglandins is stimulated by oestrogens
(Thorburn & Challis, 1979), and there have been two reports of
abnormal release of oestrogens during Cj^ psittaci infection, showing
impaired oestrogen production (Martel et al., 1983; Fredriksson et
al., 1988). The premature release of oestradiol 17fB we observed in
peripheral plasma and the increased levels in the amniotic fluid of
infected sheep may partly induce the increased levels of PGE^
observed in amniotic and allantoic fluids in infected sheep.
In addition to controlling the release of PGE=, there is evidence
that oestradiol 17B may facilitate the infectivity of C_;_ trachomatis
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in vivo and in vitro (Rank et al., 1982; Bose & Goswanmi, 1986;
Sugarman & Agbor, 1986). The premature release of oestradiol 17(3
from the uterus, and the elevated intrauterine concentrations
associated with psittaci infection, may induce metabolic and
vascular changes enhancing chlamydial growth during late gestation,
and it is likely that these effects are at least partly mediated by
PGE=. The decline in peripheral plasma progesterone concentrations
started around day 122 of gestation, this coincided with the
increases in PGE^ we observed in the amniotic and allantoic fluids
of infected sheep. Since a decline in progesterone levels is
associated with an increase in prostaglandin levels (Taylor et al.,
1982), the decrease in progesterone observed during chlamydial
infection may be a further cause of increased prostaglandin levels
in infected sheep.
The pathogenesis which we describe may be relevant to other
mammalian species, because the placenta and foetal membranes are
major sources of steroid hormones and prostaglandins in most
species, including humans, during late pregnancy. There are
considerable inter - species differences in the pattern of hormone
secretion, and in the relative importance of the stimuli which
initiate labour (Allen, 1975). However, in all mammalian species,
pregnancy is dependent on maintained progesterone secretion, and
oestradiol and prostaglandins stimulate uterine responses at the
time of parturition (Thorburn & Challis, 1979; Bedford et al.,
1972). Premature progesterone withdrawal can initiate labour and
increase oestradiol synthesis in the sheep (Mitchell et al.,
1983). The abortifacient agent Actinobacillus seminis has been
reported to cause a decline in plasma progesterone in pregnant ewes
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(Smith & Hughes, 1974), although this occurred earlier in pregnancy
than the inhibition which we observed in Chlamydia-infected sheep
(figure 6.4). Premature increases in oestradiol 17f3 and
prostaglandin F=,;< synthesis have been observed during infectious
abortion due to intrauterine surgery (Bedford et al., 1972; Silver
et al., 1986) or endotoxin infusion (Roberts et al., 1975)
respectively. There has been a recent report of decreased plasma
progesterone and oestradiol 17(3 concentrations and elevated
peripheral PGF^ metabolite concentrations in four sheep infected
with psittaci (Fredriksson et al., 1988). There has only been
one report on PGE^, which is thought to play a role in the
initiation of labour (Bleasdale & Johnston, 1982), in infectious
abortion (Romero et al., 1988). Our report is the first description
of the effect of C^. psittaci infection on the intrauterine
distribution of oestradiol 17(3 and prostaglandin E= during
pregnancy.
In conclusion, mild infection with psittaci was associated with
abnormalities in the intrauterine concentrations of PGE^ in amniotic
fluid, utero-ovarian vein, and allantoic fluid. In the two
intrauterine sacs, we detected the premature secretion of PGEs;,
which reached the concentrations of PGE^ which were found just prior
to parturition in the control sheep. In the utero-ovarian vein,
there was evidence of impaired secretion of PGE=. These results
suggest that chlamydial infection causes the release of PGE= from
intrauterine tissues. This release may have been partly facillitated
by premature increases in oestradiol 17f3 and decreases in
progesterone that were also associated with infection by C_^
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psittaci. It is likely that the changes in placental steroid and
prostaglandin synthesis observed here, contribute to the premature




Since Quackenbush first demonstrated in 1942 that normal parturition
will not occur in rats fed a-linolenic acid as the main dietary
source of EFA, it has been known that n3 fatty acids will inhibit
parturition. Due to the importance of prostaglandins Ea and in
the initiation and maintenance of labour it has been suggested that
the n3 effect on parturition may be acting through disruption of
prostaglandin production. A fish oil diet high in n3 fatty acids
has been shown to decrease PGE= production by intrauterine tissues
(Leaver et al, 1986). Prior to the studies described in this
thesis, however, a number of questions regarding the incorporation
and metabolism of the n3 and n6 fatty acids in the uterus remained
unanswered. It was not known to what extent the n3 fatty acids
would be incorporated into the uterus or whether the n6 fatty acids
would be specifically retained in response to a diet containing
predominantly n3 fatty acids. Inhibition of elongation and
desaturation of n6 fatty acids by n3 fatty acids could result in low
conversion of 18C n6 precursors to the 20C n6 prostaglandin
precursors and incorporation of 20:5n3 could result in competition
with arachidonic acid for cyclooxygenase enzymes, so inhibiting
formation of PGE2 and PGF^. Prior to the current investigation no
measurement of 3-series prostaglandin production in the uterus had
been made.
Infection by the intracellular parasite Chlamydia psittaci instead
of impairing parturition, may result in premature labour or
abortion. As with the n3 fatty acids, this effect could be mediated
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through abnormal prostaglandin production, we therefore measured
PGE2 production in pregnant sheep infected with C^_ psittaci and
compared this to levels in control uninfected sheep. In this final
chapter the overall conclusions of findings presented in this thesis
shall be discussed and summarised and some ideas for future
investigations that have arisen as a result of the present study
shall be suggested.
7.1 Effects of Dietary n3 and n6 EFA an Uterine Fatty Acid
Composition
After weaning only three weeks of feeding a diet high in n3 or n6
EFA was necessary to induce significant changes in the fatty acid
composition of the rat uterus. The same dietary induced changes
were seen after feeding for up to 500 days. Uteri of rats fed a F0
diet with a high n3 fatty acid content contained higher proportions
of n3 fatty acids than rats fed a control pelleted diet or an EPO
diet, and the opposite was true for n6 fatty acids. The proportion
of arachidonic acid was significantly higher (p < 0.05) in the EPO
group than in the F0 group of adult rats (mean age 231 days) and in
both EPO (p < 0.05) and control (p < 0.05) groups of phospholipids
in young rats (mean age 44 days). 20:5n3 proportions, however, were
significantly higher in F0 groups in both total lipid in adult rats
and phospholipid in young rats than in EPO and control groups (P <
0.001 for control adult rats, others P < 0.05).
The control diet contained higher proportions of n3 fatty acids than
the F0 diets, however, uteri from rats on F0 diets contained higher
proportions of n3 fatty acids than those from control rats. This
may have been due to the control diet having a far lower n3/n6 ratio
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than the FO diets (0.183 compared to 2.899 in adult rats and 3.522
in young rats respectively) and suggests that the uterus will only
incorporate n3 -fatty acids in relatively high proportions when
sufficient levels of n6 fatty acids are not available. Huang et al.
(1987) reported similar results in rat plasma and liver.
D6 desaturase activity in the rat uterus appeared to be low,
illustrated by a comparison of proportions of 20:3n6 and arachidonic
acid in the total lipid of adult rats fed control and EPO diets.
The uteri of control rats contained significantly higher (p < 0.05)
proportions of linoleic acid than uteri of rats on the EPO diet
ill. 127. compared to 3.827. respectively). However, the uteri of EPO
fed rats contained higher proportions of arachidonic acid (9.927.
compared to 7.7Z/. respectively). The diets and uteri of control and
EPO rats contained similar proportions of 18:3n6 and 20:3n6 so the
difference was unlikely to have arisen from conversion of these
fatty acids to arachidonic acid. However, n3 fatty acids present in
the control diet and tissue may have inhibited desaturation of n6
fatty acids. Accumulation of 18:3n6 or 20:3n6 was not observed in
rats an any of the diets in any of the lipid fractions. This
suggests active D5 desaturase actvity in the uterus.
In rats of all diet groups a general trend of high 22C to 20C n3
fatty acids was observed, whereas the opposite was true for the n6
fatty acids. This indicates that either the D4 desaturase was more
active on n3 fatty acids than n6 fatty acids or that preferential
incorporation of the 22C n3 above the 20C n3 fatty acids was taking
place. Comparisons of total proportions of arachidonic acid, 20:5n3
and 22:6n3 in the EPO, FO and control diets suggest that 20:5n3 and
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22:6n3 compensate for low arachidonic acid levels in the uterus.
However, this compensation is purely structural and not functional,
at least concerning the process of parturition.
Individual lipid fractions within the uterus were found to respond
differently to changes in n3 and n6 dietary fatty acid content, with
the neutral lipid fractions, with the exception of the free fatty
acids, having higher n3/n6 ratios than the phospholipids, in
response to a diet containing a-linolenic acid as the major EFA
source. Free fatty acid, PC and PI lipid fractions were affected
least by high n3 fatty acid diet content, maintaining low n3/n6
ratios of 0.26 + 0.14, 0.3 ± 0.12 and 0.23 + 0.05 respectively. PE
was more susceptible to the high n3 dietary content than the other
phospholipids, giving an n3/n6 ratio of 0.47 + 0.12.
Very low incorporation of 20C and 22C EFA into triglyceride and
cholesterol esters was observed in rats on all of the diets,
suggesting that these lipids do not form quantitatively major pools
of eicosanoid precursors. Relatively high proportions of the 18C
EFA were, however, found in the triglyceride-cholesterol ester lipid
fractions. This lipid fraction was found to be very susceptible to
changes in dietary fatty acid content, with a high uterine n3/n6
fatty acid ratio of 1.39 resulting after three weeks of feeding rats
a diet containing 97.67. n3 EFA (in the form of a-linolenic acid
ethyl ester).
The monoglyceride, diglyceride and free fatty acid components of the
neutral lipid fraction contained higher proportions of the 20C EFA
than the triglyceride-cholesterol ester fraction. The activity of
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inositol-specific phospholipase C, ■ diacylglycerol lipase and
monoacylglycerol lipase specific for monoacylglycerol with
arachidonic acid in the sn-2 position have been identified in human
uterine decidua and foetal membranes (Di Renzo et al., 1981; Okazaki
et al., 1981), so these neutral lipid fractions are possible sources
of arachidonic acid for prostaglandin synthesis.
In addition to a dietary induced change in uterine fatty acid
composition, an age related change in fatty acid composition of
newly weaned rats compared to adult rats was also observed. Newly
weaned rats were found to contain a significantly higher (P < 0.01)
proportion of fatty acids with less than 18 carbon atoms. The high
proportion of short chain fatty acids in the newly weaned rats may
have resulted from high levels of these fatty acids in the mothers
milk (Ross et al., 1985). However, the adult rats on the semi¬
synthetic diets consumed large quantities of short chain fatty acids
compared to those on the control diet with little effect on the
proportions of short chain fatty acids in the uterus. This suggests
that dietary levels of short chain fatty acids have little influence
on the incorporation of these fatty acids in the adult rat.
7.2 Uterine Arachidanic Acid Conservation
Arachidonic acid was the fatty acid most conserved in all of the
dietary groups in phospholipid of young rats and total lipid of
adult rats, including the rats on the high n3 fatty acid diets.
Tissue/diet arachidonic acid ratios in EPQ, F0 and control diet fed
rats were higher than those for any other fatty acids tested in
total uterine lipid of adult rats and phospholipid of young rats.
There are three possible explanations for the mechanism behind the
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high tissue arachidonic acid concentrations; (1) Arachidonic acid
was specifically incorporated into the tissue, (2) Arachidonic acid
levels were increased by production from precursors, and (3)
Arachidonic acid was specifically retained despite low dietary
levels.
The studies have shown little evidence for specific incorporation of
arachidonic acid directly from the diets, with dietary levels of
arachidonic acid having little direct bearing on tissue arachidonic
acid proportions, however, the arachidonic acid content of all the
diets was very low. There was, however, some evidence for specific
incorporation of n6 fatty acids in preference to n3 fatty acids,
illustrated by the fact that the control diet contained higher
proportions of both 18:3n3 and 20:5n3 than the FO diet, however, the
uteri from the FO fed rats contained higher proportions of these
fatty acids than the control diet rats, indicating that when n6
fatty acids were available, less n3 fatty acids were incorporated.
Evidence for the production of arachidonic acid from precursors came
from the fact that, despite the EPO diet containing a lower
proportion of arachidonic acid than either the FO or control diets,
the tissue levels of arachidonic acid were highest in the EPO group.
This nnay have been due to there being no n3 fatty acids present in
the EPO diet to inhibit conversion of n6 precursors to arachidonic
acid. Arachidonic acid was present in the lipid of rats fed the FO
and a-linolenic acid diets that contained very low levels of n6
fatty acids, indicating that the arachidonic acid was selectively
retained in these rats. There was also evidence for conservation of
n3 fatty acids in the uterus as the rats on the EPO and linoleic
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acid diets maintained n3/n6 tissue ratios far higher than those in
their corresponding diets.
Arachidonic acid was found to be most conserved in the phospholipid
fractions of phosphatidylcholine and phosphatidylinositol, with
phosphatidylethanolamine being more susceptible to dietary change.
PI, PC and PE have all been suggested to be possible sources of free
arachidonic acid in uterine tissues involved in prostaglandin
synthesis at parturition (Leaver et al., 1981; Ning et al., 1983;
Okita et al., 1982). In the free fatty acid fraction the proportion
of arachidanic acid and eicosapentaenoic acid in relation to the
other EFA was higher than in the other lipid groups, suggesting
specific release of the eicosanoid precursors. Enzymes specific for
arachidanic acid release from PE and monoglyceride have been
identified in uterine decidua and foetal membranes (Okazaki et al.,
1978; Okazaki et al., 1981b). Evidence for selective release of
arachidonic acid during labour has also been found (Ogburn et al.,
1980; Okita et al., 1982).
7.3 The Effect of Dietary Fatty Acids on Uterine Prostaglandin
Production
Inhibition of 2-series prostaglandin production has been shown to
occur in uterine tissues in response to high dietary n3 fatty acid
intake (Leaver et al., 1986). However, it was not known if uterine
cyclooxygenase enzymes would metabolise n3 fatty acids to 3-series
prostaglandins. In this study evidence was presented for the
presence of 3-series prostaglandins in uteri of rats fed diets
containing different levels of n3 and n6 fatty acids. Using a very
sensitive method of mass spectrometry, synthesis of PGE3 and PGF.3--.
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was detected in the calcium ionophore, A23187, stimulated uteri o-f
rats -fed a control pelleted diet (82.67. n6 EFA) , a linoleic acid
diet (99.97. n6 EFA) or an a-linolenic acid diet (97.67. n3 EFA). In
unstimulated uteri PGE3 and PGF^. were produced only in the a-
linolenic acid -fed group. A23187 induced increased production o-f
total prostaglandin as well as causing an increase in the proportion
of 3-series to 2-series prostaglandins. This suggested that the
phospho lipases activated by A23187 were less specific -for
arachidonic acid than those in the unstimulated uterus. The
phospholipases activated by A23187 may act an a different fatty acid
pool or may be present in a different part of the uterus from
phospTtolipases active in the unstimulated uterus. Leaver et al.
(1981) reported different levels of prostaglandin synthesis in the
endometrium and myometrium of guinea pig uterus, and in the rabbit
kidney the existence of two fatty acid pools for prostaglandin
synthesis has been suggested (Schwartzman and Raz, 1979; Schwartzman
and Raz, 1981).
In rats maintained on diets containing high concentrations of n3
fatty acids growth and gestation will occur normally (Leat and
Northrop, 1981) it is only parturition that is inhibited. If there
is a similar increase in the proportion of 3-series to 2-series
prostaglandins produced at parturition as was observed in A23187
stimulated uteri compared to unstimulated uteri, this could explain
why only parturition is affected by the n3 diet. The increase in 3-
series prostaglandin production observed on stimulation with A23187
suggests that only a limited degree of substrate specificity in
prostaglandin synthesis is at the level of the cyclooxygenase.
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Rats -fed the a-linolenic acid diet synthesised lower total levels of
prostaglandins than rats -fed the linoleic acid diet. This, combined
with the increase in proportions o-f 3-series to 2-series
prostaglandins in the linolenic compared to the linoleic acid -fed
rats may cause the inhibition of parturition associated with high
dietary n3 fatty acid intake.
7.4 The Effect of Infection by Chlamydia Psittaci an Uterine
Prostaglandin Ez and Steroid Hormone Production
Premature labour and abortion in sheep often results from infection
by Chlamydia psittaci (Studdert and McKercher, 1768; Novilla and
Jensen, 1970). Ovine abortion strains of C;. psittaci may also cause
abortion in women (Roberts et al., 1967; Beer et al., 1982; Johnson
et al., 1985). Prostaglandins and steroid hormones act closely
together to control the timing, initiation and maintenance of
parturition. It is therefore possible that chlamydial infection may
cause abortion through effects on production of the steroid hormones
and prostaglandins. In this thesis, changes were reported in
patterns of production of steroid hormones and PGE^ in sheep
experimentally infected with an ovine abortion strain of psittaci
compared to uninfected sheep. In response to a relatively mild
infection, PGE= concentrations were found to significantly increase
thirteen days early in the amniotic fluid and nine days early in the
allantoic fluid, compared to uninfected sheep (P < 0.001 and P <
0.01 respectively). The increased concentrations of PGE^ seen in
the infected sheep were similar to those in uninfected sheep at
parturition. In contrast to the premature increases in PGE=
concentrations observed in the amniotic and allantoic fluids, in the
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utero-ovarian vein, PGE2 concentrations in in-fee ted sheep were only
697. of levels in control sheep. This suggested that infection by C.
psittaci disrupted the transfer of PGE= into the utero-ovarian vein.
In sheep, increased oestradiol 17(3 is associated with increased
prostaglandin synthesis (Thorburn and Challis, 1979), whereas high
progesterone concentrations are associated with low prostaglandin
concentrations (Taylor et al., 1982). A decrease in progesterone
concentrations on day 122 of gestation in infected sheep was
observed, which coincided with the increase in PGE3 in the amniotic
fluid. Premature increases in oestradiol 17(3 were observed in
peripheral plasma and amniotic fluid of infected sheep. The changes
in the steroid hormone concentrations may be partly responsible for
the elevated levels of PGE3 seen in infected sheep, however, tissue
necrosis caused by psittaci infection may also result in
increased PGE3 concentrations. The results suggest that premature
labour resulting from infection by psittaci may be initiated by
alterations in PGE2 and placental steroid release.
7.5 Future Studies
This study has demonstrated how the fatty acid composition and
prostaglandin production of the uterus may be altered by dietary
fatty acid composition and microbial infection by psittaci. In
the course of the present investigation a number of questions have
arisen that will require to be addressed in the future. These
questions will now be discussed.
Certain lipid pools were found to be more susceptible to changes in
dietary fatty acids than others. Differences in incorporation and
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release of fatty acids from individual phospholipid species has been
observed in a number of cells and tissues and more interest is now
being centred on differences between diacyl and other phospholipid
species. These were not analysed in the present study but would be
worthwhile analysing in a future study. As well as analysing
different lipid classes, the uterus could be divided into separate
tissues and fatty acid content, fatty acid release and prostaglandin
synthesis measured in the individual tissues. At parturition
various tissues are involved to different degrees in the synthesis
*
of prostaglandins so analysis of the uterus as a whole does not
necessarily give the most accurate information on the source of
fatty acids for prostaglandin synthesis.
Levels of fatty acids in serum, amniotic fluid and uterine and
foetal tissues involved in prostaglandin synthesis have been shown
to vary with gestational age, and before, during and after labour
(Ogburn et al., 1980; Olund and Lunell, 1980; Das et al., 1975;
Schwarz et al., 1975; Schwartz et al., 1977), and it has been
suggested that arachidanic acid is specifically incorporated into
phospholipids late in pregnancy. The effect that the n3 fatty acids
have on this specific incorporation has not yet been analysed and
could provide further information on the mechanism of the impairment
of parturition caused by the n3 fatty acids.
From the information obtained on the fatty acid contents of the
different lipid fractions, possible sources of fatty acids for
prostaglandin synthesis were suggested, however, further studies on
the fatty acid composition of the different lipid groups before and
after tissue stimulation is necessary for a more positive
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identification of the lipid groups involved. The results in chapter
5 suggested a different source of fatty acids may be used for
prostaglandin synthesis in the unstimulated uterus compared to the
uterus stimulated with the calcium ionophore A23187. It has been
suggested that different agonists may induce release of fatty acids
from different sources (Hsueh et al., 1781; Schwartzman and Raz,
1981; Hong and Deykin, 1979) and that the proportion of the fatty
acids released may also vary with the type of stimulus. We observed
increased release of 3-series prostaglandins in response to A23187.
However, A23187 may cause a less specific release of fatty acids
than other stimuli (Hong and Deykin, 1979) such as progesterone,
oestrogen and oxytocin, that are involved in the control of
prostaglandin synthesis during pregnancy and parturition. It would
therefore be a worthwhile study to investigate the fatty acids
released and prostaglandins synthesised in response to these
hormones in animals maintained on diets with varying n3 and n6 EFA
content. If 3-series prostaglandins are produced in similar
quantities at parturition as they are when the uterus is stimulated
with A23187 then they may be partly responsible for the n3 fatty
acid induced inhibition of parturition, possibly by antagonising the
effects of the 2-series prostaglandins. The effects of the 3-series
prostaglandins on the uterus are not known, however, in view of the
current findings this clearly requires investigation.
Injection of arachidonic acid into the amniotic fluid of pregnant
women has been shown to cause abortion (MacDonald et al., 1974). It
is possible that eicosapentaenoic acid administered in a similar way
could delay labour. If this was the case then eicosapentaenoic acid
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could be used in the management of preterm labour. It is also
possible that similar treatment could delay or prevent the premature
delivery and abortion caused by infection with C^. psittaci and an
interesting experiment would be to observe the effects of a diet
high in n3 fatty acids on pregnant sheep infected with C^. psittaci■
The effect of dietary n3 and n6 fatty acids on uterine fatty acid
content and the effect of these fatty acids and of infection by the
intracellular parasite, Chlamydia psittaci. on uterine prostaglandin
production have been investigated in this thesis. Further work is
required to investigate the incorporation of n3 and n6 EFA into the
diacyl and plasmalogen phospholipid species as well as incorporation
into specific uterine tissues. The sources of the prostaglandin
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Altered steroid hormone and prostaglandin metabolism during chlamydial infection in sheep
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Chlamydial infection is associated with premature labour in
sheep, and causes necrosis of placental tissue. The effect of
Chlamydia infection on the synthesis of progesterone was
studied, by measuring serum progesterone in seven infected
and seven control animals. Progesterone inhibits the release
of prostaglandin (PG) E2 and PGF2a from the pregnant
uterus (Taylor et al., 1978). Local inflammation at the site
of infection may also stimulate intrauterine PGE2 synthesis
(Thorburn & Challis, 1979).
The amniotic and allantoic sacs and the utero-ovarian
vein were cannulated in seven Chlamydia-infected sheep and
seven uninfected controls. Infection was by subcutaneous
inoculation of 104 5 infectious particles of an ovine abortion
strain of Chlamydia psittaci. PGE2 was detected by radio¬
immunoassay of uterine fluids (Leaver & Seawright, 1982)
without prior extraction, as parallel binding curves were
obtained in the presence and absence of fluid. However,
PGE2 in utero-ovarian plasma was immediately extracted,
is an interfering factor, and PGE2 degradation, were detected
n plasma. Anti-PGE2 antiserum was purchased from the
Institut Pasteur, Paris, and anti-rabbit IgG was donated by
he Scottish Antibody Production Unit.
The plasma progesterone of Chlamydia-infected sheep
was not significantly different from control values until day
120 of gestation (see Fig. 1). The concentration of pro¬
gesterone decreased significantly between day 119 and day
135 of gestation in Chlamydia-infected animals, but not in
;ontrol, uninfected sheep. The decline in plasma progesterone
n control sheep occurred between day 139 and 145 of preg-
lancy. Therefore, the decline in circulating progesterone
vas observed 20 days earlier in Chlamydia-infected sheep,
ind 16 days before delivery.
The concentration of PGE2 in amniotic and allantoic
luids in control animals was low (2-4ng/ml), between day
15 and day 128 of gestation. In contrast, an elevated con¬
centration of PGE2, and pulsatile release of this prostaglan-
lin, was observed in Chlamydia-infected sheep from day
19, which gradually increased until delivery. The release of
>GE2 into the utero-ovarian vein just before parturition,
tbserved in control animals, was impaired or inhibited in
Chlamydia-infected sheep. The magnitude of the increase in
'GE2 observed in Chlamydia-infected amniotic fluid (over
>ng/ml), suggested that the PGE2 was of uterine, rather
han leucocyte, origin. The relation of the timing of PGE2
elease, to the decline in plasma progesterone, also suggested
n endocrine control of this PGE, release.
Abbreviation used: PG, prostaglandin.
In summary, changes in circulating steroid hormones, and
intrauterine PGE2, were detected in Chlamydia-infected
sheep. These changes may precipitate the premature labour
associated with Chlamydia infection.
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Fig. 1. Plasma progesterone in Chlamydia-infected (a) and
control (b) sheep during late pregnancy
The mean date of lambing is indicated with an arrow. Progester¬
one was extracted from plasma using diethylether, and results
were corrected for efficiency of solvent extraction (70 + 6%),
and detected using the antiserum of Scaramuzzi et al. (1974).
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Evidence that sequential solubilization of the bile canalicular membrane occurs during the onset
of bile acid-induced cholestasis
STEPHEN G. BARNWELL
Advanced Drug Delivery Research Unit,
Ciba-Geigy Pharmaceuticals, Wimblehurst Road,
Horsham, West Sussex RH12 4AB, U.K.
Under normal physiological conditions bile phospholipid is
almost entirely composed ofpalmitoyl-linoleoyl or palmitoyl-
oleoyl phosphatidylcholine. It is generally believed that this
phospholipid is solubilized from biliary tract membranes by
bile acids yet, surprisingly, these membranes contain very
little of this type of phospholipid as their structure comprises
mainly of stearoyl-arachidonoyl-phosphatidylcholine, sphin¬
gomyelin and phosphatidylethanolamine (together with
large amounts of cholesterol relative to other hepatic mem¬
branes). To explain this phenomena Barnwell et al. (1984)
proposed that a microtubule-mediated bile acid-dependent
process carries biliary phospholipid vesicles from a storage
site in the endoplasmic reticulum to the bile canalicular
membrane (BCM) and, furthermore, as suggested by Lowe
et al. (1984), these vesicles fuse with the BCM forming fluid
microdomains of biliary phospholipid preferentially solu¬
bilized by bile acids.
Since inhibition of the transport of biliary phospholipids
to the BCM with microtubule- disrupting agents causes
cholestasis (Barnwell et al., 1984), it is likely that this pro¬
cess forms a protective and/or membrane repair function. In
the present study the possibility that the breakdown of this
process leads to the onset of bile acid-induced cholestasis
was investigated.
The experimental procedure involved the intravenous
infusion of various bile acids (cholic acid, chenodeoxycholic
acid, deoxycholic acid or their glycine and taurine conjugates)
into anaesthetized male Sprague-Dawley rats (200-250g)
fitted with a bile fistula. Administering bile acids in stepwise
increasing doses first of all increased bile flow (up to maxi¬
mum of 200% of control values) and then decreased bile
flow after maximum bile acid secretion rate had been
achieved. When bile flow had declined to 50% of that before
bile acid infusion, livers were removed and pure BCM and
microsomal membranes isolated. Bile phospholipids, from
lOmin samples collected throughout the experiments, were
separated by t.l.c., as were hepatic membrane phospholipids.
Quantification of individual phospholipid species was
followed by a detailed analysis of their fatty acid compo¬
sition by capillary column g.l.c.
The results of these analyses indicated that the quantitative
changes in biliary and hepatic membrane phospholipid
during the onset of cholestasis were essentially very similar.
In the early stages of bile acid infusion, when bile flow was
increasing, bile phospholipids were comprised almost
Abbreviation used: BCM, bile canalicular membrane.
entirely of phosphatidylcholine and contained significant
amounts of palmitic, linoleic and oleic acids only. Bile
samples collected when bile flow and bile acid secretion were
maximal still contained only phosphatidylcholine; however
the fatty acid profile of this phospholipid now includec
increasing amounts of stearic and arachidonic acids. Sub¬
sequent bile samples collected as bile flow declined con¬
tained sphingomyelin (up to 20% of the total phospholipid
while those collected when bile flow was at its minimum alsc
contained phosphatidylethanolamine. Both sphingomyelir
and phosphatidylethanolamine were found to have long-
chain fatty acids, typical of those found in BCM phos¬
pholipids, in their composition. Interestingly, a comparisor
of the total amounts of each lipid subclass secreted during
the bile acid infusion, showed little variation betweer
individual animals or with the individual bile acid infused
Microsomal and BCMs were found to be considerably
depleted in total phospholipids (up to 50%) but not choles¬
terol when compared with controls. Unlike the BCM, in
which no overall change in the proportion of each phos¬
pholipid component had taken place, the microsomal mem¬
brane contained significantly less phosphatidylcholine-
derived palmitic, linoleic and oleic acids (i.e. biliary type
phosphatidycholine).
Taken together these observations are suggested to indi¬
cate that a series of common events take place during the
onset of the cholestasis induced by a variety of different bile
acids. Initially it is envisaged that the transport of biliary
type phosphatidylcholine increases with bile acid until the
rate of new synthesis can no longer keep pace with demand
and/or the preformed pool of this material is completely
depleted. With continued bile acid transport into bile with¬
out biliary phospholipid it is likely that solubilization of the
BCM structure occurs. Samples of bile collected during the
onset of cholestasis first of all contained phosphatidyl¬
choline followed by sphingomyelin and then phosphatidyl¬
ethanolamine, thereby suggesting a sequential solubilization
of these phospholipids from the BCM. Nevertheless, the
final composition of the BCM during cholestasis was changec
only in its total phospholipid and not individual phospholipic
content. It is suggested that the consequence of the break¬
down of BCM repair is that BCM phospholipids are solu¬
bilized by bile acids resulting in a greatly increased choles-
terol/phospholipid ratio (0.35 : 1.2) and a subsequent failure
in BCM secretory function.
Barnwell, S. G., Lowe, P. J. & Coleman, R. (1984) Biochem. J. 220
723-731
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Pulmonary surfactant biosynthesis: studies in vivo and in vitro
RICHARD W. LEWIS, ROY J. RICHARDS
and JOHN L. HARWOOD
Department of Biochemistry, University College,
Cardiff CF1 1XL, Wales, U.K.
Pulmonary surfactant phospholipids are responsible for
reducing surface tension at the alveolar surface and are
essential to normal lung function. The phospholipids of
surfactant are synthesized in the endoplasmic reticulum of
the type II cells of the lung and stored in lamellar inclusior
bodies before release on to the alveolar surface (Chevalier &
Collet, 1972; Van Golde, 1976).
The successful isolation and maintenance of alveolar typ<
II cells in culture (cf. Longmore & Brown, 1984) ha:
provided a readily available homogenous cell population ir
which to study surfactant biosynthesis. However, studies b;
Mason & Dobbs, (1980) have indicated that isolated eel
preparations may gradually loss their ability to synthesizf
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Changes in Progesterone, Oestradiol lip, and Intrauterine Prostaglandin
E2 during Late Gestation in Sheep Experimentally Infected with an Ovine
Abortion Strain of Chlamydia psittaci
By H. A. LEAVER,1* A. HOWIE,1 I. D. AITKEN,2 B. W. APPLEYARD,2
I. E. ANDERSON,2 G. JONES,2 L. A. HAY,2 G. E. WILLIAMS2 AND
D. BUXTON2
1 Department of Pharmacology, University ofEdinburgh, Edinburgh EH8 9JZ, UK, and
Blood Transfusion Centre, Lauriston Place, Edinburgh EH3 9HB, UK
2Moredun Research Institute, Edinburgh EH7 7JH, UK
(Received 22 June 1988; revised 3 November 1988; accepted 16 November 1988)
The placenta is the primary site of infection of Chlamydia psittaci and is also intimately involved
in the control of parturition. Changes in the pattern of placental hormone secretion were
investigated in ewes infected with C. psittaci and in saline-injected controls. The concentration
of progesterone in peripheral plasma of infected sheep was significantly lower than in control
sheep (P<0-01). A gradual decline in plasma progesterone occurred in Chlamydia-'mfected
sheep, beginning on day 125 of gestation, in comparison with the sharper decline commencing
on day 139 of gestation in the control population. The release of oestradiol 17/8, which was
greatest on the day of parturition in control sheep, was significantly (/><0 02) increased on the
day before parturition in Chlamydia-infected sheep. The concentrations of prostaglandin E2 in
amniotic and allantoic fluids were low during late pregnancy in 12 control sheep, but were
significantly raised (P< 0-05) in four out of 12 samples obtained from Chlamydia-infected sheep
over the same period. The changes in progesterone and prostaglandin E, were temporally
related to the morphological and histochemical changes characteristic of trophoblast infection.
These findings suggest that C. psittaci infection may precipitate premature labour by altering
placental steroid and prostaglandin release.
INTRODUCTION
Premature labour and abortion are major complications associated with Chlamydia psittaci
infection of sheep (Studdert & McKercher, 1968; Novilla & Jensen, 1970). Ovine abortion
strains of C. psittaci have been demonstrated to infect women and are associated with abortion
in these subjects (Roberts et al., 1967; Beer etal., 1982; Johnson et al., 1985). In both sheep and
humans, the perinatal complications caused by C. psittaci appear to be more severe than those
associated with Chlamydia trachomatis, but the pathophysiology of both infections is similar
with respect to the site and timing of infectivity and the effect of initiating premature labour
(Sweet et al., 1987; Studdert, 1968). The widespread distribution of chlamydial infection in
sheep has been known for many years (McEwen et al., 1951; Studdert & McKercher, 1968).
However, recent applications of monoclonal antibodies and gene probe techniques have
indicated a much wider distribution of chlamydial infection than had been previously suspected
in the human population (Sweet et al., 1987).
The endocrinology of infectious abortion has been the subject of intermittent attention (Smith
& Hughes, 1974; Roberts et al., 1975; Minkoff, 1983; Lamont et al., 1985; Helm et al., 1987).
Abbreviations-. ELD50, egg LD50; PGE2, prostaglandin E2.
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However, there has been little investigation of the effects of chlamydiae on the factors which
play a role in controlling parturition (Martel et al., 1983; Rank et al., 1982; Fredriksson et al.,
1988). This is surprising, since pathological studies indicate that the infectivity of chlamydiae is
closely related to the stage of pregnancy, and disorders in the initiation of parturition result from
this infection.
The primary focus of chlamydial infection during pregnancy is the placenta. Three placental
products are important in the control of parturition, viz. progesterone, oestradiol 17/? and
prostaglandin E2 (PGE2). Progesterone is important in the maintenance of pregnancy (Bedford
et al., 1972; Taylor et al., 1982), and progesterone synthesis during late pregnancy in both sheep
and women occurs in the placenta (Linzell & Heap, 1968). The placenta is also a major source of
oestrogens in these species. The secretion and distribution of oestradiol 11fl during gestation,
and its effect on prostaglandin synthesis, have been characterized (Allen, 1975; Liggins et al.,
1972). Plasma progesterone and oestradiol lip concentrations are indicators of the placental
production and secretion of these steroids. The concentrations of oestradiol 17P in the amniotic
fluid and the utero-ovarian vein reflect the intrauterine production and diffusion of oestradiol
lip.
Changes in the concentrations of oestradiol 17p and progesterone influence the release of
PGE2 at parturition (Thorburn & Challis, 1979; Taylor et al., 1982; Olson et al., 1984). The
primary site of placental infection of C. psittaci is the chorionic membrane, which is also a major
site of placental PGE2 synthesis. PGE2 is also released in significant quantities by leucocytes,
particularly by inflammatory macrophages (Lewis, 1983). The prostaglandins exert a range of
effects within the uterus at parturition. Prostaglandins act on the myometrium, where they
stimulate and co-ordinate myometrial contraction (Wickland et al., 1984). In the cervix,
prostaglandins induce ultrastructural changes resulting in an increase in cervical patency
(Keirse et al., 1983). Stimulation of the chorionic membrane causes release of arachidonic acid
and prostaglandin E2 from the foetal membranes (Grieves & Liggins, 1976). A role for
prostaglandin E2 in initiating labour has been proposed (Bleasdale & Johnston, 1984). The
secretion of prostaglandin E2 and its metabolites increases during late pregnancy, and
prostaglandin E2 is synthesized in greater quantities than prostaglandin F2a during early labour
(Dray & Frydman, 1976). The intrauterine concentrations of PGE2 indicate the locally active
concentrations of this metabolically labile compound close to its site of action.
In this study, the relationship between the timing of changes in placental hormone
metabolism and morphological and histochemical changes in the placenta during chlamydial
infection was analysed in order to establish the sequence of pathophysiological events associated
with premature labour.
METHODS
Experimental infection ofsheep. Twenty-two Scottish Blackface ewes were infected by subcutaneous inoculation
with between 0-45 x 106 and 1-6 x 106 egg LD50 (ELD50) of ovine abortion strain S26/3 of C. psittaci between
days 90 and 115 of gestation. Twenty-three pregnant ewes were used as controls. The number of foetuses was
determined in all animals between days 60 and 80 of gestation using ultrasonography, and at birth. These
experiments were part of a study of the pathogenesis of C. psittaci infection during pregnancy, as this is a serious
cause of mortality in lambs and morbidity (infectious abortion) in pregnant sheep. In addition, Chlamydia
infection has been demonstrated to be a cause of abortion in pregnant women in contact with sheep. The study was
reviewed by the Ethics Committee of the Institution where the experiments were conducted before
commencement.
Peripheralplasma samplesfor progesterone assays. Six ewes were infected on day 90 of gestation by subcutaneous
injection with 5 x 105 ELD50 of C. psittaci strain S26/3, and six control ewes were injected with sterile saline. The
mean duration of gestation + se in control sheep was 144-7 ± 1 -08 d (n = 6), range 144-149 d, and in C. psittaci-
infected sheep, 137 ± 1 -6 d (n = 6), range 132-142 d. Only sheep with single lambs were used, as twin pregnancies
are associated with higher progesterone levels, which are not directly proportional to the number of lambs
(Bedford et al., 1972; H. A. Leaver, unpublished observations). Blood was withdrawn at 3 d intervals from the
jugular vein of infected and control sheep up to day 110 of gestation and at 2 d intervals after day 110, and placed
into tubes containing 2 IU preservative-free heparin ml-1 (Evans Medical). Plasma was prepared by
centrifugation of the heparinized sample at 2000 g for 10 min. All plasma samples were stored at — 40 °C.
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Progesterone concentrations were expressed as the means ± se of results from samples of plasma taken from three
to six individual control or infected sheep on the same day of gestation.
Progesterone radio-immunoassay. Peripheral plasma progesterone was extracted using ethyl acetate (efficiency
71 ± 3%). Progesterone was determined by a radio-immunoassay using the antiserum and technique of
Scaramuzzi et al. (1974), and [l,2,6,7,16,17-3H]progesterone radiotracer (Amersham, batch no. 10/H/4723).
Antibody-bound progesterone was precipitated using dextran charcoal. The precision of progesterone
determination was 10-2% for within-assay duplication (inter-assay coefficient of variation), and 9-6% for between-
assay replication (intra-assay coefficient of variation), for two plasma samples analysed six times within the same
assay (n = 6), and two plasma samples analysed in six different assays (n = 6), respectively (Hunter, 1978).
Peripheral plasma samples for oestradiol 17p assays. Oestradiol 17 /? was analysed in peripheral plasma samples
collected for progesterone analysis (see above), and in peripheral plasma samples from a second group of animals,
consisting of four ewes infected on day 113-115 of gestation by subcutaneous injection with 0-5 x 106 ELD50 of C.
psittaci strain S26/3, and five control ewes injected with sterile saline. This second group were catheterized 2 d after
injection, on day 115-117 of gestation, for intrauterine sampling (see below). The mean durations of gestation ± se
in this second group were 143-8 + 1-1 d (n = 5), range 141-147 d, in control sheep and 139-8 ± T1 d (n = 4), range
137-141 d, in C. psittaci-'miecteA sheep. Two of the control ewes had twins, and three had single lambs. All seven
lambs survived. Two of the infected ewes bore twins, and two bore single lambs. Two out of six lambs of the C.
/w/rrari-infected sheep were born dead: one of twin lambs was dead on delivery, and another, single lamb, died of
asphyxia during delivery. In group two, blood was withdrawn from the jugular vein at 24 h intervals during the last
3 d of gestation, and placed into tubes containing 2 IU preservative-free heparin ml-1. Plasma was prepared by
centrifugation (see above) and stored at — 40 °C. Oestradiol 17/? concentrations were expressed as pg ml"1 + se in
the plasma of control or infected sheep, sampled on separate days before parturition.
Utero-ovarian venous plasma, amnioticfluid and allantoicfluid samplesfrom catheterized animalsfor oestradiol 17/?
assays. The intrauterine distribution of oestradiol 17/? during chlamydial infection was analysed in the six control
sheep injected with saline, and in the six sheep infected with 5 x 10s ELD50 of C. psittaci strain S26/3 on day 113-
115 of gestation, whose peripheral plasma oestradiol 17/? was determined. This third group consisted of the sheep
used for peripheral plasma oestradiol (see above), plus two additional infected sheep and one additional control
sheep. The mean durations of gestation were 144-5 ± IT d (n = 6), range 141-148 d, in the control group, and
141-3 + 1-8 d (n = 6), range 137-141 d, in the infected group. In the control group, three of the ewes had twins and
three had single lambs, and in the infected group, four of the ewes bore twins, and two bore single lambs. In the C.
/M/«ac(-infected group, two out of ten lambs were born dead: one of twin lambs was dead on delivery, and another,
single lamb, died of asphyxia during delivery. In the control group, all nine lambs survived.
Ewes were implanted with indwelling catheters into the amniotic and allantoic cavities and into the utero-
ovarian vein on day 115-117 of gestation (Mellor, 1980). Amniotic and allantoic sacs of each foetus were
catheterized using Foley two-way balloon catheters (size 12 Ch, with 30-40 ml balloon; Eschmann, Sussex, UK).
Small samples (0-5-2 ml) of amniotic and allantoic fluids were withdrawn using minimal suction at 24 h intervals
from day 137 of gestation in control sheep and from day 133 of gestation in infected sheep. Sterility within each
two-way tap was maintained by twice-daily flushing with thiomersal solution, consisting of thiomersal (BDH;
0-1% in ethanoi)/acetone/ethanol (1:500:500, by vol.). Amniotic and allantoic fluids were placed immediately
into 10 ml of'analytical-reagent'-grade methanol, and stored at — 40 °C.
A utero-ovarian vein was also catheterized using 1 -4mm external diameter vinyl tubing (Portex Ltd). A two-way
luer stopcock was attached to each catheter. Vascular catheters were sampled daily and flushed with a heparin
saline solution (80 IU preservative-free heparin ml-1) twice daily. Blood was placed into tubes containing 2 IU
preservative-free heparin ml"1; plasma was prepared by centrifugation (see above), and stored at — 40 °C.
Oestradiol 17/? radio-immunoassay. Oestradiol 17/i radio-immunoassay was carried out on samples taken from
amniotic fluid, allantoic fluid, the utero-ovarian vein, and peripheral plasma, using a kit (Steranti Research; batch
no. S703). The addition of up to 50 pi of fluids did not significantly change the binding curve of the anti-oestradiol
serum, unless methanol was present. The aqueous-methanol amniotic and allantoic fluid samples were taken to
dryness, and resuspended in 50 pi standard human serum containing < 0-01 pg oestradiol ml"1. The anti-oestradiol
serum was raised in rabbits, and the secondary precipitating goat anti-rabbit IgG was coupled to a solid phase.
The accuracy of the assays was controlled by using human serum with three known oestradiol concentrations, viz.
27-7 ± 3-68, 60-2 ± 6-60 and 176 ± 13-1 pg ml-1. The sensitivity of the assay was 3-1 pg oestradiol ml-1 at 2-5
standard deviations from the mean, and the inter-assay and intra-assay coefficients of variation were 11-4% and
6-83%, respectively (n = 6).
Amniotic and allantoic fluid samples for PGE2 assays. A fourth group of animals was used in these experiments.
Twelve ewes were infected on day 90 of gestation by subcutaneous in;' ction with 0-45 x 106 ELD50 of C. psittaci
strain S26/3; 12 control ewes were injected with saline. Four ewes (tv/o infected animals and two controls) were
killed on each of the following days ofgestation; 97, 103,109,115, 120 and 125. Amniotic fluid, allantoic fluid, and
placental tissues were removed at necropsy. Amniotic and allantoic fluids were withdrawn, using a syringe and
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gauge 16 needle, during aseptic delivery of foetuses 5 min (range 3-8 min) after killing of the ewes. Care was taken
during sampling to withdraw fluid as far as possible from the site of the puncture, as PGE2 may be released during
rupture of foetal membranes, or from blood or endothelial cells (Leaver et al., 1988). Blood-stained or meconium-
stained samples were discarded (Leaver et al., 1988). Three allantoic and two amniotic samples from the control
group, and one allantoic and two amniotic samples from the infected group, were rejected on this basis. All
samples (3-10 ml) were placed immediately in methanol (10 ml), and stored at — 40 °C prior to PGE2
radioimmunoassay. In both control and C. psittaci-mfected ewes, five animals were carrying single lambs, and
seven had twins. The local PGE2 concentrations in amniotic and allantoic fluids of individual foetuses were
analysed. The PGE2 concentrations of individual foetal sacs were expressed as ng per ml of amniotic fluid or
allantoic fluid on day 97-125 of gestation.
Prostaglandin E2 radio-immunoassay. Prostaglandin E2 radio-immunoassay was carried out on samples of
amniotic and allantoic fluids, either taken to dryness and resuspended in buffer, or extracted using ethyl acetate.
There was no significant difference in the PGE2 concentration in ethyl acetate-extracted and in methanol-treated
samples, after correcting for the efficiency of extraction. Addition of amniotic or allantoic fluid to PGE, standards
did not influence the binding curve of the anti-PGE2 antiserum. Radio-immunoassay of PGE2 was carried out
using anti-PGE2 antiserum (Institut Pasteur, Paris; batch no. D7), and [5,6,8,11,12,14,15(n)-3H] PGE2
radiotracer (Amersham; batch no. 60) under previously described conditions (Leaver et al., 1987). Antiserum was
precipitated using donkey anti-rabbit IgG donated by the Scottish Antibody Production Unit, Carluke,
Lanarkshire, UK. The precision of PGE2 determination was 12-6% for within-assay duplication, and 9-6% for
between-assay replication (n = 6).
Pathology ofplacentae. Placentae were removed from 12 infected and 12 control ewes (fourth group of animals
used for PGE2 assays). Two infected and two control sheep were killed on each of the following days of gestation:
97, 103, 109, 115, 120, 125. Six cotyledons from each uterine horn bearing a foetus were examined in paraffin
section, stained by haematoxylin and eosin. C. psittaci inclusions were identified using an immunoperoxidase
method (Finlayson et al., 1985).
Statistics. Results were expressed as mean ± standard error (se) of the mean for n determinations. The
normality of distribution of each group being tested was analysed using the standard score (z test), and the
statistical significance of differences between paired and unpaired data was analysed using the paired and
unpaired Student's f-tests, respectively (Moroney, 1951). The unpaired f-test incorporated the Behrens Fisher
statistic and, therefore, did not assume that the variances of the population groups being compared were the same.
results
Plasma progesterone in sheep infected with C. psittaci
The mean peripheral plasma progesterone concentrations of six control sheep and of six sheep













Fig. 1. Progesterone in peripheral plasma of control and C. psittaci-infected sheep. Ewes were infected
by subcutaneous injection on day 90 of gestation with 5 x 105 ELD50 of C. psittaci strain S26/3. The
filled arrow indicates the mean day of parturition in infected, and the open arrow, in control ewes (the
mean duration of gestation in control sheep was 144-7 ± 1-08, n = 6, and in C. psittaci-infected sheep,
137 ± 1-6, n = 6). All animals had a single lamb. Progesterone concentrations are the means of three to
six determinations of plasma progesterone from individual control (O) or infected (#) sheep on
separate days of gestation.
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Table 1. Oestradiol 17[S in peripheral plasma, utero-ovarian venous plasma and amniotic fluid of
C. psittaci-infected and control sheep
Oestradiol 17/1 concentrations (mean +








Control (n = 5)
Infected (n = 4)
Control (« = 6)
Infected (n = 6)
Control (n = 6)





































* Indicates significant differences between control and infected groups (/><0-02), using the Student's unpaired
r-test.
t The concentrations of oestradiol 17/J in sheep infected subcutaneously with C. psittaci (strain S26/3, 5 x 105
ELDS0), and of control ewes injected with sterile saline.
was significantly (P<0-05) earlier in the infected group. The profiles of progesterone release in
the two populations showed the following differences. There was a greater variation in the
concentration of plasma progesterone in infected animals. The mean plasma progesterone
concentration in infected animals, compared on eight days between days 100 and 130 of
gestation, was 80 + 5-3% of the mean plasma progesterone concentration in control animals.
The concentration of progesterone in the plasma of control sheep dropped sharply during the 8 d
before parturition, while that of infected sheep showed a more gradual decline, commencing 13
d before parturition, on day 125 of gestation. The difference between the mean progesterone
concentrations, paired between day 100 and day 144 of gestation and analysed using the paired
Student's Mest, was highly significant CPcOOl, no. of paired concentrations = 22). The
difference between the curves was significant well before delivery: when plasma progesterone
levels from individual infected sheep were paired randomly with progesterone concentrations in
controls on the same day of gestation, and were compared between days 125 to 135 of gestation,
using the paired t-test, a significant difference was observed (/><0-05, no. of paired
concentrations = 9). The progesterone concentrations in infected and control sheep were also
analysed in relation to the day of parturition, using the paired r-test for samples collected
between 0 and 8 d before parturition, and between 9 and 20 d before parturition. There was a
significant (P<0-05) difference in plasma progesterone concentrations between 16 paired
samples from infected and control sheep in the earlier (day —9 to —20) period. However, there
was no significant difference in the plasma progesterone concentration of 16 paired samples
from infected and control sheep during the period of progesterone decline immediately before
parturition (day — 8 to 0).
Oestradiol 17ft in C. psittaci-infected and control sheep
The oestradiol 17/? concentrations in the peripheral plasma of the sheep whose progesterone
secretion is shown in Fig. 1 were assayed at 48 h intervals. In the C. psittaci-infected group, a
■pre-partum increase in plasma oestradiol 17/? was detected in the one sheep sampled at 24 h
'before parturition (24 pg ml-1, compared with 9-2 pg ml^1 and 12-9 pg ml-1 in two control
sheep). The five C. psittaci-infected sheep sampled on the day of parturition had a mean plasma
oestradiol concentration of 7-2 ± 4-8 pg ml-1, which was significantly (P<005) lower than that
of control sheep (45 ± 7-3 pg ml-1, n = 4).
Peripheral plasma oestradiol 17/? was analysed daily in a second group of ewes, consisting of
four infected and five control sheep during the 2 d prior to parturition (Table 1). The duration of
gestation in the infected group (139-8 ± 1-1 d, n = 4) was not significantly different from that of
the control group (143-8 ± 1-1 d, n — 5). Abnormalities in the timing of oestradiol 17/? release
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Fig. 2. Prostaglandin E, in amniotic and allantoic fluid in (a) control and (ft) C. psi'rma'-infected sheep.
Twelve ewes were infected by subcutaneous injection on day 90 of gestation with 4-5 x 105 ELD50 of C.
psittaci strain S26/3, and 12 controls were injected with sterile saline. Four ewes (two infected and two
control) were killed on each of the following days of gestation: 97, 103, 109, 115, 120 and 125. Amniotic
and allantoic fluids were withdrawn during aseptic delivery of foetuses, 5 min post mortem. In both the
control and C. psittaci-infected groups of ewes, five animals were carrying single lambs, and seven had
twins. Five and three samples, respectively, were rejected from the control and infected groups because
they were stained with blood or meconium. The PGE2 concentrations in amniotic fluid (open symbols)
and allantoic fluid (filled symbols) of individual foetuses were analysed. Amniotic fluid and allantoic
fluid from the same animal are shown as like pairs of open and filled symbols.
were observed in the sheep infected with C. psittaci compared with controls. The characteristic
rise in plasma oestradiol 17/?, which was observed on the day of parturition in control animals,
was detected 24 h earlier in C. psittaci-infected sheep. In contrast with the control group, the
mean peripheral plasma oestradiol 17/3 concentration in the C. psittaci-infected group 24 h
before parturition was higher than the mean concentration of oestradiol 17/? on the day of
parturition.
As uterine prostaglandin release is controlled by oestradiol 17/? (Liggins et al., 1972; Olson et
al., 1984), the effect of chlamydial infection on the concentration of oestradiol 17/? within the
uterus of these sheep was analysed by cannulation of the utero-ovarian vein and amniotic sacs.
The oestradiol 17/? concentrations in the utero-ovarian plasma and amniotic fluid were
determined (Table 1). The oestradiol 17/? concentrations in utero-ovarian venous plasma of
control sheep were similar to previously reported values (Bedford et al., 1972). There was no
significant difference in the oestradiol 17)? concentrations released into the utero-ovarian vein
by infected, compared with control uteri. However, significantly higher local intrauterine
concentrations of oestradiol 17)? were observed in the amniotic fluid of C. /wfttad-infected
animals compared to controls (Table 1), indicating that chlamydial infection may have
compromised local intrauterine diffusion barriers.
Intrauterine prostaglandin E2 in C. psittaci-infected and control sheep
The concentrations of prostaglandin E2 in the amniotic fluid and allantoic fluid of 24 ewes,
killed between day 97 and day 125 of gestation, were determined, in order to investigate whether
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premature release of prostaglandins occurred during late gestation (see Fig. 2). The
concentrations of prostaglandin E2 in amniotic and allantoic fluids were low (0-89 ± 0-12 ng
ml-1, n — 12), between days 97 and 125 in the 12 control sheep, but were significantly raised in
four out of 12 samples obtained from C. psittaci-infected sheep over the same period (6-46 + 1 -49
ng ml-1, P<0 05). The PGE2 concentrations in the amniotic and allantoic fluids of the same
animals showed a highly significant correlation (P <0-01) in the infected group (n = 12), but not
in the control sheep (n = 12). The distribution of intrauterine PGE2 concentrations was wider in
infected sheep than the distribution of PGE2 in the corresponding control population (Fig. 2).
Placental pathology of chlamydial infection
The histopathology of placentae during chlamydial infection was investigated, in order to
study the histological distribution of C. psittaci inclusions, the associated necrosis and the extent
of leucocyte infiltration into the placenta of the 24 sheep used for PGE2 determinations (see
above). Placental lesions consistent with those seen in cases of ovine chlamydial abortion
(Stamp etal., 1950; Studdert, 1968; Novilla & Jensen, 1970) were observed in the cotyledons of
all animals in the infected group killed on days 125 and 120 of gestation and in one of the two
infected animals examined on day 115 of gestation. The placental cotyledons of these sheep
showed foci of infection, which consisted of C. psittaci inclusions in the cytoplasm of trophoblast
cells, identified by immunoperoxidase staining, associated with cellular necrosis and phagocyte
infiltration. The severity of the lesions increased during the period (days 115-125 of gestation)
when infection was detected. No lesions were detected in the placentae from infected ewes killed
between days 97 and 110 of gestation or in any of the placentae of control sheep examined on
days 97-125 of gestation.
DISCUSSION
A characteristic feature of infection with both C. psittaci and C. trachomatis during pregnancy
is a period of latency, followed by the onset of infection of the foetal membranes and placenta
during the last quarter of gestation (Stamp et al., 1950; Studdert, 1968; Novilla & Jensen, 1970;
Johnson etal., 1985; Aitken, 1986; Sweeter al., 1987).The severity of infection and the perinatal
mortality associated with C. psittaci is greater than for C. trachomatis in both women and sheep
(Sweet et al., 1987; Studdert, 1968). However, both chlamydial species are associated with the
initiation of premature labour.
The chorionic membrane of the placenta is the primary focus of intrauterine C. psittaci
infection, which then spreads to the caruncular regions of the placenta (McEwen et al., 1951;
Studdert, 1968). We observed a disruption of placental steroidogenesis, and a stimulation of
foetal membrane prostaglandin synthesis during the early stages of chlamydial infiltration into
the uterus.
In addition to evidence of changes in steroid hormone and prostaglandin synthesis by C.
psittaci-infected tissues, we detected changes in the intrauterine distribution of oestradiol 17)?
and PGE2. Similar concentrations of oestradiol 17/? and PGE2 were detected in the amniotic
and allantoic fluid of infected, but not of control sheep, and this may reflect changes in foetal
membrane integrity during chlamydial infection.
The pathogenesis which we describe may be relevant to other mammalian species, because
the placenta and foetal membranes are major sources of steroid hormones and prostaglandins in
most species, including humans, during late pregnancy. There are considerable inter-species
differences in the pattern of hormone secretion, and in the relative importance of the stimuli
which initiate labour (Allen, 1975). However, in all mammalian species, pregnancy is dependent
on maintained progesterone secretion, and oestradiol and prostaglandins stimulate uterine
responses at the time of parturition (Thorburn & Challis, 1979; Bedford et al., 1972). Premature
progesterone withdrawal can initiate labour and increase oestradiol synthesis in the sheep
(Mitchell et al., 1983). The abortifacient agent Actinobacillus seminis has been reported to cause a
decline in plasma progesterone in pregnant ewes (Smith & Hughes, 1974), although this
occurred earlier in pregnancy than the inhibition which we observed in Chlamydia-infected
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sheep (Fig. 1). Premature increases in oestradiol 17/? and prostaglandin F2(r synthesis have been
observed during infectious abortion due to intrauterine surgery (Bedford et al., 1972; Silver et
al., 1986) or endotoxin infusion (Roberts et al., 1975) respectively. There has been a recent report
of decreased plasma progesterone and oestradiol 17)? concentrations and elevated peripheral
PGF2ci metabolite concentrations in four sheep infected with C. psittaci (Fredriksson et al.,
1988). There has only been one report on PGE2, which is thought to play a role in the initiation
of labour (Bleasdale & Johnston, 1984) in infectious abortion (Romero etal., 1988). Our report is
the first description of the effect of C. psittaci infection on the intrauterine distribution of
oestradiol 17)? and prostaglandin E2 during pregnancy.
The effect of the hormonal environment on chlamydial infectivity during pregnancy has
recently been investigated in vivo and in vitro. It was found that oestradiol 17)? enhanced the
growth of C. trachomatis in a guinea-pig model (Rank et al., 1982), and in cultured human
lymphoma cells (Bose & Goswami, 1986; Sugarman & Agbor, 1986). The early increases in
plasma oestradiol 17)? concentrations, and the high intrauterine concentrations of this steroid
which we detected, may induce the metabolic and vascular changes which enhance chlamydial
growth at a specific stage of late gestation.
In conclusion, experimental infection of ewes with C. psittaci was associated with changes in
placental steroid and prostaglandin synthesis. It is likely that the premature decline in
progesterone, and the premature rise in oestradiol 17)? and prostaglandin E2 concentrations
which we report, contribute to the initiation of premature labour in C. psittaci-infected sheep.
We are very grateful to Vicky Sweeting and John Seth of the Edinburgh Radioimmunoassay Team for advice on
oestradiol 17)? radioimmunoassay, and to Professor David Mellor for advice on surgical techniques and scientific
guidance. This work was supported by a project grant from the Agricultural and Food Research Council.
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Summary — The initiation of premature labour by an ovine abortion strain of Chlamydia
psittaci was studied in relation to Prostaglandin E2 (PGE2), which plays a major role in
parturition. The local intrauterine concentration of PGE2 was monitored after experimental
infection with C. psittaci, during late gestation, using a catheterised sheep model.
Indwelling catheters were implanted into the amniotic and allantoic cavities of six control
sheep, and into six sheep infected with an ovine abortion strain of C. psittaci. The release
of PGE2 into the utero-ovarian vein of these sheep was also monitored. Infection with C.
psittaci was associated with a premature rise in PGE2 in the amniotic fluid between days
122 and 135 of gestation (P<0.01). A premature increase in PGE2 was defected between
days 127 and 136 of gestation (P<0.05) in the allantoic fluid of sheep infected with C.
psittaci, but not in the control uninfected sheep. Chlamydial infection significantly
decreased the secretion of PGE2 into the utero-ovarian vein: The mean concentration of
PGE2 in the utero-ovarian vein of infected sheep was 68.8 ± 5.2% of the PGE2
concentration of control sheep between days 122 to 141 of gestation (P<0.01). The release
of PGE2 into the utero-ovarian vein increased between days 126 to 136 of gestation in
infected and control sheep (P<0.01). The results from the catheterised sheep model
indicate that C. psittaci infection is associated with a local intrauterine release of PGE2. The
magnitude of this release was similar to the PGE2 release in control sheep prior to
parturition. The PGE2 released during chlamydial infection may be active in initiating
premature labour.
Abbreviations: ELD50, egg LD50; PGE2, prostaglandin E2; PGF2n, prostaglandin F2lV
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Introduction
There is increasing evidence of an involvement
of the Chlamydiae in premature labour. In
humans, placental C. trachomatis infection is
associated with prematurity and low birthweight
(1), while C. psittaci has been reported to cause
infectious abortion and premature labour in
women and sheep (2, 3. 4). The severity of infec¬
tion and the perinatal mortality associated with
the C. psittaci species is greater in both women
and sheep (1. 5, 6). However, both chlamydial
species are associated with the initiation of
premature labour.
The primary focus of C. psittaci infection of
the placenta, the chorionic foetal membrane, is
also a major site of prostaglandin synthesis at
parturition, and stimulation of the fetal
membranes releases prostaglandins and initiates
labour (7. 8. 9. 10). The prostaglandins E; and
F;„ which are released within the uterus play a
major role in mammalian parturition (11. 12).
stimulating uterine contraction, controlling the
tone and responsiveness of uterine musculature
(13). and increasing the compliance of the
uterine cervix before labour (14).
The synthesis of PGE; increases during late
gestation in both sheep and women (7. 15. 16).
The inhibition of prostaglandin synthesis delays
premature delivery in sheep (8). and infusion of
PGE; and PGF;n into the aorta of pregnant
sheep stimulates uterine contractions similar to
those detected at term (12). An increase in
uterine PGE; concentration in infectious abor¬
tion associated with bacterial endotoxin has been
reported in women (17. 18). and there has been
a recent report of elevated PGF;Q metabolite
concentrations in the plasma of four sheep
infected with C. psittaci (19).
The predominant prostaglandin produced by
sheep and human chorion is PGE; (7. 20. 15.
21). In contrast to PGF;a, the concentration of
PGE; increases during late gestation and early
labour, and there is evidence that PGE; has a
role in the initiation of labour, while PGF;n is
involved in the progression and the coordination
of labour after it has been initiated (9).
The timing of C. psittaci infection has led to
investigation of endocrine factors which might
play a role during this period of gestation. The
infection of the placenta by the Chlamydiae does
not begin until a relatively advanced stage of
gestation. In the case of C. psittaci infection of
sheep, placental infiltration is detected between
days 100 to 120 of gestation, commencing in the
chorioallantoic membrane, and proceeding to
infiltrate the caruncular region of the placenta
(6. 22). It has been reported that Oestradiol 17B
acts as a "growth factor" for the Chlamydiae in
several species (23. 24. 25). and we recently
demonstrated that C. psittaci infection of sheep
was associated with a premature decline in circu¬
lating Progesterone and premature release of
Oestradiol 17B (26). We also detected abnor¬
mally high PGE; concentrations in the amniotic
fluid of some chlamydia infected sheep.
The PGE; synthesised by the fetal membranes
is converted to PGF;Q, and both PGE; and
PGF;ft are metabolised, at a variable rate, to a
range of inactive oxygenated metabolites. The
variability of the activities of the enzymes of PG
metabolism, together with the contribution of
blood and vascular cells to the circulating PG
pool, combine to make the measurement of
peripheral PG an indirect indicator of uterine
PG synthesis (27). In contrast, the intrauterine
concentrations of PGE; indicate the local
concentrations of biologically active PGE;.
Therefore, we used a catheterised sheep model
to investigate the pattern of PGE; release within
the uterus during C. psittaci infection.
Methods
Twelve Scottish Blackface ewes were implanted
with indwelling catheters into the amniotic and
allantoic cavities and into the utero-ovarian vein
on day 113 of gestation (28. 29). Amniotic and
allantoic sacs of each foetus were catheterised
using Folex two-way balloon catheters (size
12 Ch. with 30-40 ml balloon: Eschmann.
Sussex. England). A utero-ovarian vein was also
catheterised using 1.4 mm external diameter
vinyl tubing (Portex Ltd. Kent. England). A
two-way luer stopcock was attached to each cath¬
eter. Vascular catheters were sampled daily and
flushed with a heparin saline solution
(80 I.U. ml"1 preservative-free heparin. Evans
Medical. Dunstable. Beds) twice daily. Blood
was placed into tubes containing 2 I.U. ml"1
preservative-free heparin, and plasma was
prepared by centrifugation and stored at -40°C.
Small samples (0.5-2 ml) of amniotic and allan¬
toic fluids were withdrawn using minimal
suction. Sterility within each 2-wav tap was
maintained by twice daily Hushing with thiom-
ersal solution, consisting of thiomersal 0.1%
alcohol (British Drug Houses. Poole. Dorset):
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acetone:ethanol = 1:500:500. v/v/v. On day 115
of gestation, six ewes were infected by subcuta¬
neous injection of 4.5 x ltP ELD?(i of an ovine
abortion strain of C. psittaci, and six controls
injected with sterile saline. Single samples of
amniotic fluid, allantoic fluid or utero-ovarian
vein were taken from each sheep on alternate
days up to day 130 of gestation, and daily from
day 130 until parturition. Occasionally, it was
not possible to withdraw samples on the required
day, particularly from the allantoic cavity, due
to catheter blockage. Amniotic fluid and allan¬
toic fluid was placed immediately into 10 ml of
""analytical reagent" grade methanol, and stored
at -40°C. Samples which were stained with
blood or meconium (30) were discarded. Utero
ovarian plasma (0.2 ml) was immediately extracted
using 2 ml of redistilled diethylether, vortex
mixed, then immersed in acetone/dry ice until
,the aqueous layer was frozen. The organic layer
was decanted, and the extraction was repeated
three times. The extraction of PGE: was
94-99% using this technique. Samples were
stored at -40°C before radioimmunoassay. The
mean duration of gestation was 144.5 ±1.1 days
in the control group, and 141.3 ± 1.8 days in the
infected group, and the difference between these
gestation periods was not significant. In the
control group, three of the ewes had twins and
three, single lambs, and in the infected group,
four of the ewes bore twins, and two. single
lambs. In the chlamydia infected group, two out
of ten lambs were born dead: one of twin lambs
was dead on delivery, and another, single lamb,
died of asphyxia during delivery. In the control
group, all nine lambs survived.
Prostaglandin £; radioimmunoassay
Radioimmunoassay of PGE: was carried out
using antiserum from the Institut Pasteur. Paris
(Batch nos D2. D7. D12 and D13). standard
PGE; (Upjohn. Crawley. Sussex), and H PGE:
radiotracer [5.6,8,11.12.14.15 (n) - 'H], batch
no. NET 428 (Amersham. Buckinghamshire),
under previously described conditions (10).
Samples were taken to dryness, and resuspended
in 20 mM HEPES buffer pH 7.4. containing
0.01% azide. and 1% gelatine. The donkey anti-
rabbit immunoglobulin serum used to precipitate
the hapten- IgG immune complex, and the
normal rabbit serum used in the assay were
donated by the Scottish Antibody Production
Unit. Carluke, Lanarkshire. The sensitivity of
the assay was 0.28 pg ml-1 of plasma, and
0.401 pg ml-1 of amniotic or allantoic fluid. The
precision profile of the assay was monitored as
described by Hunter (31), using the mean coef¬
ficient of variation of two amniotic fluid samples,
five utero-ovarian venous plasma samples, and
seven allantoic fluid samples, analysed from
triplicate determinations within the eight
radioimmunoassays carried out (intra-assay coef¬
ficient of variation); and seven allantoic fluid
samples, analysed five times within two different
assays (inter-assay coefficient of variation). Also,
two standard PGE: samples (Upjohn. 10-40 pg
per tube) were included at the beginning and end
of each assay in addition to the standard curve.
The inter-and intra-assav coefficients of variation
of the three types of sample controls were not
significantly different. The mean inter-assay
coefficient of variation of sample controls was
13.9% ± 1.98 (n=7). and the mean intra-assay
coefficient of variation was 10.8% ± 1.04
(n= 15).
Statistical analysis of data
Results described in the text are expressed as the
mean PGE: concentration ± standard error of
the mean for n samples of amniotic fluid, allan¬
toic fluid, or utero-ovarian venous plasma.
Results described in the Figures illustrate the
mean PGE: concentration in fluid/plasma of each
individual sheep, sampled on a specific day of
gestation, and sequential results from individual
sheep are joined. The difference between the
means was tested using parametric statistics after
analysing the normality of distribution of the
data, using the standard score (z score) of each
population tested (32). Of the 38 population
pairs analysed, only one population (utero-
ovarian venous plasma PGE: in infected and
control sheep between day 136 of gestation
and labour) showed a distribution which was
significantly different from the normal distri¬
bution (Z= 1.862. P<().()5). and. therefore,
parametric statistics were not used to analyse this
sample group. In the remaining normally distrib¬
uted data, the variances of data groups being
compared were also analysed, using Snedecors"
Variance Ratio test. In 31 of these 38 data
groups, the variances of the populations being
compared were not significantly (P<().()5)
different from each other, and the t test was used
to test the Null Hypothesis for two sets of
populations with normal distributions. Seven of
the 38 data groups analysed showed signifi¬
cantly different variances, and the unpaired
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Students' t test for two sets of normal popu¬
lations with different variances, incorporating
the Behrens-Fischer statistic, was used to analyse
this data. The sample groups which showed
significantly different variances are identified in
the results section. Paired data was analysed
using the paired Students' t test, after testing the
data for normality of distribution. When more
than one sample was available on the same day
of gestation (in allantoic fluid samples, comparing
infected and control sheep, see results), data was
paired randomly, i.e. samples were taken for
statistical analysis in the order in which the
sampling from individual sheep was originally
carried out.
Results
Prostaglandin £3 in amniotic fluid during
chlamydia infection
The concentration of PGE2 in the amniotic fluid
of six catheterised control sheep is shown in Fig¬
ure 1A. Amniotic fluid PGE2 increased during late
gestation in the control group. The concentration
of PGE2 between 122 to 135 days of gestation in
control animals (2.72 ± 0.27 ng/ml. n = 29
samples) increased significantly from day 136 of
gestation to the day of parturition (7.23 ±
0.72 ng/ml. n=41 samples), in samples taken
from the same animals, compared using the
unpaired Students' test for sample groups with
different variances (P<0.01. n=67).
In the six sheep infected with C. psittaci. the
concentration of PGE2 in the amniotic fluid
increased earlier in gestation (Fig. IB). A signif¬
icant increase in PGE2 concentration was
observed after day 122 of gestation in the chla-
mydia-infected group, when samples from the
same sheep were compared using the unpaired




Fig I Prostaglandin E; in Amniotic Fluid of Control and
Chlamydia Infected Sheep. Amniotic fluid was withdrawn by
catheter from A. control or B. Sheep infected with an ovine
abortion strain of C. psittaci (4.5 x ICR ELD<„) on day 115
of parturition. The arrow indicates the mean date of partu¬
rition. The PGE; concentrations are the mean of triplicate
determinations carried out on amniotic fluid of each indi¬
vidual sheep. Serial results from each individual sheep are
joined.
Students' t test (P<0.001. n = 43). The mean
concentration of PGE: was 2.55 ± 0.45 ng ml-1
(n = 14) on days 111 to 121 of gestation,
compared with 6.42 ± 0.44 ng ml-1 (n = 21) in
Table 1 Mean PGE; concentration in amniotic fluid of six control and six
chlamydia infected sheep during late gestation. The mean PGE: concentrations
in sheep whose individual PGE; profiles were shown in Figure I. in ng/ml of
amniotic fluid ± SEM for n samples of amniotic fluid, withdrawn from
indwelling catheters in control sheep or sheep infected with 4.5 x UP ELD<(,
and ovine abortion C. psittaci strain on the stated days of gestation.
Gestation
Idas',) 111-121 122-122 IM-parturition
Control — 2.7: r (1.27(29)' 7.23 £ <1.72(41)
Infected 2.55 ± 0.451 14) 6.42 ± 0.44(21) 6.48 + 0.42(21)
'The concentration of PGE: in the amniotic fluid of chlamydia infected sheep, between
days 122 to 135 of gestation, was significantly greater than that-of control sheep, using
the unpaired Students' t test for sample groups with different variances (P<1).()1. n= 58).
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the same sheep on days 122 to 135 of gestation.
There was no significant increase in the concen¬
tration of PGE2 in the amniotic fluid between
days 122 to 135 of gestation, compared with day
136 of gestation onwards, in the chlamydia
infected group.
Prostaglandin £2 in utero-ovarian vein during
chlamydia infection
The concentration of PGE2 in the utero-ovarian
vein of six control sheep showed a pulsatile
release of PGE2, increasing in amplitude from
day 126 of gestation (Fig. 2A). The mean
concentration of PGE2 in utero-ovarian plasma
of control sheep between days 122 to 125 of
gestation was 1.34 ± 0.205 ng ml-1 (n=12), and
this increased to a concentration of 2.38 ±
0.241 ng ml"' (n = 28) in the same sheep between
days 126 to 136 of gestation. This increase in
PGE2 concentrations was significant using the
unpaired t test (P<0.01, n= 36). The PGEy
concentrations in the utero-ovarian venous
plasma showed a similar pattern of release in
chlamydia infected sheep (Fig. 2B). The greatest
increase in PGE2 was observed after day 122 of
gestation. The concentration of PGE2 in utero-
ovarian plasma of infected sheep was 0.922 ±
.123 ng ml-1 (n=28) between days 110 to 121 of
gestation, increasing to 1.52 ± 0.153 ng ml-1
(n = 53) in the same ewes between days 122 to
135 of gestation. This increase in PGE2 was
significant using the unpaired t test for sample
groups with different variances (P<0.01, n= 81).
The increase in PGE2 concentrations in the
utero-ovarian vein of infected sheep (from 1.08
± 0.149 ng ml-1 on days 122 to 125. n=14; to
1.55 ± 0.140 ng ml-1 on days 126 to 136, n=43),
was not significant. There was a further increase
in PGE2 concentrations in utero-ovarian vein of
chlamydia infected sheep late in gestation. The
concentration of PGE2 from day 137 of gestation
a. pge2 in utero-ovarian vein (infected sheep)
6-1
Fig 2 Prostaglandin E, in Utero-Ovarian Vein of Control
and Chlamydia Infected Sheep. Utero-ovarian plasma was
withdrawn by catheter from A. Control Sheep or B. Sheep
infected with an ovine abortion strain of C. psirtaci (4.5 x
1()5 ELD,,,) on day 115 of parturition. The arrow indicates
the mean date of parturition. The PGE: concentrations are
the mean of triplicate determinations, carried out on utero-
ovarian plasma of six individual sheep. Serial results from
individual sheep are joined.
in the chlamvdia-infected sheep increased to 1.96
± 0.228 ng ml-1 (n = 31) of utero-ovarian venous
plasma. This was significantly greater than the
PGEy concentration detected in the same ewes
between days 122 to 125 of gestation, using the
Table 2 Mean PGE; concentration in utero-ovarian venous plasma of six
chlamydia infected and six control sheep during late gestation. The mean PGE:
concentration in sheep whose individual PGE; profiles were shown in Figure 2. in
ng ml"' of utero-ovarian venous plasma ± SEM for n samples of utero-ovarian
venous blood, withdrawn from indwelling catheters in control sheep or sheep
infected with 4.5 x 1(F ELD,„ of an ovine abortion strain of C. psittaci on the
stated period of gestation.
Gestation 1ST- parturition
(days) 111-121 122-125 126-136
Control - 1.34 ± 0.205(12) 2.38 ± 0.241(28) 2.51 ±0.19(53)
Infected 0.922 ± 0.123(28) 1.08 ± I). I49( 14) 1.55 ± 0.140(43) 1.9b ± 0.23(31)
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unpaired t test for sample groups with different
variances (P<0.01, n=32).
The increase in utero-ovarian venous PGE;
concentrations in infected sheep occurred more
gradually, over a longer time span, compared
with the increase in utero-ovarian venous plasma
(see Table 2). In the utero-ovarian vein, the
concentration of PGE; increased sharply after
day 126 of gestation. The mean PGE: concen¬
tration in the utero-ovarian venous plasma of
control sheep increased by 78%, if samples
collected in the period between days 126 to 136
of gestation were compared with samples
collected between days 122 to 125. In contrast,
the increase in mean PGE; over the same period
in the infected group (44%) was proportionately
lower than the increase in the control group.
The mean concentrations of PGE; in the
utero-ovarian vein of infected sheep were
compared with the mean PGE; concentrations
detected in control sheep on the same day of
gestation throughout the period when infected
and control sampling overlapped (between days
122 to 141 of gestation). Over this period, the
mean PGE; concentration in the utero-ovarian
vein of infected sheep was 68.8 ± 5.2% the
mean PGE; concentration of control sheep
(range 52.6% to 96.8% for 12 data pairs). The
mean PGE; concentrations in the utero-ovarian
venous plasma of infected sheep were signifi¬
cantly lower than the mean PGE; concentrations
detected in control sheep, using the paired t test
for samples with different variances (P<0.01.
n=12). This suggested that the transfer of PGE;
into the utero-ovarian vein was compromised by
chlamydial infection.
Prostaglandin £: in allantoic fluid during
chlamydial infection
The sampling of allantoic fluid was infrequent
after day 130 of gestation, due to catheter
a pge2 in allantoic fluio (control sheep)
8 pge2 in allantoic fluio (infected sheep)
pge2 ? i
Fig 3 Prostaglandin E; in Allantoic Fluid of Control and
Chlamydia Infected Sheep. Allantoic fluid was withdrawn by
catheter from A. Control Sheep or B. Sheep infected with
an ovine abortion strain of C. psitiaci (4.5 x UP ELDs,,) on
day 115 of parturition. The PGE: concentrations are the
mean of triplicate determinations, carried out on allantoic
fluid of individual sheep. Serial results from individual sheep
are joined. The mean day of parturition is indicated by an
arrow.
blockage caused by particulate matter, and to
the increase in allantoic fluid viscosity which
occurs during this period. This problem was most
acute during the five days before parturition,
when the allantoic fluid was decreasing in
volume (29). The concentration of PGE; in the
Table 3 Mean PGE; concentration in allantoic fluid of six chlamydia-infected and
six control sheep during late gestation. The mean PGE- concentration in sheep
whose individual PGE: profiles were shown in Figure 3. in ng ml'1 of utero-
ovarian venous plasma ± SEM for n samples of utero-ovarian venous blood,
withdrawn from indwelling catheters in control sheep or in sheep infected with 4,5
x HP ELD;,, of an ovine abortion strain of C. psittaci during the stated period of
gestation.
(jestution
(<Uiv.s) 111-121 I22-I2t> 127-122 I2b-purturttwn
Control — 2.56 ± u,46(7) 2.6,s ± 2.52(7) S. 15 — 2.15(17)
Infected 2.UK ± 0.22(21) 3.IKI ± (I.3XI 11) 6.(14- 1.11(3(1) v.75 ± 1.61(23)
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allantoic fluid of the six control sheep increased
during late gestation (Fig. 3A). The concen¬
tration of PGE2 in allantoic fluid between days
122 to 135 of gestation was 3.66 ± 0.922 ng ml"'
(n=21), increasing to 8.13 ± 2.15 ng ml-1
(n=17) in the same sheep between day 136 and
the day of parturition. This increase was signif¬
icant, when analysed using the unpaired t test
(P<0.05, n=38). The concentration of PGE2 in
the allantoic fluid of six sheep infected with C.
psittaci is shown in Figure 3B. The increase in
allantoic fluid PGE2 occurred earlier in infected
sheep than in controls. The concentration of
PGE2 in the allantoic fluid of infected sheep
between days 111 to 126 of gestation was 2.33
± 0.196 ng ml-1 (n=32), increasing to 6.04 ±
1.12 ng ml-1 (n= 30) in the same sheep between
days 127 to 135 of gestation. This increase was
significant, P<0.01 (n = 62). using the unpaired
t test. The concentration of PGE2 in the allantoic
fluid of the same sheep, taken between days 136
of gestation and the day of parturition, was 9.75
± 1.61 ng ml-1 (n = 23). This was not signifi¬
cantly higher than the PGE2 concentration
between days 127 to 135 of gestation in the same
sheep. The concentration of PGE2 in the allan¬
toic fluid of the infected sheep between days 127
to 135 of gestation was 6.04 ± 1.11 ng ml-1
(n=30), and in the control sheep, 2.68 ± 2.52 ng
ml-1 (n = 7). The difference between these
groups was not significant, due to the increase
in PGE2 concentrations, during this period.
However, when the PGE2 concentrations in the
allantoic fluid of individual infected and control
sheep, taken on the same day of gestation,
between days 127 to 135 were paired and
analysed using the paired t test, the PGE2
concentrations in infected sheep were signifi¬
cantly higher than the PGE2 concentrations in
the allantoic fluid of control sheep taken on the
same day of gestation (P<0.02).
Discussion
In this paper we report premature increases in
PGE2 concentrations in two intrauterine
compartments monitored during late gestation in
sheep infected with an ovine abortion strain of
C. psittaci. Increases in amniotic fluid PGE2
associated with C. psittaci infection, were
observed from day 122 of gestation, and this was
thirteen days before any changes in PGE2 in
amniotic fluid of control sheep (Fig. 1). In the
allantoic fluid, the concentration of PGE2
increased from day 127 of gestation, nine days
before the increase observed in controls (Fig. 3).
It should be noted that the chlamydial infection
established in our catheterised sheep was rela¬
tively mild. The mean period of gestation of the
infected group (141.3 ± 1.8 d) was not signifi¬
cantly different from the control group (144.5
±1.1 d), and 80% of the lambs from infected
sheep survived.
The difference between PGE2 profiles in
infected and control groups was greatest in the
amniotic fluid. This was the fluid space in closest
contact with the focus of C. psittaci infection
(29) which spreads from the chorionic membrane
to caruncular tissue (6). The amniochorion is
also the primary site of infection of both C. psit¬
taci and C. trachomatis in human (2, 5). Our
studies indicated that the localised infection of
C. psittaci was associated with the release of
PGE2 from the amniochorion.
A comparison of the PGE2 profiles in the
utero-ovarian venous plasma in infected and
control sheep suggested that C. psittaci infection
disrupted the local caruncular exchange of
PGE2. The concentration of PGE2 detected in
the utero-ovarian vein of infected sheep was
69% that of control animals. It is possible that
the impaired exchange of metabolites at this site,
which is responsible for approximately 83% of
uterine blood flow (33), may be a cause of the
low birth weight associated with chlamydial
infection (1. 6). It is also possible that impaired
vascular function masked the increase in PGE2
release in infected sheep indicated by the amni¬
otic and allantoic fluid PGE2 profiles. The
increase in utero-ovarian venous PGE2 concen¬
trations detected in infected sheep occurred
more gradually, over a longer time span than the
increase in utero-ovanan venous plasma. Evidence
of increased prostaglandin release into the
peripheral circulation was recently reported by
Fredriksson et al.. (1988). who detected a
premature increase in peripheral PGF metabolite
concentrations in sheep infected with C. psittaci.
In the amniotic and allantoic fluid, the concen¬
trations of PGE2 detected during the period of
premature PGE: release in sheep infected with
C. psittaci. reached concentrations which were
not significantly different from the concen¬
trations of PGE: released by the uteri of control
sheep prior to parturition. This indicated that the
PGE2 released during chlamydial infection may
be active in inflating events associated with
premature labour. It is possible that the inflam-
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matory leucocytes infiltrating the uterus at the
sites of C. psittaci infection (34, 6, 2, 22, 26) may
contribute to the PGE2 pool in intrauterine fluids
of infected sheep. However, when the magnitude
of the premature increases in PGE2 which we
detected in intrauterine fluids of infected sheep
(between three and four ng mT1 of amniotic or
allantoic fluid) were compared with the concen¬
trations of PGE2 synthesed by inflammatory
leucocytes (35. 36). the premature release of
PGE2 in amniotic and allantoic fluids was found
to be an order of magnitude greater than the
amount of PGE2 sythesised by leucocytes. This
suggested that most of the PGE2 detected in the
fluids of infected sheep was of uterine, rather
than of leucocyte, origin.
The uterine synthesis of prostaglandins is stim¬
ulated by oestrogens (12), and there have been
three reports of abnormal release of estrogens
during C. psittaci infection, showing impaired
oestrogen production (37. 19) and premature
oestradiol release (26) respectively. In addition
to controlling the release of PGE2. there is
evidence that oestradiol 17(3 may facilitate the
infectivity of C. trachomatis in vivo and in vitro
(23. 24, 25). The premature release of oestradiol
17(3 from the uterus, and the elevated intra¬
uterine concentrations associated with C. psittaci
infection (26). may induce metabolic and
vascular changes enhancing chlamydial growth
during late gestation, and it is likely that these
effects are at least partly mediated by PGE2.
A characteristic of infection with both C. psit¬
taci and C. trachomatis during pregnancy is a
period of latency, followed by the onset of
placental infection of the fetal membranes and
placenta during the last quarter of gestation (34.
6. 4, 3. 22. 1). In the sheep model of C. psittaci
infection which we used, we detected histochem-
ical evidence of C. psittaci infiltration between
days 110 and 120 of gestation (22. 26). There¬
fore. the histochemical evidence of C. psittaci
infection either slightly preceded, or occurred
simultaneously with, the evidence of increased
PGE2 release which we detected from day 122
of gestation. This indicated that the intrauterine
release of PGE2 was sensitive to early fetal
membrane infection with C. psittaci.
In conclusion, mild infection with C. psittaci
was associated with abnormalities in the intra¬
uterine concentrations of PGE2 in amniotic fluid,
utero-ovarian vein, and allantoic fluid. In the
two intrauterine sacs, we detected the premature
secretion of PGE2, which reached the concen¬
trations of PGE2 which were found just prior to
parturition in the control sheep. In the utero-
ovarian vein, there was evidence of impaired
secretion of PGE2. These results suggest that
chlamydial infection causes the release of PGE2
from intrauterine tissues. The resulting localised
increase in PGE2 may stimulate the induction of
premature labour in chlamvdia-infected sheep.
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242 ingtoshowanyspecificityf rt en3f ttyacids.Afurther differencelayntheadminist reddosfe sentialya ids usedinthisstu y,whichasv rylow(5-10mg/kg).T is amountw ldsupplylesstha0.2%ftheen rgyintakef thepregnantat,whichpresentso lyapproximately20% oftheess ntialfat yacidswhichth seratwouldonsume





























































































FO(Hi-EPA,EfamolLtd.Guil ford,U.K.)FO2(SevenasH lthCa e,Hull,U.K.),andEveningPrimroseOi :EPO(EfamolLt .,Gui df rd,U.K.) weresubjecttoalkalinehydrolysisandmethylation(L aver&Po er,1981).Gaschromatographyw scarriedutusingCarb waxb ndedcapillary columnDBwax(J&WScientific,RanchoCordova,Calif rnia,USA)at 180-230°C(4°C/min)andPye2 4gaschromatographwithfla eio isation detector,usingheptadeca oica idsint r alst ard
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sentialfat yacidcontentofthcommercialpell ddicon¬ sistedofapproximately0.8%n6fat yac dsn0.01n3 fattyacidssproportionoftheotalcal rificv luet diet. TheEffectofFishOilnParturition In1985,wereportedthatfishoil,givenast predomina t dietaryssentialfat yacidsource(>99.7%ofdietares en¬ tialfattyacid),inh bi edti iti t onndeprogression oflabourinrats(Leaverl,1986).Ith sexperiments andintheexperimentsr ortithisp rwfedasemi¬ syntheticdie ,lowine sentialfat yacids,witd lral supplementationwithpredo ina tlyn3fat yacids(fisho l) orpredominantlyn6fattyaci s(eveningprimroseoil).Th dietconsistedffa16.5e %,owhich3.enas tu¬ ratedfat(hydrogenatec conutil)nd3.0e %w sessen¬ tialfattyacidsupplement(fi hoilreveni gprimroseoil). Thefattyacidcompositionfthedietarf giv nth s ratsishownnThble2.e3/n6ratioofessentialfat y acidsinthefisho ldiet,eveningprimroseili tand thepelleteddi tishownnTib6.ess ntialfat yacid contentfthdietcorr spondedminimumrecommend¬ edssentialfat yacidintakeorman,althoughlessth nh lf ofthisdosewillcursignsfessentialfat yac ddefi i cy intheratandoth rnimals(Holm n,1968).T therc m¬ ponentsfthdietwerepr t i(fatfreCas i ,BDHPool , UK)15.7en%,carbohydrate(D-glucos68.7%anno - digestiblef bre(cellulos11.02g/kcal,kao in5.5 /kcal).The dietwassupplementedithDLmethioni(2.6g/kcal),Vita¬ minpremix(2.76g/kcal)andmi eralpremix(12.9g/kc l)ll fromSpecialDietervices,Cambr dgeUK.Inorderta o d oxidation,essentialfat yacidsuppl mentswerstoreun¬ dernitrogenanddministeredorallydosf1.5ml/kg ratbodyweight/d.Ineachfurdiexperiments,twog o ps ofratsreceivedsemisynth ticdi tsupplementew teith r fishoil(predominantlyn3attyac d)rveningprimroseil (predominantlyn6fattyac d)nthesewercompar dith acontrolgroupreceivingn rmalp lle eddi t.
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FIG.1.GrowthfRatsfedSemisyntheticDieSupplementedithF sO lor EveningPrimroseOiloraN rmalPelletedDi t(CRM,BSSN sEdinbur h,U.K.) A.PreweaninggrowthB.Postweaninggrowt .
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oreveningprimroseil(EPO)supple entedsemi-synth ticdi ,onacontrol pelleteddi(CRMi ,BSSNessE inburghUK)."Indicatevalsignificantly differentfromcontrol(p<0.05usingtheunpairedStudent't st).viv l indicatesthenumb rofp pswhichreachedweaningag(22d).FrLe vert al,1986). intrauterinedevelopme tfp psduringg stationw sor¬ malasjudgedbyirthweightandsurv v lofp psdel ¬ veredbyCaesarianSectionaftersacrificingthmoth r(T bl 4). Incontrastwi hthelimitedeffectsofaf shldi gestation,amajoreffectonthiniti tionandprogre sion oflabourwasobserved.L rdelay dinthfishoil fedrats,whichshowedsignifi antlylon ergest t onthan
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Tkble4














Resultsindicatethemeanperc ntageofuc s fultin s,b r hw ightups
or21daysurvivalperlittfterCaesar nectio±SEM.Thf g sn parenthesisindicatethnumb rofp gnancies,upw igh d,dlitt rmo itore respectively. theotherdieta ygroups(Thble3).durationflab urw prolongedandvaginalbleedingwasobservedi atfish oil.Perinatalmort lityw shighithefis iroup,com¬ paredwiththgroupofr tsfedsameemisynth ticdi t supplementedwitheve ingprimroseoil,ritthgr up fedthecontroldie .Approximately83%fpupsdi dwi hin 5daysofparturition,nd%mothersieilab urduring 60deliveriesoffishldrats.Inurinitialr portwat¬ tributedhperinatalmort lityttra msuffereddur¬ ingprolon edarturition.Whavinvestigatedwhe her impairedlact tioncont ibutedthp pmor alityit immediatepostnataleriod.Theostnatalsurvivra f ratsfedishoil,comparedwithcont olpellet ddi t, showninThble5.Maternalnursingbehaviourwastsig¬ nificantlyimpairedthfishoiledratsnstrongevid ce oflactation(milkinespups,milkso idups omachs) wasobservedin20—30%fthdepups.Itialsof un thatesucklingactivityofweakerpupsreduc d. Therefore,althoughpartialinhibitionoflac ti nm yav contributedtp pmortality,herwasoevidencethi wasam jorfactor.Thesurvivalr teoftfi hipupsw ch survivedo er5dayswasnotsignificantlydiffer ntfr mth controlgroup.Theeffectsft isfishidi tnparturition bearstrongresembla cetoheff ctfC18n3lin lenic
FishandFishOil247
Ihble5
PostnatalSurviv lRa efLitters:RatFedishOiloControl Diet 0hrs24hr48rs72hr96rs1 0hr FishOil8.90±.325.37±.713.± 22.42±.740± 751.84±.73 Control9.42±.478.75±.397. 2±.567.41±.697.41±.697.25±. 2 Meanlittersizeofratsfedor60daysfromwean ngnthsemi-syntheticdi t supplementedwithfisho lHIEPA(F0 fTable2),orw thnormalpelleted diet.Th rewe19littersinthf shoilgroupa d12litte sinthecon rol group. acidreportebyQuackenbrushetl(1942)andLeat&North¬ rop(1979)andindicatetha3fattyac deffe tmb actinginfishoildietwhichcont inspred min ntly,but notexclusively,n3fattyacids(n3fat yacid:78-86%oftot l polyunsaturatedfattyacid). TheprostaglandinE2contentinthein rauteri et ss s ofratsfedaishoildietfor60dayswdeterm n dus g radioimmunoassayandanti-PGE2antibo yobt i edfrom theInstitutPa e r,Paris.ThprostaglandinE2concentr ¬ tioninfetalmembranes,obtaineddur gparturitiofrom 6ratswa2.8±0.7ng/gifishoiledratsa d19.1±4.0 ng/giratsfedco troldi t.Inute inewall(myometrium withattacheddecidua),0.8±.16ng/gofPGE2wasde¬ tectedinfishoilfedra sand7.5±0 4ng/gi con ols.Th prostaglandinE2inthefetalmembranea duterinwallof fishoilfedratswsignificantly(p<0.05,n=6)low rthan thatofeveningprimroseoilfedc ntroldietfedra s. Wehavlsoinvestigatedt eproductionoft3se ies prostaglandinsbytheuterusofratfedann3fatacidi usingmassspectrometry.Thmethyl-TMSma sspec rum ofprostaglandinF3owascharacterisedbyseveralhig molecularweightfragm ntsbeari gthn3doublb d whichweret omassunitss all rthanecorrespo ding fragmentsofPGF2o(Fig.5).Ouranalysisofprostaglandin Foreleasedbyuterintissueincubat s(Purifi dbys l cic
248 acidchromatographyandthinlayerchrom tography)b¬ tainedfromratsfethesemisyntheticd supplemented with3en%linolenicac ds owedevidencefprodu tionfPGF3,(fragmentationofPGFMdTMSt377,402,77,49 and582D ltons).Thepredominantfragmen sd t ctedi themasssp ctrumofPGFMdTMSin6(linoleicac d)fed ratsndiPGF2astandardh m ssof379,404,79,494,569,8Daltons.Furthera alysisfe2nd3ries prostaglandinsinr tfeishoildlinolenicacidrei progress. n-3andn-6FattyAci siUterineLip dsaft rF hOilFeeding Itwaslikelyth teuterinef ttyacidcompositionfhe ratsfedfishoildietnflu nceduterinea tivityobservedduringlabour,althoughfewreportsdesc ibingheeff ctfdietaryfattacidsonute inelipidcompositionhavebe published.Wthereforeanalysedt eff ctftfishildi t onuterinelipid,o rtdetermineheeff ctofafishildietonuterinen3and6f tyacid.Theincorporationf3andn6f ttyacidsi tothemajoru rinelipidswasanaly ed.Theuterinelipidfattyacidcompositionfra sf hefi hoildiet,thev ningprimroseo ld eta dthc trol,pel ¬
eddietwasd termined,afterlkalinehydrolysisdm thy- lationfuterinelipid,bygaschromatography.Thepr portion ofn3and6essentialf ttyaciditheto lu rinelipidofthet r edietarygroupssshowninT ble6.hn3/n6e - Table6 N3/N6FattyAcidRatioinUterineLipidsofRat DietGroupDietFat yAcidTissueFattyAcid Control0.210.202±0.273(n=16)EPO0.0040.067±0.088(n=)FO6.281.01±1.12(n=24)*
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DietNeutralLipidPhos holipid Control0.022±.0118(4)1460 9 EPO0.0098±61(6)**0.03371765)* FO0.076±68(6)1 2.21(6)* Then3/n6ratiooftsfedr mweaningr21dayscon olpelle edsemi¬ syntheticEFAdeficientesupplements(wiev ngprimroseoilEPO)fi oil(FO).*Significantlydifferentfr mcontrolp<0.02;*<.01.Thnumber

















Then3/n6fattyacidrat oiC18,20n2cl sseswasal ulatedor
































Then3/n6fattyacidrat oiC18,20d2classesw salculatedfornr t fedcontrolpelleteddi ,osemisy theticisuppleme edwithfisho(FO), FO,HIEPA;oreveningprimroseil(EPO)fo21days.**denotes ratiossignificantlydifferentfromthcontrolgroupu i gWilc xRank nonparametricstatistics,p<0.01;< d:C22fa yacidwerebelowth levelofd tection(<0.01%ftotalfa yacidinNL). oilfeed ngwasobservedinthC20fattyacidp ol,nt mostsignificanchangefora yindividualatta idwasb¬ servedineicosapetaenoicacid,whichincreaby1220% thefishoilgroupc mparedwitthecontr lgr up.Therwas amodestincreasetheut rinont tfdocosahexanoic acidinthefishoilgroup(165%fc ntr l).T eadmi ister d fishoilconsistedf22%eic sapentaenoica idn7% docosahexanoicacid(Thble2).Therefore,t erew slittlevi¬ denceofsele tiveincorporationfthC22,comparedwith theC20n3fattyacidsintothemajorl pidpoolsoft uter¬ us,whenacontroldiet(n3/ 6r ti0.0125)wacomparedit afishoildiet(n3/n6r t o5.2).Aqu ntitativelygrea erch ge inthen3contentoftC22p olwasobserv dav rylo dietaryn3levels(theveningprimroseoidi t;n3/n6rat 0.0026),comparedwithm der tamountsofn3fattya d inthecontroldiet(n3/ 6rati0.0125).T 3contentofth uterineC22poolofratsfedthev ningp imroseoildiw significantlydepleted,comparedwiththC22n3fat ya ds inthecontroldietgroup.Tam ntofuterinep lyunsatu¬ ratedfattyacidesterifietoC18,20nd2p olsshowed relativelysmallchangesa soci tedwithfisoilfeeding.A significant(p<0.01)decreaseo12%inthamountpoly-
252 unsaturatedfa yaciesterifiedtoC18,an22%in r ase
intheC22classwaobservedinthuterusoftfi hil group,comparedwiththc ntrolgroup.Theseexp riments indicateth tincorporationfietaryn3nd6f tt acidsintothemajoruterinelip sdiff sfr mth ris ues (seeKinsellaithvolume)nshowingar lativelyighc ¬ pacitytoesterifyC20fa td.Also,th ewasevi ence thateuterineC20polyunsaturatedf tyacipoolw scon¬ servedunderwidelydiffer ntdi taryn3/n6loa s. Thechangesintotalu rinelipidf ttyacid,i n u¬ trallipidandphospholipidf ttyacicompositionafterfish oilfeedingshowedthatproportionfn6fattyac dsi themajorlipidpo lswadecr sedfr m86.5%fess ntial fattyacidsinthenormaldi t,t52.1%fessentialfa yacids afterthfishoildiet.Thus,t ef shoildi tresultedna changeof34.4%int proportionf6f ttyacidithees¬ sentialfattyacidcompositionftheajorut rinelipi s. Thesechangesines entialfat yc dcompositionit l uterinelipid,neutrallip da dphospholipidarequ ntitatively smallerth nobservedchangesit efficacyofparturi¬ tioninf shiledrats(fetalsurvivalr te,seT b3)which wasdecre sedby80%,orthute inecontentfprostaglan¬ dinE2,whichasdecre sedbyov r80%.H w ver,the majoruterinelipidpoolsncludewideangefmolecular species,anditn ssarytoconsidertheactivityfspecif¬
iclipidsnrelationtoloca isation,metabolicturnover,d theirphysiologicalr leinparturition. MetabolicallyActiveandPhys ologicallySignificant LipidPoolsintheUterus Thebestcharacterisedrolfessentialf yaci stpar¬ turitionisthereleaseofarachidoniccidpro taglandinsE2andF2o.Ther leofpr staglandinswillbdiscussed thenexts ction.Otherpossiblefun tionsfe sentialfat yacidsinparturition(seeT ble11)willalsobd scu sed relationtoheactivityft en3a d6f taci s.Ih section,wellconsiderthreleasefarachidoniccidfr mtheut rus,andpossiblesitesf3f ttyacidinvolvement
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inthisprocess. Inconsideringthephysiologicalrolfuterinelipids, itsimportanttdentifyhepoolsfarachidonatew ich contributet ,a dwhosreleaiscontroll dbyheignals whichregulateuterinfunctio .Thephysi ogicalsignalsor parturitionrenotwelldefin d.Mosinvestigationh centredonhormo alinflue ces,a dthsteroi soxyto¬ cinhavebeeshowntinflu ceimi ga dpr gressof parturition(Thorburn,1979,Soloffetl ;Ellw d80 Poyser,1981).ThphysiologicalrolefprostaglandinsE2 andF2ainparturitionh sbeenwelles ablishedith respectasnyoth rpros aglandin-mediatedproc ss,buin¬ vestigationoftheroleh rloc lmediat rsi nlybegin¬ ning.Othecellularlev l,currentund rstandingofth triggeringeventsaparturitioreoorlydefin d,part fromcertainr latio sthormonea dpros glandins,lit¬ tleisknownabouthecellularstruct resandmol cular responseswhicharctivat dparturition.T ig als whichllbeconsideredi r lationtuter nelip dpoolsa outlinedinTibl12. Thedistributionofarachido icidnlipidsfnon¬ pregnantuterusishownnFi .2.T emajorp lf ARACHIDONICIDINUTERI ELIP S •:>VOr-■ Vv*v\WVv* \*yyV'" rysPHOSPHOLIPIDS CHOLESTEROLESTE S TRIACYL6LYCER0L FATTYACIDS DIACYLGLYCEROL HOHACYLGLYCEROL
254 FIG.2.ADistributionofA achidonicAcidntheL pidsftheN -Pr gnantGuinea-PigU rusAnimalsf dthenormalp lleteddi .L pidsw resepa ated
bysilicicacidchromatography,andthef ttacidcompositionfeachfr ct nwasanaly ed(Le v r&Po ser,1981).Thisdistributiond dn tcha geignifi¬ cantlyduringtheoestrouscycle.B.Distrib tionfArachidonicAcidntheP s¬ pholipidsft eNon-pregnantGuinea-Piguterus.Lipidsweresepartedbyth nlayerchromatographyandanalysedbgaschromatography(Leaver&P yser,1981).Thear aofphosphatidylcholine(PtdCho),en losedbydott dliindicatestheproportionfarachidonatewhichd re sedates rous.Thip portionfarachidonateincreasedint pho phatidylinositol(Pt lns),fr cti nates rous. arachidonateliesnt phospholipids,fw ichphos- phatidylethanolaminewasel rg stc mponent.Furth r separationofthephosphatidylinositol/phosphatidylserinefractionindicatedthatver70%fthearachidonateit isfractionwasesterifiedtphosphatidylinositol.Un erti ¬fluenceofestradiol,thp oportionfrachidoniccidester ¬fiedtophosphatidylinositolincreased,andhat phosphatidylcholinedecreased.Thincorp rationandr leaseofarachidoniccidbytheselippoolswamonitoredth nonpregnantut rusa darachidonate-specificchangei thepatternofes erificationinttheuterinephospholipids,underthinfluenceofstradiol,w sobserved(Lea rn
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Ning1981;ietal1983).Boththeuptakeandt erel ase
ofarachidoniccid(butn tofleicac d)withinuteri ephos¬ pholipidswereincreas dbyestradiol.Th rewastimulation ofendogenousarachidonateinc rporationintt phos¬ pholipids,particularlyPtdlntestrous(L aver&Poyser,1981;Fig.2B),orunderthinfluenceofexogenousestradiol17b(Groveetal,1987).Thincreasent ear chidoniccid contentfuterinephospholipidsw ichoccursdur ngla e gestation(Schwartzl,1975)maylsober sultfsimi¬ larestrogentimulatedacyl ion. Atparturition,thedepletiofthea achidoniccidc n¬ tentofthef talmembranephospholipidswithhig t proportionfarach donate,phosphatidylethanolamine(PtEt) andphosphatidylinositol(Pt s)sugge tst as mede re ofselectivityf rarachidona eispresentnt ph pholi- pasesactingonthfetalm mbrane(Okitat,1982;Okazakietl,1978;L averetl,1983).ThepHd pendance andthesubcellulardi tributionofhephospholipaseactivi¬
tyinhumanfet lmembranesduri glaboursuggesttha lipasesnvolvedinearlyl bourarenotpre ominantlylysosomalinorigin,assuggestedbyonfthearliestt ¬ oriesfc llactivationtparturition(Gu tavii,1972).Thefattyacidcompositionfdi cylglycerolreleasedduringpar¬ turitionresemblesthatff talmembraneP dlns(Okitat al,1982;Leaveretl,1983),andther lativedecr asei arachidonateinPtdl sa dPt Eti ica eh tphospholi¬ paseA2andpho pholipaseCb thr le seap roximately50%ofthefetalmembraneboundrachidonated ri gear¬
lylabour(Okitaetal,1982;azakietl1981).Thectivi¬ tyoftheselipa eswithrespectton3fat yacidsnd eicosapentaenoiccidh snotb nanalysed.ThephospholipaseA2andphospholipaseCactivityfhumanfet lmembranesisctivatedbyrelativelyh ghc l¬ ciumconcentrations(2-4mol/1Ca++c u esh lfmaximal activation)butdecidualphospholipaseCcalcium- independent(Okazakil,1978;DRe zotl,1981).The effectofincr asingtheintracellularalciumconcentrationinhumanandiGui eaPigendometriumssimilartth














258 FIG.3.UptakeandReleaseofUCAr chidonicAcidiHumanF t lMe bra es andDeciduaobtainedatElectiveCaesarianS ctiondI b tedwithOxy ¬ cin(1x10u/ml).Tissuewasimmediatelyri sedice-col0.9%saline,ndex- plantswereplac din4Csodiumar chidonate(0.5pCi/pl)iT isH 1buff r pH7.5,1.8mM/1MgCl,,CaCl,l.OmM,ATP7.5mMol/1t4° ."Uptake"in¬ cubationswereperformedinshakingwat rb tht37°Cf0-30i ."R lease" incubationswerecarriedoutft r30minuptake,f0-30min.Thctionwas terminatedwi h5%trichloroaceticaci .T ssuePtdInsP3waextra tedusing acidifiedchloroform,aniso at dusingp eparativetlx.(J llestl,1981).Arachi¬ donicacidincorporatedintoPtdInsP3waexpr s edpercentagefissue- boundradioactivity(30-40%oftissue-bound"Cwasesterfie ). rapidtu noverofinositolndphosphatei c mpoundc - chromatographingwithIns145P3(F .4)Thisrele sef Ins145P3wascalciumi dependent(r l asewasnotimu¬ latedby5-60minincubationw thhec lciumionophore A231875ug/mlandnextracellularc lci miocon entra¬ tionf1.8mmol/1).Thus,inhumanfet lembranes,weiden- FIG.4.IonExchangeChromatographicseparationfphosphoin sitidesd rive fromAmniochorion.Amniochorionexplantsfr mt esametienttel ctive
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Caesariansect owereincubatedfo60minL" containingb ff rw thei her 0.25mCiofPphosphater2 i3Hin sitol.Lip dswerdeacyl d,andt watersolubleproductsersepara dusingDow x1(f rm tef rm)column, andthefollowingelutants:A,5mMNa;B,4O7/0.18Mammoniumfor ate;,0. Mformicacid/0.3a moniumfor ate;C,0.1f r icacid/0.75ammonium formate(Crebatal,1983). tifiedhesynthesisofacompoundkn wtr l a ecalcium withinthecell.Tharac idoniccidest r fiedtoPtdl s2 representedonly1—3.5%fexog nousradiolabeledrachi¬ donicac dddedtohfetalmembranes,anapproximate¬






























tion,implantation,dlact tion(Poyser1981).Prostagl n¬ dinsynthesisatparturitioniffefromth r prostaglandin-mediatedprocessesinthqu n ityfarachi- donicac dprostaglandinireleased,whicht oh e ordersfmagnitudegrea erth ncha greporinovu¬ lation,lac atioandimplantation(MacDonaldetl,1974; BussmanandDeis,1979;Ogburntl80Le ver, 1987;Poyser,81).Afurtherdifferencebetw ntholf prostaglandinsatarturit on,comp redwithotherspects ofplacentation,isthdistancebetweenmajorit sf synthesis(thfetalmembranea duterid cidua)tar¬ gettissues(thmyometriumanduterinece vix;Wi k- landetal,1984;Ellwood,980).Theref re,parturition prostaglandinEandFppeart ctinmore'hormon l' capacityth ninotherprostaglandin-mediatedrocess s, diffusinglocallyintothemyom tr umandervix,o r¬ dinating,ndpossiblyinducin ,lab urbyextracellular, ratherth nintracellular,modeoftion. Thesusc ptibilityoflabourtpharmacologicalagen s whichaffectprostaglandinconc ntra ion,togetherith effectofthn3fattyacidsnpros aglandinsynthesis,indi¬ cateth tprostaglandinsynthesisilikelyi factio then3fattyacidsndofiishiltpar¬ turition.Thereisevide cefocomp tetivein bitionft actionofthen6fa tydsreirm tabolitesby3
262 acidsinthispro ess.Tproportionsofdiet ryn3fattyacid




Levelof OrganisationMolecularActivit esReference HormonalSte oids,Oxytocin MediatorProstaglandins, PAF,IL1TNF IntracellularLysosomes,Lip se, activation Ca+-fmobilisation Receptorexpression Enzymemodification Membraneodification
Fuchs(1978);Grove(1987 Lewis(1973);Leaver( 984,1987); Billah(1983);Silver(1986) Gustavii(1972);Okazaki(1978, 1981)Leaver( 6) Leaver(1982,1986);Grove( 7 Soloff(1979) Burn(1988);Nishizuka(1988) Okita(1982),Leaver(1985and Thbles6-9)
Theeffectofadminist redar chidonicacinindu gp r¬ turition,andthereleaseofarachido ateinhundredfold higherproportiont anreleasedeicos noids(MacD nal , 1974),indicatesth tara hidonicac ,npossiblyot eres¬ sentialfat yacids,madire lstimulatepar urition.Acel¬ lulartargetforarachidonicneicosape taenoica idh recentlybe nproposed(Nishizuka,1987).How v r,thereis currentlylittleevidencethatn3fa tyaci sdiffer ntl ton6fattyacidsi ctiva ingpro e nkin sC. Abettercharact risedactiv orofproteinkinasCisd ¬ acylglycerol.Thea tivityofthediacylglyc rolwhi hismobi¬ lisedintheplasmamembranei re ontocertainstimuli hasbeenshowntoinv lvepr t ink aseCarespondi g cellularsystem,whichinturncontrolscertainco tractilepr ¬ teinsa dnzymeactivities(Pr issl,1987,Bela ,1986). Amajorspeciesofdiacylglyc rolreleasedtparturitionis the2-arachidonyldiacylglycer l.However,thshortec in diacylglycerolsarmoreactivinstimulatingproteinkin s Cinothertissues.Atparturition,thericompetitionbe¬ tweenooth renzymesfordiacylglycerol,diacylglycerol kinaseanddiacylglycerollipas ,bothfwhichshow




onProstaglandinFSyn hesisbyendometrialxp tfrA.Gui aigand B.Human,incubatedMedium199&0%Foet lCalfS ru37°Cf r6h. PGF2outputwasexpressedapercentagefF;>sythesi edinthabs c ofion phorerarachid nate. Interleukin1andTNFction(Suffystl,987),is interestingthicontext,aafishoildii ib sleuco¬ cyteeicosanoidrele seandthseverityofinflammations¬ sociatedwiththesmedi tors(Leslial,1985).Taspect ofTNFandInterleukin1ctiomaybimp r antthe treatmentofinf ctiodur gpregnancywithan ibi tics,b ¬ causeantibioticspreventbact rialrolifer tion,ud o remove,andmayctuallyinc asethereleaofendotoxin frombacterialllwal s(Sh nep&M gan,1984).Th eis evidencethateicosanoidsareme iatorofndot xicity C20:4METABOLISM Vx PAF<™^Pl"8« OHfattycids
Ca+
FIG.7.ThemetabolismofArachid nicidduri grlyP rtur tion,indicati g quantitativelymajorpathw ysdthesi eofac nex racellularsign l .2000b % Stimulation A23167
266 (Flynn,1985;Parratt,)a dcompetitiveinhibitionf theiroxiceffects(Conteal,1986)mayb ndvan age, particularlydu ingpregnancwhensusc ptibilitytoen¬ dotoxinisincreased(L tal,1988). HealthImplicationsofF sO lDieturi g Pregnancy Intheabovediscussion,wh vefocuss dont rap ity andextentofthincorporationn3f tyaci st fishoildiet,andthespecificitymetabolieff ctscaused bythen3fattyacids,withparticularreferenceopa tu i¬ tion.Theseaspectsff hiling st onh vimporta ti ¬ plicationsinthemanagementofpre nancy,bec useo trary toheobviousconclusionatfishilsho dba deddur¬ ingpregnancy,thefollowi gfi din ssu ge tt ath ¬ bitionofparturitionisreadilyr ve sibleeffect:Fi s ly, rapidtu noverofheuter nelipidswhichrel aseess tial fattyacidsparturitionwaobse ved.Secondly,therw rapidinco porationfex gen usss tialfat yciin theseuterinelipidsatparturition. Highdietaryconcentrationsff s ilactl keer3fat¬ tyacidpreparationswhichh veprev uslybe nportedt inhibitparturition.However,t esevidenceat sblock canbereversedyonlytwodaysfn6f ttacife ding(L at &Northrop,1980).Althought eexperimentsnfishil dietandn3f t yci swhicheh vdescr bedbeen performedinrats,thesvidenceatfi hildimay influencehumanparturition.Womenfr mthFa oIsl ds consumingadietwithh gmarinelcontentvbee reportedthavprolongedgestation,ac nseque tly,b ¬ bieswithhigherrteight(Ols ntal,1986).T empair¬ mentofparturitionwhichasobservedinthF roIsla womenithahigdietaryn3f tcidintakew sl sse¬ verethaneeff ctoffishile dingwithessentialfat y aciddepletedi tinourraexperiments,wh chindicaten extremes atofdi taryn3load.Ouexperim ntsindicate thateeff c sofn3fat yacidp rturitionresembleth r effectsinplateletaggregation(S ndersl1982;r
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andRoshani,1983)aniinflammation(Leslietal1985)
incompetetivelyi hibi ingt eff c sfn6fat yacid . Thissuggestst am jorfactdeterminingtheeff ctof then3fattyacidisb lanceofn /n6f tyacidsith diet.Itisthereforessentialocharacteriset ssentialfa y acidsintheotaldiet,additiontohempositionft 'essentialfat yac dsupplement!Iilik lytharewith whichQuackenbrushtalpreparedth irdi t(tot li t saponificationdlipextraction,trem veessentialf ¬ tyacidsfromheb saldiet)allowedt unequivocaldem n¬ strationofann3f tycideffectoparturition.I r experiments,thelown6fattyacidcon ntfcoco utili thebasaldi t(Thble2)ch ngedt n3/n6r iofrom 24.4(FO,)and7.44( 02)itheadministeredfishoilt6.28 and3.68,respectively,ithotaldi t(Tabl6).hl kof detailedn3/n6fattycianaylsisofhdi ti eF roeIs¬ landstudy(Olsenetal,1986)ope sthossibilityt at dietarycomponentsunrelatedth3fatacidsayaf¬ fecttheonsetflabour(Ackman,1988).Iithereforeim¬ portantthatfurtherc n rolledepidemio ogicals udiesb carriedout,ind rtestablishpot ntialsksfn3f tty acidoverloaddur ngtheirtrimesterofp eg ancy. Prematurelabo rof enoccursbe of alndute ine maturation,andisassociatedwi hnincre seperi atal mortality.Ana uralp oduct,ithefo mfishilayb amoreacceptableagentfodelayingl bourth tpha maco¬ logicalintervention,particularlyfben fici lfectoff sh oilnfetald velopmentccurs(Cl rkeel,1988,ds Fujimotoealinthisvolume). CONCLUSION Inconclusion,wehavpresentedwvidencethatdi tary n3fattyacidsndfishoilinh bitt ei itiationofpar uri¬ tionbycompetingwiththn6fa tyacids.Islik lythat thisin ib tionlieatthelev lofpro taglandinproduction, althoughotheressentialf t yac dco t iningc mpou ds mayalsobeinvolvedniniti tingl bour.Theincorp ration ofdietaryC20polyunsatu atedfattacidsndtheretention
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ofthesefattyacidsbyeuteruwasmorpr nouncedth
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16 TheEffectofDi taryDocosahexaenoateot e LearningAbilityofRats KenshiroFujimoto,1K zoYao,1TferuoMiyazawa,1 HarukoHirono,2MasazumiNishik wa,3ShojiKimura,3K zuteruMaruyamaandMichioNonaka3 INTRODUCTION Docosahexaenoicacid(DHAor22:6,n-3)isonefthmajor n-3long-chainpolyunsaturatedfa ycidsifi hoils,nditscontentft nreachesmorethan35%.Iisw llk ownthatt etissuesofthn rvoussystemi volvedinsophi ti¬ catedactions,e.g.thebr in,1t esy apticjunctio 2andthe photoreceptorsinthretina,3 exceptionallyichinDHA.AlthougheiversfsometypesfanimalsshowhighcontentfDHA,t valuefluctuat swidelymongspe¬ cies.Incontrast,theDHAcontentfb hthb aindre¬ tinaisconsistentlyhighi llanimals.Generallyt edistributionofpolyunsaturatedfa yacityp si lantnd DepartmentofF odChe istry,FacultyfAgr cu ture,'IbhokuUnive sity,Sendai,Miyagi981,Japan.
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